Canada Gazette, Part I, Volume 151, Number 2: GOVERNMENT NOTICES
January 14, 2017
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Notice of intent concerning Significant New Activity Notice No. 13712a (variation to Significant New Activity Notice No. 13712)
Notice of intent: Significant New Activity Notice
(Section 85 of the Canadian Environmental Protection Act, 1999)
Whereas the Minister of the Environment and the Minister of Health (the ministers) have assessed information in respect of the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and poly-methylene polyphenylene isocyanate, Chemical Abstracts Service Registry No. 68920-56-9, under section 83 of the Canadian Environmental Protection Act, 1999;
Whereas the Minister of the Environment published on June 18, 2005, Significant New Activity Notice No. 13712 in Part I of the Canada Gazette, Vol. 139, No. 25;
Whereas the substance is not specified on the Domestic Substances List;
And whereas the ministers suspect that a significant new activity in relation to the substance may result in the substance becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999,
Therefore, the Minister of the Environment hereby proposes to vary Significant New Activity Notice No. 13712, pursuant to subsection 85(2) of the Canadian Environmental Protection Act, 1999, in accordance with the following Annex.
George Enei
Assistant Deputy Minister Science and Technology Branch
On behalf of the Minister of the Environment
ANNEX
1. The Annex to Significant New Activity Notice No. 13712 is proposed to be replaced by the following:
ANNEX
Information Requirements
(Section 85 of the Canadian Environmental Protection Act, 1999)
- 1. In relation to the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate, Chemical Abstracts Service Registry No. 68920-56-9, a significant new activity is
- (a) the use of the substance in the manufacture of a consumer product to which the Canada Consumer Product Safety Act applies; or
- (b) any activity involving a consumer product to which the Canada Consumer Product Safety Act applies that contains the substance, if the product involved in the activity, during any one calendar year, contains a total quantity of the substance greater than 10 kg.
- 2. Despite item 1, the use of the substance as a research and development substance or as a site-limited intermediate substance as these expressions are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers), or as an export-only substance, is not a significant new activity.
- 3. For each proposed significant new activity, the following information must be provided to the Minister at least 90 days before the commencement of the proposed new activity:
- (a) a description of the proposed significant new activity in relation to the substance;
- (b) the anticipated annual quantity of the substance to be used in relation to the significant new activity;
- (c) the information specified in items 3 to 7 of Schedule 4 of the New Substances Notification Regulations (Chemicals and Polymers); and
- (d) the test data and test reports from a Local Lymph Node Assay toxicity study that is conducted according to the methodology described in OECD Test Guideline 429, entitled Skin Sensitization: Local Lymph Node Assay.
- (e) a description of the consumer product that contains the substance, the intended use of that consumer product and the function of the substance in that consumer product;
- (f) a description of how the consumer product is intended to be used or applied;
- (g) the total quantity of the consumer product expected to be sold in Canada in a calendar year by the person undertaking the significant new activity;
- (h) a summary of all other information or test data in respect of the substance that are in the possession of the person proposing the significant new activity, or to which they have access, and that are relevant to identifying hazards of the substance to the environment and human health and the degree of environmental and public exposure to the substance;
- (i) the identification of every other government agency, either outside or within Canada, that the person proposing the significant new activity has notified of the substance and, if known, the agency's file number, the outcome of the assessment and the risk management actions in relation to the substance imposed by the agency;
- (j) the name, civic and postal addresses and telephone number and, if any, the fax number and email address of the person proposing the significant new activity and, if they are not resident in Canada, of the person resident in Canada that is authorized to act on behalf of that person; and
- (k) a certification that the information is accurate and complete, dated and signed by the person proposing the significant new activity if they are resident in Canada or, if not, by the person resident in Canada that is authorized to act on their behalf.
- 4. The above information will be assessed within 90 days after the day on which it is received by the Minister.
EXPLANATORY NOTE
(This explanatory note is not part of the notice of intent.)
Description
The notice of intent (NOI) is an opportunity for the public to comment on proposed variations to the Significant New Activity (SNAc) Notice issued by the Minister of the Environment to apply the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (Chemical Abstracts Service [CAS] Registry No. 68920-56-9), pursuant to section 85 of CEPA.
In January 2015, a public commitment was made by Environment Canada and Health Canada to review all orders and notices that were adopted between 2001 and 2014 (see footnote 1) to impose SNAc requirements. The purpose of the review is to ensure that SNAc orders and notices are consistent with current information, policies and approaches. (see footnote 2) Resulting changes to SNAc orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. This NOI reflects the results of the review of the SNAc Notice on the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate identified by stakeholders as a priority.
Within 60 days of publication of the NOI, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the final notice to vary the SNAc requirements in relation to this substance.
A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related orders and notices that pertain to consumer products.
Current SNAc requirements (see footnote 3) remain in effect until such time as the variations proposed in this NOI are published as a final notice.
Applicability of the proposed SNAc Notice
At this time it is proposed that the notice would require any person (individual or corporation) engaging in a significant new activity in relation to Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate (CAS Registry No. 68920-56-9), to submit a Significant New Activity Notification (SNAN) containing all of the information prescribed in the notice at least 90 days prior to any use of the substance for the significant new activity.
In order to address human health concerns, the notice would target the use of the substance in consumer products to which the Canada Consumer Product Safety Act (CCPSA) (see footnote 4) applies. Notification would be required for any manufacture of such products with the substance. For any other consumer product–related activity, notification would also be required if the total quantity of the substance used that is contained in the product is greater than 10 kg, for any given calendar year. The substance is not known to be currently used in consumer products in Canada.
Activities not subject to the SNAc Notice
Industrial or commercial activities not related to consumer products are proposed to be excluded from the variation to the notice.
Any activity involving a consumer product that contains the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate, other than the manufacture of such a product, would not be subject to the SNAc Notice if the product contains a total quantity of the substance of 10 kg or less in a calendar year.
Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the SNAc Notice, as the potential exposure concerns related to health are from the use of consumer products. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote 5) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.
The proposed SNAc Notice would not apply to products to which the CCPSA does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions) or to uses of the substance that are regulated under the acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The SNAc Notice would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to the substance when it is in items such as, but not limited to, wastes or manufactured items.
Furthermore, it should be noted that individual components of a mixture may be subject to notification under the SNAc Notice. See subsection 81(6) and section 3 of CEPA and section 3.2 of the Guidelines for the Notification and Testing of New Substances (Chemicals and Polymers) for additional information. (see footnote 6)
Information to be submitted
The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90 days before the day on which the substance Clarified oils (petroleum), catalytic cracked, reaction products with cresol and polymethylene polyphenylene isocyanate is used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct a human health and environmental assessment within 90 days after the complete information is received.
The information requirements in the proposed SNAc Notice relate to general information in respect of the substance, details surrounding its use, and exposure information.
As an outcome of the assessment of the substance, potential concerns related to irritation, skin sensitization, and carcinogenicity to humans from potential new activities were identified. The test prescribed under section 3 of the SNAc Notice will allow the characterization of the aforementioned toxicity endpoints, and will address the areas of potential concern.
Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.
Compliance
When assessing whether or not a substance is subject to the SNAc provisions, (see footnote 7) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier's offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant Safety Data Sheet (SDS). (see footnote 8)
Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all substances that may be subject to a notice due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.
If any information becomes available that reasonably supports the conclusion that this substance is toxic or capable of becoming toxic, the person who is in possession or has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.
A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if their activities were covered by the original SNAN. The Substances Management Advisory Note Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999 provides more detail on this subject. (see footnote 9)
Under section 86 of CEPA, any person who transfers the physical possession or control of a substance subject to a notice shall notify all persons to whom the physical possession or control is transferred of the obligation to comply with the notice, including the obligation to notify the Minister of any significant new activity and to provide all the required information outlined above.
A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.
Where a person has questions concerning their obligations to comply with a notice, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote 10)
CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote 11) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.
ANNEX A: “Consumer product” definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 12)
In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:
Consumer products
4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.
Tobacco products
(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.
Natural health products
(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.
CCPSA, Schedule 1 (Subsection 4(1) and paragraph 37(1)(c))
- 1. Explosives within the meaning of section 2 of the Explosives Act.
- 2. Cosmetics within the meaning of section 2 of the Food and Drugs Act.
- 3. Devices within the meaning of section 2 of the Food and Drugs Act.
- 4. Drugs within the meaning of section 2 of the Food and Drugs Act.
- 5. Food within the meaning of section 2 of the Food and Drugs Act.
- 6. Pest control products within the meaning of subsection 2(1) of the Pest Control Products Act.
- 7. Vehicles within the meaning of section 2 of the Motor Vehicle Safety Act and a part of a vehicle that is integral to it — as it is assembled or altered before its sale to the first retail purchaser — including a part of a vehicle that replaces or alters such a part.
- 8. Feeds within the meaning of section 2 of the Feeds Act.
- 9. Fertilizers within the meaning of section 2 of the Fertilizers Act.
- 10. Vessels within the meaning of section 2 of the Canada Shipping Act, 2001.
- 11. Firearms within the meaning of section 2 of the Criminal Code.
- 12. Ammunition within the meaning of subsection 84(1) of the Criminal Code.
- 13. Cartridge magazines within the meaning of subsection 84(1) of the Criminal Code.
- 14. Cross-bows within the meaning of subsection 84(1) of the Criminal Code.
- 15. Prohibited devices within the meaning of paragraphs (a) to (d) of the definition “prohibited device” in subsection 84(1) of the Criminal Code.
- 16. Plants within the meaning of section 3 of the Plant Protection Act, except for Jequirity beans (abrus precatorius).
- 17. Seeds within the meaning of section 2 of the Seeds Act, except for Jequirity beans (abrus precatorius).
- 18. Controlled substances within the meaning of subsection 2(1) of the Controlled Drugs and Substances Act.
- 19. Aeronautical products within the meaning of subsection 3(1) of the Aeronautics Act.
- 20. Animals within the meaning of subsection 2(1) of the Health of Animals Act.
[2-1-o]
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Notice of intent to amend the Domestic Substances List under subsection 87(3) of the Canadian Environmental Protection Act, 1999
Whereas the 26 substances set out in this Notice are specified on the Domestic Substances List; (see footnote a)
Whereas the Minister of the Environment previously published Orders in the Canada Gazette, Part II, pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, (see footnote b) amending the Domestic Substances List to indicate that subsection 81(3) of that Act applies to those substances; (see footnote c), (see footnote d), (see footnote e), (see footnote f), (see footnote g), (see footnote h), (see footnote i), (see footnote j), (see footnote k), (see footnote l), (see footnote m), (see footnote n), (see footnote o), (see footnote p)
Whereas the Minister of the Environment and the Minister of Health (the ministers) are satisfied that the 26 substances are only being manufactured in or imported into Canada by any person for a limited number of uses;
And whereas the ministers suspect that the information concerning a significant new activity in relation to 24 of those substances may contribute to determining the circumstances in which these substances are toxic or capable of becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999;
Therefore, notice is hereby given that the Minister of the Environment intends to amend the Domestic Substances List pursuant to subsection 87(3) of the Canadian Environmental Protection Act, 1999, by varying or rescinding the significant new activities in relation to those substances set out in this Notice.
Public comment period
Any person may, within 60 days of publication of this Notice, file with the Minister of the Environment comments with respect to this proposal. All comments must cite the Canada Gazette, Part I, and the date of publication of this Notice and be sent by mail to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819-938-5212, or by email to eccc.substances.eccc@canada.ca.
The final screening assessments for these substances may be obtained from the Government of Canada's Chemical Substances website (www.chemicalsubstanceschimiques.gc.ca).
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this Notice may submit with the information a request that it be treated as confidential.
George Enei
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment
Mike Beale
Assistant Deputy Minister
Environmental Protection Branch
On behalf of the Minister of the Environment
ANNEX
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
64-67-5 S′ 75-56-9 S′ 77-78-1 S′ 100-44-7 S′ 106-88-7 S′ 106-89-8 S′ 123-31-9 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
62-56-6 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
79-46-9 S′ 115-96-8 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
90-94-8 S' |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
93-15-2 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
111-15-9 S' |
|
7. The note to Group B in Part 2 of the Domestic Substances List is proposed to be amended by deleting the following:
122-60-1 S′
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
122-60-1 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
1314-62-1 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
2425-85-6 S' |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
2426-08-6 S′ 7328-97-4 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
3445-11-2 N-S |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
6786-83-0 S' |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
7758-01-2 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
10448-09-6 S' |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
17540-75-9 S′ |
|
| Column 1 Substance |
Column 2 Significant new activity for which substance is subject to subsection 81(3) of the Act |
|---|---|
72102-55-7 S′ |
|
18. Part 1 of the Domestic Substances List is proposed to be amended by adding the following in numerical order:
- 68551-44-0
- 69430-47-3
19. Part 2 of the Domestic Substances List is proposed to be amended by deleting the following in numerical order:
- 68551-44-0 S′
- 69430-47-3 S′
Coming into Force
20. This Order would come into force on the day on which it is registered.
EXPLANATORY NOTE
(This explanatory note is not part of the Notice of Intent.)
Description
The Notice of Intent (NOI) is an opportunity for the public to comment on proposed amendments to the Domestic Substances List (DSL), to vary the significant new activity (SNAc) requirements of the Canadian Environmental Protection Act, 1999 (CEPA), for 24 substances and to rescind the SNAc requirements for 2 substances, pursuant to subsection 87(3).
In January 2015, Environment Canada and Health Canada published a document outlining an initiative to review all Orders and notices that were adopted between 2001 and 2014 to impose SNAc requirements. (see footnote q) The purpose of the review is to ensure that SNAc Orders and notices are consistent with current information, policies and approaches. (see footnote r) Resulting changes to SNAc Orders and notices are expected to provide greater clarity of scope and improved ease of compliance by industry, while protecting Canadians and their environment. Key elements of the review include the following:
- a review of completed risk assessments for substances subject to the SNAc provisions of CEPA, including assessments of Significant New Activity Notifications (SNANs) received on epichlorohydrin (CAS RN 106-89-8), benzyl chloride (CAS RN 100-44-7), and hydroquinone (CAS RN 123-31-9), (see footnote s) and other available information to confirm that the rationale for applying the SNAc is consistent with current policies;
- confirmation that the information requested in the SNAc Order or notice is consistent with the current SNAc policy and approach; and
- an analysis of wording to ensure clarity and consistency with the current approach to the drafting of SNAc definitions.
This NOI reflects the results of the review of SNAc requirements identified by stakeholders as priorities, as well as SNAc requirements targeting the use of existing substances in consumer products (Consumer Product SNAc Review Group (see footnote 13).
Within 60 days of publication of the Notice of Intent, any person may submit comments to the Minister of the Environment. These comments will be taken into consideration during the development of the Order amending the DSL to vary the SNAc requirements for 24 substances and to rescind the SNAc requirements for 2 substances.
A number of other SNAc instruments are to be published in the near future that will also target consumer products. As a result, stakeholder input provided in response to the consumer product language proposed in this NOI may not be reflected in upcoming NOIs due to publication timelines. However, any input received will be taken into consideration during the development of all related Orders and notices that pertain to consumer products.
The DSL amendments are not in force until the Order is adopted by the Minister pursuant to subsection 87(3) of CEPA. The Order must be published in the Canada Gazette, Part II. Any current SNAc requirements remain in effect until such time as an Order is published.
Applicability of the proposed Order
At this time, it is proposed that the Order amending the DSL would require any person (individual or corporation) engaging in a significant new activity in relation to the substances listed in the tables below, to submit a SNAN containing all of the information prescribed in the Order at least 90 or 180 days, as specified in the Order, prior to the import, manufacture or use of the substance for the significant new activity. Potential activities with respect to the substances requiring a SNAN submission would include, but would not be limited to, the activities summarized in Tables 1–5. Tables 1–5 also summarize whether activities involving the use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance (i.e. special categories) would require the submission of a SNAN. The terms “research and development substance” and “site-limited intermediate substance” are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). (see footnote t) An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets.
Activities not subject to the proposed Order
Tables 1–5 provide a summary of substance-specific activities that would not be subject to the Order amending the DSL. Tables 1–5 also summarize whether special categories (i.e. use of the substance as a research and development substance, or as a site-limited intermediate or export-only substance) would be excluded from the proposed Order.
For activities in relation to consumer products the proposed Order would not apply to products to which the Canada Consumer Product Safety Act (CCPSA) does not apply (see Annex A for the CCPSA definition of “consumer product” and exemptions), with the exception of cosmetics (in some cases) within the meaning of section 2 of the Food and Drugs Act. The Order would not apply to uses of the substances that are regulated under any of the following Acts of Parliament listed in Schedule 2 of CEPA, including the Pest Control Products Act, the Fertilizers Act and the Feeds Act. The Order would also not apply to transient reaction intermediates, impurities, contaminants or partially unreacted intermediates, or in some circumstances to items such as, but not limited to, wastes, mixtures or manufactured items. However, it should be noted that individual components of a mixture may be notifiable under the Order. See subsection 81(6) and section 3 of CEPA, and section 3 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers for additional information on the activities and conditions described above. (see footnote 14)
| Chemical substance (CAS RN) |
Activities targeted by the current Orders |
Activities targeted by the proposed Order |
Activities excluded from the proposed Order |
|---|---|---|---|
Methyl eugenol (93-15-2) Diethyl sulfate (64-67-5) Dimethyl sulfate (77-78-1) |
The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in its isolated (synthesized or extracted) form, in consumer products. The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product. |
Given the concerns for human health, the Orders are proposed to be varied to clarify the consumer products to which the Orders apply. The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the Canada Consumer Product Safety Act (CCPSA). (see footnote u) In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with the safety data sheet (SDS) disclosure concentration threshold. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. In the case of methyl eugenol, the proposed concentration threshold is ≥0.0002% to align with the limit set by the Pest Management Regulatory Agency for methyl eugenol in pest control products applied to the skin and with Health Canada's Cosmetic Ingredient Hotlist entry that describes a limit of 0.0002% for methyl eugenol in other leave-on and oral hygiene products. For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold would enable all other activities to be subject to notification and thus would be protective of human health. |
Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. See section 2 and Schedule 1 of the Act for the definition of "consumer product" and exemptions. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. The terms "research and development substance" and "site-limited intermediate substance" are defined in subsection 1(1) of the New Substances Notification Regulations (Chemicals and Polymers). An export-only substance is a substance that is manufactured or imported in Canada and destined solely for foreign markets. |
| Potassium bromate (7758-01-2) | The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in a consumer product, as well as any industrial or commercial activity involving, in any one calendar year, more than 1 000 kg of the substance, with a few exclusions. |
It is proposed that the Order for this substance be applicable in the same fashion as for the above substances. In addition, the Order would maintain the requirement for notification of use of the substance in any other activities not involving consumer products above 1 000 kg with some exceptions. |
Any industrial or commercial activity relating to cleaning products, paints and coatings, and as an oxidizer in flour milling would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order, as the potential exposure concerns related to health are from use of consumer products. |
n-BGE (2426-08-6) TGOPE (7328-97-4) |
The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance in the manufacture of consumer products. The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, in its uncured or undried form, in consumer products, other than an activity involving its use in an epoxy-based paint, epoxy-based coating or epoxy-based adhesive. |
Given the concerns for human health, the SNAc Orders are proposed to be varied to clarify the consumer products to which the SNAc Orders apply, which includes cosmetics. The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA, while the application of the term "cosmetic" in SNAc definitions is consistent with the meaning of section 2 of the Food and Drugs Act. In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. For most substances, these concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. There would also be an additional notification threshold (250 mL) for the size of the consumer product containing these substances. For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus would be protective of human health. |
Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from the use of consumer products or cosmetics. |
| Chemical substance (CAS RN) |
Activities targeted by the current Orders |
Activities targeted by the proposed Order |
Activities excluded from the proposed Order |
|---|---|---|---|
Methyloxirane (75-56-9) Epichlorohydrin (106-89-8) Benzyl chloride (100-44-7) Hydroquinone (123-31-9) Ethyloxirane (106-88-7) Thiourea (62-56-6) 2-EEA (111-15-9) Pigment Red 3 (2425-85-6) |
The current Order applies to activities involving, in any one calendar year, more than 1 000 kg of the substance as a component in polyurethane foam, as well as other activities involving, in any one calendar year, more than 100 kg of the substance. Use as a stabilizer in benzyl chloride is excluded. The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance. The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance with some exclusions. |
Given the concerns for human health, the Orders are proposed to be varied to be more targeted and to only require notification for activities related to consumer products. The application of the term "consumer product" in SNAc definitions is proposed to be consistent with the CCPSA. In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. For all other activities relating to consumer products containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health. |
Industrial and commercial activities not related to consumer products would be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. For thiourea, the use of the substance in a silver polish or metal cleaner that contains the substance at a concentration equal to or less than 7% with proper labelling (i.e. instructions to wear gloves when using the product) would also be excluded. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a paint containing the substance would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. |
| Michler's ketone (90-94-8) | Industrial and commercial activities not related to consumer products would be excluded. In addition, any activity relating to a dye or pigment containing the substance at a concentration of less than 5%, or to an ink containing the substance at a concentration of less than 3%, would also be excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. |
||
TCEP (115-96-8) 2-Nitropropane (79-46-9) MAPBAP acetate (72102-55-7) Phenoxymethyl oxirane (122-60-1) |
The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance. The current Order applies to activities involving, in any one calendar year, more than 100 kg of the substance, with some exclusions. The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance with exceptions for use in drugs. |
Given the concerns for human health, the SNAc Orders are proposed to be varied to be more targeted and to require notification for activities related to consumer products and cosmetics. In order to minimize the availability of products to consumers at concentrations of concern, the notification threshold for the manufacturing of consumer products or cosmetics containing these substances is proposed to be aligned with SDS disclosure concentration thresholds. These concentration thresholds are set at either ≥0.1% or ≥1.0%, depending on the hazard class. For all other activities relating to consumer products or cosmetics containing the substance at or above the concentration specified in the Order, it is proposed that the quantity threshold be lowered from 100 kg to 10 kg. While the concentration threshold will capture activities of concern, the 10 kg quantity threshold will help ensure that small quantity users are not subject to notification requirements. Users of consumer products or cosmetics are unlikely to exceed the 10 kg quantity threshold; however, this threshold will enable all other activities to be subject to notification and thus protective of human health. In addition, the Order for phenoxymethyl oxirane would also maintain the requirement for notification of use of the substance in any other activities not involving consumer products or cosmetics above the notification threshold of 100 kg. |
Industrial and commercial activities not related to consumer products or cosmetics are excluded. Consumer products to which the CCPSA does not apply would be excluded from the requirements of the Order, with the exception of cosmetics within the meaning of section 2 of the Food and Drugs Act. The use of the substance MAPBAP acetate in wood products or pulp and paper products would also be excluded. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance would be excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products or cosmetics. |
| Chemical substance (CAS RN) |
Activities targeted by the current Orders |
Activities targeted by the proposed Order |
Activities excluded from the proposed Order |
|---|---|---|---|
Solvent Blue 4 (6786-83-0) Phenyl-D4 (10448-09-6) |
The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance. The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance. |
The quantity threshold for these SNAcs is proposed to be increased from 100 kg/year to 1 000 kg/year, which would still be considered protective of the environment. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN. |
There are no additional exclusions. |
| Chemical substance (CAS RN) |
Activities targeted by the current Orders |
Activities targeted by the proposed Order |
Activities excluded from proposed Order |
|---|---|---|---|
| DTBSBP (17540-75-9) | The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than an activity involving its use as an antioxidant or corrosion inhibitor in brake fluid at a concentration of less than or equal to 1% by weight. |
Given the potential risks to the environment of this substance, it is proposed to clarify the SNAc definition and remove any functional descriptor while maintaining the applicability of any activity involving the substance. Significant new activities could include, but are not limited to, its use in polyurethane foam, or in PVC resin. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export-only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns associated with the substance, the above-mentioned activities would require the submission of a SNAN. |
Any activity related to brake fluid containing the substance at a concentration of less than or equal to 1% is excluded. |
| 2-Pyrrolidinone, 1-(2-hydroxyethyl)(3445-11-2) | The current Order applies to any activity involving the substance as a component in personal care products. |
Given the potential human health risks of this substance and potential use in cosmetics and personal care products, it is proposed to replace reference to "personal care products" with any activity relating to "cosmetics, drugs or natural health products." Significant new activities could include, but are not limited to, cosmetics and personal care products that are applied dermally. |
Industrial and commercial activities and activities related to the use of the substance in consumer products other than in cosmetics, drugs or natural health products are excluded. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance and an export-only substance are excluded from the proposed Order as the potential exposure concerns related to health are from use of consumer products. |
| Vanadium pentoxide (1314-62-1) | The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance, other than its use in a ferrovanadium alloy, as a catalyst for an industrial process, as an oxidizing agent, as a corrosion inhibitor, in a chemical fertilizer, or in a bismuth vanadate pigment. |
Given that the SNAc requirements are still considered relevant for this substance, it is proposed to maintain the same definition of significant new activities, which could include, but are not limited to, its use in production of other metals or as a medicinal ingredient. Activities involving the use of the substance as a research and development substance, a site-limited intermediate substance or an export–only substance could result in the release of the substance to the Canadian environment. Given the ecological concerns (in addition to human health concerns) associated with the substance, the above-mentioned activities would require the submission of a SNAN. |
Any activity related to use in an alloy, fertilizer, pigment, or as an oxidizing agent or corrosion inhibitor is excluded. |
| Chemical substance (CAS RN) |
Activities targeted by the current Orders |
Activities targeted by the proposed Order |
Activities excluded from proposed Order |
|---|---|---|---|
MDnM-hydride (69430-47-3) |
The current Order applies to any activity involving, in any one calendar year, more than 100 kg of the substance. |
The review concluded that no environmental risk would be identified related to notification of new uses of these two substances. Therefore, the SNAc Orders are proposed to be rescinded. |
There are no additional exclusions. |
FAZ (68551-44-0) |
Information to be submitted
The NOI sets out the proposed requirements for information that would need to be provided to the Minister 90–180 days, as specified in the Order, before the day on which the substances are imported, manufactured or used for a significant new activity. The Department of the Environment and the Department of Health will use the information submitted in the SNAN to conduct human health and environmental assessments within 90–180 days after the complete information is received.
The information requirements in the proposed Order relate to general information in respect of the substance, details surrounding its use, and to exposure information.
As an outcome of the review process, specific information requirements for a toxicity study with a dermal mode of action and sediment toxicity studies are being proposed for the substances bearing the following CAS RNs: 3445-11-2, 6786-83-0, and 17540-75-9. The data from these tests will help to assess human use scenarios that could lead to high exposures and risk to human health (for 3445-11-2) or clarify if the substance would partition to sediments if released to water (for 6786-83-0 and 17540-75-9).
Similarly, the information requirements for acute and chronic toxicity, reproductive and developmental toxicity, mutagenicity, and sediment toxicity studies, are being maintained for the substances bearing CAS RNs 10448-09-6, and 72102-55-7, since the review confirmed that there was concern for future uses to the environment and human health given the hazardous nature of and potential for exposure to these substances.
Additional guidance on preparing a SNAN can be found in section 4 of the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.
Compliance
When assessing whether or not a substance is subject to the SNAc provisions, (see footnote v) a person is expected to make use of information in their possession or to which they ought to have access. The phrase “to which they ought to have access” means information in any of the notifier's offices worldwide or other locations where the notifier can reasonably have access to the information. For example, manufacturers are expected to have access to their formulations, while importers or users of a substance, mixture, or product are expected to have access to import records, usage information, and the relevant SDS. (see footnote w)
Although an SDS is an important source of information on the composition of a purchased product, it should be noted that the goal of the SDS is to protect the health of workers in the workplace from specific hazards of chemical products. Therefore, an SDS may not list all product ingredients that may be subject to an order due to human health or environmental concerns. Any person requiring more detailed information on product composition is encouraged to contact their supplier.
If any information becomes available that reasonably supports the conclusion that a substance is toxic or capable of becoming toxic, the person who is in possession or who has knowledge of the information and is involved in certain activities with the substance is obligated, under section 70 of CEPA, to provide that information to the Minister without delay.
A company can submit a SNAN on behalf of its clients. For example, in cases where a person takes possession and control of a substance from another person, they may not be required to submit a SNAN, under certain conditions, if the activities were covered by the original SNAN. The Substances Management Advisory Note “Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” provides more detail on this subject. (see footnote x)
Any person who transfers the physical possession or control of a substance subject to an order should notify all persons to whom the physical possession or control is transferred of the obligation to comply with the order, including the obligation to notify the Minister of any significant new activity and to provide all of the required information outlined above.
A pre-notification consultation (PNC) is recommended for notifiers who wish to consult during the planning or preparation of their SNAN to discuss any questions or concerns they have about the prescribed information and test plans.
Where a person has questions concerning their obligations to comply with an order, believes they may be out of compliance, or would like to request a PNC, they are encouraged to discuss their particular circumstances with the program by contacting the Substances Management Information Line. (see footnote y)
CEPA is enforced in accordance with the publicly available Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. (see footnote z) In instances of non-compliance, consideration is given to factors such as the nature of the alleged violation, potential harm, intent, and history of compliance.
ANNEX A
Consumer Product Definition in the Canada Consumer Product Safety Act (CCPSA) (see footnote 15)
In section 2 of the CCPSA, “consumer product” means a product, including its components, parts or accessories, that may reasonably be expected to be obtained by an individual to be used for non-commercial purposes, including for domestic, recreational and sports purposes, and includes its packaging. Section 4 of the CCPSA describes the application of the Act as follows:
Consumer products
4. (1) This Act applies to consumer products with the exception of those listed in Schedule 1.
Tobacco products
(2) This Act applies to tobacco products as defined in section 2 of the Tobacco Act but only in respect of their ignition propensity.
Natural health products
(3) For greater certainty, this Act does not apply to natural health products as defined in subsection 1(1) of the Natural Health Products Regulations made under the Food and Drugs Act.
Schedule 1 of the CCPSA (Subsection 4(1) and paragraph 37(1)(c))
- Explosives within the meaning of section 2 of the Explosives Act.
- Cosmetics within the meaning of section 2 of the Food and Drugs Act.
- Devices within the meaning of section 2 of the Food and Drugs Act.
- Drugs within the meaning of section 2 of the Food and Drugs Act.
- Food within the meaning of section 2 of the Food and Drugs Act.
- Pest control products within the meaning of subsection 2(1) of the Pest Control Products Act.
- Vehicles within the meaning of section 2 of the Motor Vehicle Safety Act and a part of a vehicle that is integral to it — as it is assembled or altered before its sale to the first retail purchaser — including a part of a vehicle that replaces or alters such a part.
- Feeds within the meaning of section 2 of the Feeds Act.
- Fertilizers within the meaning of section 2 of the Fertilizers Act.
- Vessels within the meaning of section 2 of the Canada Shipping Act, 2001.
- Firearms within the meaning of section 2 of the Criminal Code.
- Ammunition within the meaning of subsection 84(1) of the Criminal Code.
- Cartridge magazines within the meaning of subsection 84(1) of the Criminal Code.
- Cross-bows within the meaning of subsection 84(1) of the Criminal Code.
- Prohibited devices within the meaning of paragraphs (a) to (d) of the definition “prohibited device” in subsection 84(1) of the Criminal Code.
- Plants within the meaning of section 3 of the Plant Protection Act, except for Jequirity beans (abrus precatorius).
- Seeds within the meaning of section 2 of the Seeds Act, except for Jequirity beans (abrus precatorius).
- Controlled substances within the meaning of subsection 2(1) of the Controlled Drugs and Substances Act.
- Aeronautical products within the meaning of subsection 3(1) of the Aeronautics Act.
- Animals within the meaning of subsection 2(1) of the Health of Animals Act.
[2-1-o]
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Notice with respect to substances included as part of the 2017 Inventory Update
Pursuant to paragraph 71(1)(b) of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”), notice is hereby given that the Minister of the Environment requires, for the purpose of assessing whether the substances listed in Schedule 1 to this notice are toxic or are capable of becoming toxic, or for the purpose of assessing whether to control, or the manner in which to control the listed substances, any person described in Schedule 2 to this notice who possesses or who may reasonably be expected to have access to the information required in Schedule 3 to this notice to provide that information no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time.
Responses to this notice shall be submitted to the Minister of the Environment, using the online reporting system available through Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/. Inquiries concerning the notice may be directed to the Substances Management Coordinator at 1-800-567-1999 (toll-free in Canada), 819-938-3232 (outside of Canada) [telephone], or eccc.substances.eccc@canada.ca (email).
Pursuant to section 313 of the Act, any person who provides information in response to this notice may submit, with the information, a written request that the information or part of it be treated as confidential.
Pursuant to subsection 71(4) of the Act, the Minister of the Environment may, on request in writing from any person to whom this notice applies, extend the time or times within which the person shall comply with this notice. The person seeking such extension shall submit, prior to the deadline, a request to the Minister of the Environment, to the attention of the Substances Management Coordinator, Chemicals Management Plan, Gatineau, Quebec K1A 0H3 or eccc.substances.eccc@canada.ca (email).
Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
SCHEDULE 1
Substances
| CAS RN (see footnote 16) | Name of the substance | Nom de la substance |
|---|---|---|
| 52-68-6 | Phosphonic acid, (2,2,2-trichloro-1-hydroxyethyl)-, dimethyl ester | Acide phosphonique, (2,2,2-trichloro-1-hydroxyéthyl)-, diester méthylique |
| 75-15-0 | Carbon disulfide | Disulfure de carbone |
| 80-08-0 | Benzenamine, 4,4′-sulfonylbis- | Dapsone |
| 84-76-4 | 1,2-Benzenedicarboxylic acid, dinonyl ester | Phtalate de dinonyle |
| 84-77-5 | 1,2-Benzenedicarboxylic acid, didecyl ester | Phtalate de didécyle |
| 84-78-6 | 1,2-Benzenedicarboxylic acid, butyl octyl ester | Phtalate de butyle et d'octyle |
| 85-69-8 | 1,2-Benzenedicarboxylic acid, butyl 2-ethylhexyl ester | Phtalate de butyle et de 2-éthylhexyle |
| 94-96-2 | 1,3-Hexanediol, 2-ethyl- | 2-Éthylhexane-1,3-diol |
| 98-56-6 | Benzene, 1-chloro-4-(trifluoromethyl)- | 4-Chloro-α,α,α-trifluorotoluène |
| 101-20-2 | Urea, N-(4-chlorophenyl)-N′-(3,4-dichlorophenyl)- | Triclocarban |
| 110-82-7 | Cyclohexane | Cyclohexane |
| 111-30-8 | Pentanedial | Glutaral |
| 119-07-3 | 1,2-Benzenedicarboxylic acid, decyl octyl ester | Phtalate de décyle et d'octyle |
| 120-56-9 | Ethanol, 2,2′-[1,2-ethanediylbis(oxy)]bis-, dibenzoate | Dibenzoate de éthylènebis(oxyéthylène) |
| 121-75-5 | Butanedioic acid, [(dimethoxyphosphinothioyl)thio]-, diethyl ester | Malathion |
| 123-33-1 | 3,6-Pyridazinedione, 1,2-dihydro- | Pyridazine-3,6-diol |
| 131-54-4 | Methanone, bis(2-hydroxy-4-methoxyphenyl)- | 2,2′-Dihydroxy-4,4′-diméthoxybenzophénone |
| 142-59-6 | Carbamodithioic acid, 1,2-ethanediylbis-, disodium salt | Nabame |
| 142-82-5 | Heptane | Heptane |
| 540-84-1 | Pentane, 2,2,4-trimethyl- | 2,2,4-Triméthylpentane |
| 1071-93-8 | Hexanedioic acid, dihydrazide | Adipohydrazide |
| 1312-46-5 | Iridium oxide (Ir2O3) | Tétrahydroxyde d'iridium |
| 1314-08-5 | Palladium oxide (PdO) | Monoxyde de palladium |
| 1314-15-4 | Platinum oxide (PtO2) | Dioxyde de platine |
| 1322-94-7 | 1,2-Benzenedicarboxylic acid, mono(dimethylcyclohexyl) ester | Hydrogénophtalate de (diméthylcyclohexyle) |
| 1461-25-2 | Stannane, tetrabutyl- | Tétrabutylstannane |
| 2164-17-2 | Urea, N,N-dimethyl-N′-[3-(trifluoromethyl)phenyl]- | Fluométuron |
| 2226-96-2 | 1-Piperidinyloxy, 4-hydroxy-2,2,6,6-tetramethyl- | 4-Hydroxy-2,2,6,6-tétraméthylpipéridinoxyle |
| 2432-90-8 | 1,2-Benzenedicarboxylic acid, didodecyl ester | Phtalate de didodécyle |
| 3741-80-8 | 2-Benzothiazolesulfenamide, N-(2-benzothiazolylthio)-N-(1,1-dimethylethyl)- | N-(2-Benzothiazolylthio)-N-(tert-butyl)-2-benzothiazolsulfénamide |
| 7439-88-5 | Iridium | Iridium |
| 7440-04-2 | Osmium | Osmium |
| 7440-05-3 | Palladium | Palladium |
| 7440-06-4 | Platinum | Platine |
| 7440-16-6 | Rhodium | Rhodium |
| 7440-18-8 | Ruthenium | Ruthénium |
| 7647-10-1 | Palladium chloride (PdCl2) | Dichlorure de palladium |
| 10025-65-7 | Platinum chloride (PtCl2) | Dichlorure de platine |
| 10025-83-9 | Iridium chloride (IrCl3) | Trichlorure d'iridium |
| 10025-99-7 | Platinate(2-), tetrachloro-, dipotassium, (SP-4-1)- | Tétrachloroplatinate de dipotassium |
| 10026-00-3 | Platinate(2-), tetrachloro-, disodium, (SP-4-1)- | Tétrachloroplatinate de disodium |
| 10049-07-7 | Rhodium chloride (RhCl3) | Trichlorure de rhodium |
| 10049-08-8 | Ruthenium chloride (RuCl3) | Trichlorure de ruthénium |
| 10102-05-3 | Nitric acid, palladium(2++) salt | Dinitrate de palladium |
| 10489-46-0 | Sulfuric acid, rhodium(3++) salt (3:2) | Trisulfate de dirhodium |
| 12030-49-8 | Iridium oxide (IrO2) | Dioxyde d'iridium |
| 12035-82-4 | Platinum oxide (PtO) | Oxyde de platine |
| 12036-10-1 | Ruthenium oxide (RuO2) | Oxyde de ruthénium (IV) |
| 12036-35-0 | Rhodium oxide (Rh2O3) | Trioxyde de dirhodium |
| 12044-52-9 | Platinum arsenide (PtAs2) | Arséniure de platine (PtAs2) |
| 12135-42-1 | Ruthenium hydroxide (Ru(OH)3) | Trihydroxyde de ruthénium |
| 12137-21-2 | Platinum oxide (PtO2), monohydrate | Monohydrate d'oxyde de platine (PtO2) |
| 12137-76-7 | Palladium selenide (PdSe) | Séléniure de palladium (PdSe) |
| 12237-63-7 | C.I. Pigment Red 169 | Hexakis(cyano-C)ferrate(4-)/2-[6-(éthylamino)-3-(éthylimino)-2,7-diméthyl-3H-xanthén-9-yl]benzoate d'éthyle et de cuivre(2++) |
| 12307-90-3 | Rhodium, chloro[(1,2,5,6-<C)-1,3,5,7-cyclooctatetraene](pyridine)- | Chloro[(1,2,5,6-<C)cycloocta-1,3,5,7-tétraène](pyridine)rhodium |
| 13444-93-4 | Osmium chloride (OsCl3) | Trichlorure d'osmium |
| 13454-96-1 | Platinum chloride (PtCl4), (SP-4-1)- | Tétrachlorure de platine |
| 13569-65-8 | Rhodium chloride (RhCl3), trihydrate | Trihydrate de chlorure de rhodium (RhCl3) |
| 13820-53-6 | Palladate(2-), tetrachloro-, disodium, (SP-4-1)- | Tétrachloropalladate de disodium |
| 14024-41-0 | Iridate(3-), hexachloro-, tripotassium, (OC-6-11)- | Hexachloroiridate de tripotassium |
| 14284-93-6 | Ruthenium, tris(2,4-pentanedionato-O,O′)-, (OC-6-11)- | Tris(pentane-2,4-dionato-O,O')ruthénium |
| 14898-67-0 | Ruthenium chloride (RuCl3), hydrate | Trihydrate de chlorure de ruthénium (RuCl3) |
| 14972-70-4 | Rhodate(3-), hexachloro-, trisodium, (OC-6-11)- | Hexachlororhodate de trisodium |
| 14996-60-2 | Osmium chloride (OsCl3), hydrate | Hydrate de chlorure d'osmium (OsCl3) |
| 14996-61-3 | Iridium chloride (IrCl3), hydrate | Hydrate de chlorure d'iridium (IrCl3) |
| 15231-91-1 | 2-Naphthalenol, 6-bromo- | 6-Bromonapht-2-ol |
| 15336-18-2 | Rhodate(3-), hexachloro-, triammonium, (OC-6-11)- | Hexachlororhodate de triammonium |
| 15752-05-3 | Iridate(3-), hexachloro-, triammonium, (OC-6-11)- | Hexachloroiridate de triammonium |
| 15869-63-3 | Platinum chloride (PtCl4), pentahydrate | Pentahydrate de chlorure de platine (PtCl4) |
| 16871-54-8 | Platinate(2-), hexachloro-, (OC-6-11)- | Hexachloroplatinate(2-) (OC-6-11) |
| 16919-58-7 | Platinate(2-), hexachloro-, diammonium, (OC-6-11)- | Hexachloroplatinate de diammonium |
| 16921-30-5 | Platinate(2-), hexachloro-, dipotassium, (OC-6-11)- | Hexachloroplatinate de dipotassium |
| 16923-58-3 | Platinate(2-), hexachloro-, disodium, (OC-6-11)- | Hexachloroplatinate de disodium |
| 16940-92-4 | Iridate(2-), hexachloro-, diammonium, (OC-6-11)- | Hexachloroiridate de diammonium |
| 16941-12-1 | Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)- | Acide hexachloroplatinique |
| 16941-92-7 | Iridate(2-), hexachloro-, dihydrogen, (OC-6-11)- | Acide hexachloroiridique |
| 18497-13-7 | Platinate (2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)- | Hexahydrate d'acide (OC-6-11)-hexachloroplatinique |
| 19186-97-1 | Tris[2,2-bis(bromomethyl)-3-bromopropyl]-phosphate | 3-Bromo-2,2-bis(bromométhyl)propan-1-ol, phosphate (3:1) |
| 19223-55-3 | 1-Propanaminium, 2-hydroxy-N,N-dimethyl-N-[3-[(1-oxododecyl)amino]propyl]-3-sulfo-, hydroxide, inner salt | Hydroxyde de (2-hydroxy-3-sulfopropyl)diméthyl[3-[(1-oxododécyl)amino]propyl]ammonium |
| 20765-98-4 | Rhodium chloride (RhCl3), hydrate | Hydrate de chlorure de rhodium (RhCl3), |
| 20816-12-0 | Osmium oxide (OsO4), (ß-4)- | Tétraoxyde d'osmium |
| 20845-92-5 | Hexanoic acid, 2-ethyl-, rhodium(3++) salt | Tris(2-éthylhexanoate) de rhodium |
| 21360-80-5 | Rhodium(2++), pentaamminechloro-, (OC-6-22)-, sulfate (1:1) | Sulfate de pentaamminechlororhodium |
| 21656-02-0 | Rhodium hydroxide (Rh(OH)3) | Trihydroxyde de rhodium |
| 23013-82-3 | Ruthenate(2-), hexachloro-, dipotassium, (OC-6-11)- | Hexachlororuthénate de dipotassium |
| 25057-89-0 | 1H-2,1,3-Benzothiadiazin-4(3H)-one, 3-(1-methylethyl)-, 2,2-dioxide | Bentazone |
| 25085-20-5 | Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine | Acide adipique polymérisé avec la N-(2-aminoéthyl)éthane-1,2-diamine |
| 25724-58-7 | 1,2-Benzenedicarboxylic acid, decyl hexyl ester | Phtalate de décyle et d'hexyle |
| 25973-55-1 | Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylpropyl)- | 2-(2H-Benzotriazol-2-yl)-4,6-di-tert-pentylphénol |
| 26023-84-7 | Platinate (2-), hexachloro-, dihydrogen, hydrate, (OC-6-11)- | Hydrate d'acide (OC-6-11)-hexachloroplatinique |
| 27636-21-1 | 1,6-Hexanediamine, polymer with (chloromethyl)oxirane | Hexane-1,6-diamine polymérisée avec le (chlorométhyl)oxirane |
| 30980-84-8 | Iridium oxide (IrO2), hydrate | Hydrate d'oxyde d'iridium (IrO2) |
| 32740-79-7 | Ruthenium oxide (RuO2), hydrate | Hydrate d'oxyde de ruthénium (RuO2) |
| 32916-07-7 | Nitric acid, palladium(2+), dihydrate | Dihydrate de nitrate de palladium (2+) |
| 35541-81-2 | 1,4-Cyclohexanedimethanol, dibenzoate | Dibenzoate de cyclohexane-1,4-diméthanol |
| 36550-26-2 | Palladate(2-), hexachloro-, dihydrogen, (OC-6-11)- | Hexachloropalladate(2-) de dihydrogène |
| 36732-58-8 | Rhodate(2-), hexachloro-, dihydrogen, (OC-6-11)- | Hexachlororhodate(2-) de dihydrogène (OC-6-11) |
| 36861-47-9 | Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-[(4-methylphenyl)methylene]- | (±)-1,7,7-Triméthyl-3-[(4méthylphényl)méthylène]bicyclo[2.2.1]heptan-2-one |
| 39373-27-8 | Rhodium oxide (Rh2O3), pentahydrate | Pentahydrate d'oxyde de rhodium (Rh2O3) |
| 44470-26-0 | Ruthenate(2-), hexachloro-, dihydrogen, (OC-6-11)- | Hexachlororuthénate(2-) de dihydrogène (OC-6-11) |
| 52734-36-8 | 2-Propenoic acid, 2-methyl-, 2-(3-oxazolidinyl)ethyl ester, homopolymer | Méthacrylate de 2-(oxazolidin-3-yl)éthyle homopolymérisé |
| 52785-06-5 | Platinum oxide (PtO2), hydrate | Hydrate d'oxyde de platine (PtO2), |
| 54968-01-3 | Iridium hydroxide (Ir(OH)3) | Hydroxyde d'iridium [Ir(OH)3] |
| 55127-80-5 | Oxirane, 2,2′-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, homopolymer, di-2-propenoate | 2,2′-[Isopropylidènebis(p-phénylèneoxyméthylène)]dioxirane homopolymérisé, diacrylate |
| 57214-10-5 | Formaldehyde, polymer with 1,3-benzenedimethanamine and phenol | Formaldéhyde polymérisé avec le benzène-1,3-diméthanamine et le phénol |
| 57876-28-5 | Iridate(2-), hexachloro-, dihydrogen, hexahydrate, (OC-6-11)- | Hexahydrate d'acide (OC-6-11)-hexachloroiridique |
| 61827-62-1 | 1,2-Benzenedicarboxylic acid, hexyl octyl ester | Phtalate d'hexyle et d'octyle |
| 64109-12-2 | Palladium oxide (PdO), hydrate | Hydrate d'oxyde de palladium (PdO) |
| 64741-73-7 | Distillates (petroleum), alkylate | Distillats (pétrole), alkylation |
| 67703-99-5 | Hexanedioic acid, polymer with N¹-(2-aminoethyl)-1,2-ethanediamine and 1,2-dichloroethane | Polymère de l'acide hexanedioïque avec la N¹-(2-aminoéthyl)éthane-1,2-diamine et le 1,2-dichloroéthane |
| 67859-71-6 | Phosphoric acid, rhodium(3++) salt (1:1) | Phosphate de rhodium |
| 68071-36-3 | Ethanol, 2,2′,2″-nitrilotris-, compds. with polyethylene glycol mono-C12-15-alkyl ethers phosphates | 2,2′,2″-Nitrilotriéthanol, composés avec des phosphates d'éthers mono-C12-15-alkyliques du polyéthylèneglycol |
| 68188-19-2 | Paraffin waxes and Hydrocarbon waxes, chloro, chlorosulfonated | Cires de paraffine et cires d'hydrocarbures, chloro, sulfochlorées |
| 68228-02-4 | Neodecanoic acid, palladium(2++) salt | Néodécanoate de palladium(2++) |
| 68412-56-6 | Platinum, chloro octanol complexes | Platine, complexes chloro d'octanol |
| 68425-21-8 | Turpentine, oil, mixed with Venice turpentine, sulfurized, tetrachloropalladates | Essence de térébenthine, mélangée avec la térébenthine de mélèze, sulfurisée, tétrachloropalladates |
| 68425-76-3 | Ethanol, 2,2′-iminobis-, polymer with α-tridecyl-ω-hydroxypoly(oxy-1,2-ethanediyl) phosphate | 2,2′-Iminodiéthanol polymérisé avec le phosphate de l'α-tridécyl-ω-hydroxypoly(oxyéthylène) |
| 68442-70-6 | 1,2-Benzenedicarboxylic acid, mixed cetyl and stearyl esters | Phtalates mixtes de cétyle et de stéaryle |
| 68478-92-2 | Platinum, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes | Platine complexé avec le 1,1,3,3-tétraméthyl-1,3-divinyldisiloxane |
| 68515-41-3 | 1,2-Benzenedicarboxylic acid, di-C7-9-branched and linear alkyl esters | Phtalates de dialkyles en C7-9, ramifiés et linéaires |
| 68515-42-4 | 1,2-Benzenedicarboxylic acid, di-C7-11-branched and linear alkyl esters | Phtalates de dialkyles en C7-11, ramifiés et linéaires |
| 68515-44-6 | 1,2-Benzenedicarboxylic acid, diheptyl ester, branched and linear | Phtalates de diheptyle ramifié et linéaire |
| 68515-45-7 | 1,2-Benzenedicarboxylic acid, dinonyl ester, branched and linear | Phtalates de dinonyle ramifié et linéaire |
| 68585-32-0 | Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane | Hexachloroplatinate(2-) de dihydrogène (OC-6-11), produits de réaction avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinylcyclotétrasiloxane |
| 68648-91-9 | 1,2-Benzenedicarboxylic acid, di-C7-11-alkyl esters | Phtalates de dialkyles en C7-11 |
| 68916-29-0 | Balsams, Douglas-fir, sulfurized, iridium salts | Baumes de Douglas sulfurisés, sels d'iridium |
| 68916-30-3 | Balsams, Douglas-fir, sulfurized, rhodium salts | Baumes de Douglas sulfurisés, sels de rhodium |
| 68916-31-4 | Balsams, Douglas-fir, sulfurized, ruthenium salts | Baumes de Douglas sulfurisés, sels de ruthénium |
| 68916-35-8 | Balsams, copaiba, sulfurized, platinum salts | Baumes de copahu sulfurisés, sels de platine |
| 68917-69-1 | Turpentine, Venice, sulfurized, hexachlororhodate | Térébenthine de mélèze sulfurisée, hexachlororhodate |
| 70321-75-4 | Balsams, Douglas-fir, sulfurized, palladium salts | Baumes de Douglas sulfurisés, sels de palladium |
| 71033-08-4 | Oxirane, 2,2′-[(1-methylethylidene)bis[4,1-phenyleneoxy[1-(butoxymethyl)-2,1-ethanediyl]oxymethylene]]bis- | 2,2'-[(1-Méthyléthylidène)bis[4,1-phénylénoxy[1-(butoxyméthyl)éthylène]oxyméthylène]]bisoxirane |
| 71832-62-7 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with N,N'-bis(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, [(dodecyloxy)methyl]oxirane, [(methylphenoxy)methyl]oxirane and [(tetradecyloxy)methyl]oxirane | p,p′-Isopropylidènediphénol polymérisé avec la N,N′-bis(2-aminoéthyl)éthylènediamine, le (chlorométhyl)oxirane, le (dodécyloxy)méthyloxirane, le (méthylphénoxy)méthyloxirane et le (tétradécyloxy)méthyloxirane |
| 72245-02-4 | Amines, tallow alkyl, ethoxylated, 2-ethylhexanoates | 2-Éthylhexanoates d'alkyl(de suif)amines éthoxylées |
| 72854-22-9 | Paraffin waxes and Hydrocarbon waxes, chloro, sulfonated, ammonium salts | Sels d'ammonium de cires de paraffines et de cires d'hydrocarbures chlorées et sulfonées |
| 73018-55-0 | Platinum, dicarbonyldichloro-, reaction products with 2,4,6-triethenyl-2,4,6-trimethylcyclotrisiloxane | Dicarbonyldichloroplatine(II), produits de réaction avec le 2,4,6-trivinyl-2,4,6-triméthylcyclotrisiloxane |
| 73936-91-1 | Phenol, 2-(2H-benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)- | 2-(2H-Benzotriazol-2-yl)-6-(1-méthyl-1-phényléthyl)-4-(1,1,3,3-tétraméthylbutyl)phénol |
| 85204-21-3 | 2-Butenoic acid, 4-[(2-ethylhexyl)amino]-4-oxo-, (Z)-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1) | Acide 4-[(2-éthylhexyl)amino]-4-oxoisocrotonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1) |
| 89415-87-2 | 2,4-Imidazolidinedione, 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 1,3-Dichloro-5-éthy1-5-méthylimidazolidine-2,4-dione |
| 90193-94-5 | 1,2-Benzenedicarboxylic acid, mixed decyl and octyl diesters | Acide phtalique, mélange de diesters de décyle et d'octyle |
| 91082-67-6 | Turpentine, Venice, sulfurized, reaction products with dihydrogen hexachloroiridate(2-) | Térébenthine de mélèze sulfurisée, produits de réaction avec l'hexachloroiridate(2-) diacide |
| 91082-70-1 | Turpentine, Venice, sulfurized, reaction products with osmium chloride (OsCl3) | Térébenthine de mélèze sulfurisée, produits de réaction avec le chlorure d'osmium (OsCl3) |
| 94266-84-9 | Amines, polyethylenepoly-, polymers with adipic acid, 1,2-dichloroethane and diethylenetriamine, hydrochlorides | Polyéthylènepolyamines polymérisées avec l'acide adipique, le 1,2-dichloroéthane et la 3-azapentane-1,5-diamine, chlorhydrates |
| 95193-73-0 | 1,2-Benzenedicarboxylic acid, di-C16-18 and C18-unsatd. alkyl esters | Acide benzènedicarboxylique-1,2, esters de dialkyles en C16-18 et insaturés en C18 |
| 97375-25-2 | Platinum, carbonyl chloro 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane complexes | Platine, complexée avec le 2,4,6,8-tétraméthyl-2,4,6,8-tétravinyltétrasiloxane, chlorés et carbonylés |
| 97765-58-7 | Balsams, Canada, sulfurized, iridium salts | Baumes du Canada sulfurisés, sels d'iridium |
| 97766-48-8 | Turpentine, Venice, sulfurized, platinum salt | Térébenthine de mélèze sulfurisée, sel de platine |
| 100402-68-4 | Palladium, isooctyl 3-mercaptopropanoate complexes | Palladium, complexé avec le 3-mercaptopropionate d'isooctyle |
| 100432-49-3 | Bicyclo[3.1.1]heptane-3-thiol, 2,6,6-trimethyl-, rhodium(3++) salt | 2,6,6-Triméthylbicyclo[3.1.1]heptane-3-thiolate de rhodium(3++) |
| 100432-50-6 | Bicyclo[3.1.1]heptane-2-thiol, 2,6,6-trimethyl-, rhodium(3++) salt | 2,6,6-Triméthylbicyclo[3.1.1]heptane-2-thiolate de rhodium(3++) |
| 109909-39-9 | Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[2,4,6-tris(1-methylpropyl)phenoxy]-, sodium salt | α-Sulfo-ω-(2,4,6-tri-sec-butylphénoxy)poly(oxyéthylène), sel de sodium |
| 111381-90-9 | 1,2-Benzenedicarboxylic acid, heptyl undecyl ester, branched and linear | Phtalate d'heptyle/undécyle, ramifiés et linéaires |
| 111905-52-3 | Alcohols, C9-11-branched and linear, butoxylated ethoxylated | Alcools en C9-11 ramifiés ou linéaires, butoxylés, éthoxylés |
| 118421-10-6 | 1,2-Cyclohexanediamine, reaction products with N-[4-oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)oxiranemethanamine | Cyclohexane-1,2-diamine, produits de réaction avec la N-[4-(oxiranylméthoxy)phényl]-N-(oxiranylméthyl)oxiraneméthanamine |
| 124232-16-2 | Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(tridecyloxy)- | α-(3-Carboxy-1-oxopropyl)-ω-(tridécyloxy)poly(oxyéthylène) |
| 126019-82-7 | Phenol, 2(or 4)-C9-10-branched alkyl derivs., phosphorothioates (3:1) | Phosphorothioates (3:1) de (dérivés alkyliques 2(ou 4)-ramifiés en C9-10)phénol |
| 126820-93-7 | Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes and sulfur | Sel d'or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d'isooctyle palladium et le soufre |
| 126820-94-8 | Bicyclo[3.1.1]heptanethiol, 2,6,6-trimethyl-, gold(1++) salt, reaction products with palladium isooctyl 3-mercaptopropanoate complexes, sulfur and 2,6,6-trimethylbicyclo[3.1.1]heptanethiol silver(1++) salt | Sel d'or(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol, produits de réaction avec des complexes de 3-mercaptopropionate d'isooctyle palladium, le soufre et le sel d'argent(1++) du 2,6,6-triméthylbicyclo[3.1.1]heptanethiol |
| 129828-23-5 | Fatty acids, tall-oil, reaction products with Bu phenylmethyl phthalate, 2-(dimethylamino)ethanol, morpholine and overbased calcium petroleum sulfonates | Acides gras, produits de réaction du tallöl avec le phtalate de butylphénylméthyle, le 2-(diméthylamino)éthanol, la morpholine et des sulfonates de pétrole à proportion plus que stoechiométrique de calcium |
| 131298-44-7 | C9-11-branched alkyl benzoate | Esters alkyliques en C9-11 ramifiés de l'acide benzoïque |
| 134112-54-2 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with 4-amino-α,α,4-trimethylcyclohexanemethanamine, 5-amino-1,3,3-trimethylcyclohexanmethanamine, (chloromethyl)oxirane, 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine | 4,4′-(Isopropylidène)diphénol polymérisé avec la 4-amino-α,α-4-triméthylcyclohexaneméthanamine, la 5-amino-1,3,3-triméthylcyclohexaneméthanamine, le (chlorométhyl)oxirane, la 2,2,4-triméthylhexane-1,6-diamine et la 2,4,4-triméthylhexane-1,6-diamine |
| 137397-37-6 | Decanedioic acid, polymer with carbonic dichloride and 4,4′-(1-methylethylidene)bis(phenol), 4-(1-methyl-1-phenylethyl) phenyl ester (9CI) | Acide décanedioïque polymérisé avec du dichlorure carbonique et du 4,4′-(propane-2,2-diyl)bis(phénol), ester 4-(2-phénylpropane-2-yl) phénylique (9CI) |
| 146729-34-2 | Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxopropyl)-ω-(pentadecyloxy)- | α-(3-Carboxyoxoprop-1-yl)-ω-(pentadécyloxy)poly(oxyéthylène) |
| 147170-44-3 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-(C8-18 and C18-unsatd. acyl) derivs., inner salts | Dérivés N-(acyliques en C8-18 et en C18-insaturé) du 3-amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, sels internes |
| 149778-23-4 | Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, polymer with 2-ethylhexyl 2-propenoate and 2-propenamide | Chlorure de N,N,N-triméthyl-2-[oxy(acryloyl)]éthanaminium polymérisé avec l'acrylate de 2-éthylhexyle et l'acrylamide |
| 149879-98-1 | 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[[(13Z)-1-oxo-13-docosenyl]amino]-, inner salt | N-(carboxyméthyl)-N,N-diméthyl-3-[[(13Z)-1-oxo-13-docosényl]amino]-1-propanaminium, sel interne |
| 151574-14-0 | Ammonium α-sulfo-ω-[2-(1-propenyl)-4-nonyl(branched)phenoxy]poly(1-30)(oxyethylene) | α-Sulfo-ω-(4-nonyl-2-allylphénoxy)poly(oxyéthylène), ramifié, sels d'ammonium |
| 154862-43-8 | 2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]- | 3,9-Bis[2,4-bis(1-méthyl-1-phénéthyl)phénoxy]-2,4,8,10-tétraoxa-3,9-diphosphaspiro[5.5]undécane |
| 162030-42-4 | 1,4-Benzenedicarboxylic acid, di-C11-14-isoalkyl esters, C13-rich | Téréphtalates de diisoalkyle en C11-14, enrichis en C13 |
| 163149-26-6 | Tall oil polymeric reaction products with maleic anhydride, rosin, zinc oxide and calcium hydroxide | Tallöl, produits de réaction avec l'anhydride maléique, la colophane, l'oxyde de zinc et l'hydroxyde de calcium |
| 165883-95-4 | Siloxanes and Silicones, di-Me, 3-(ethylamino)-2-methylpropyl group-terminated | Di-Me siloxanes et silicones terminés par le groupe 3-(éthylamino)-2-méthylpropyle |
| 180685-83-0 | Tannins, polymers with N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]ethanaminium chloride, graft | Tannins polymérisés avec le chlorure de N,N,N-triméthyl-2-[(1-oxo-2-propényl)oxy]éthanaminium, greffé |
| 182371-64-8 | Hexanedioic acid, polymer with N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine, N-(2-aminoethyl)-1,2-ethanediamine and (chloromethyl)oxirane, sulfate | Acide adipique, polymérisé avec la N-(2-aminoéthyl)-N′-[2-[(2-aminoéthyl)amino]éthyl]-éthylènediamine, la N-(2-aminoéthyl)-éthylènediamine et le (chlorométhyl)oxirane, sulfate |
| 185857-36-7 | Alkanes, C10-C13-branched and linear | Alcanes en C10-C13 linéaires et ramifiés |
| 188627-10-3 | Siloxanes and Silicones, di-Me, [[[3-[(2-aminoethyl)amino]-2-methylpropyl]methoxymethylsilyl]oxy]- and (C13-15-alkyloxy)-terminated | Di-Me siloxanes et silicones terminés par les groupes [({3-[(2-aminoéthyl)amino]-2-méthylpropyl}méthoxyméthylsilyl)oxy] et (C13-15-alkyloxy) |
| 190085-41-7 | Benzoic acid, 2-hydroxy-, 2-butyloctyl ester | Salicylate de 2-butyloctyle |
| 193098-40-7 | 1,6-Hexanediamine, N,N′-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymers with morpholine-2,4,6-trichloro-1,3,5-triazine reaction products, methylated | 1,6-Hexanediamine, N,N′-bis(2,2,6,6-tétraméthyl-4-pipéridinyl)-, polymères formés avec des produits de réaction de la morpholine-2,4,6-trichloro-1,3,5-triazine, méthylés |
| 207596-32-5 | Nitric acid, palladium(2+) salt, hydrate (2:1:?) | Hydrate de nitrate de palladium (2+) (?/2/1) |
| 210920-40-4 | Tin, Butyl, 1-dodecanethio, 2-mercaptoethanol thio complexes | Complexes de Bu dodécane-1-thiol 2-mercaptoéthanol thioxo étain |
| 220689-12-3 | Phosphonium, tetrabutyl-, salt with 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonic acid (1:1) | Perfluorobutane-1-sulfonate de tétrabutylphosphonium (1/1) |
| 237753-63-8 | Alcohols, C13-15, reaction products with N-[3-(dimethoxymethylsilyl)-2-methylpropyl]1,2-ethanediamine, glycidol, and hydroxy-terminated di-Me siloxanes | Produits de réaction d'alcools C13-15 avec la N-[3-(diméthoxyméthylsilyl)-2-méthylpropyl]éthane-1,2-diamine, le glycidol et les di-Me siloxanes terminés par le groupe hydroxy |
| 671756-61-9 | 1-Tetradecanesulfonic acid, (dimethylphenyl)- | Acide xylyltétradécane-1-sulfonique |
| 676143-36-5 | 1-Hexadecanesulfonic acid, (dimethylphenyl)- | Acide xylylhexadécane-1-sulfonique |
| 848301-65-5 | Naphtha (Fischer-Tropsch), light, C4-10-branched and linear | Naphta (Fischer-Tropsch), léger, linéaire et ramifié en C4-10 |
| 848301-66-6 | Kerosine (Fischer-Tropsch), full-range, C8-16-branched and linear | Kérosène (Fischer-Tropsch), pleine gamme, linéaire et ramifié en C8-16 |
| 848301-67-7 | Distillates (Fischer-Tropsch), C8-26- branched and linear | Distillats (Fischer-Tropsch), linéaires et ramifiés en C8-26 |
| 848301-71-3 | Residual oils (Fischer-Tropsch), base oil production, C40-70-branched, cyclic and linear aliphatic hydrocarbon fraction | Huiles résiduelles (Fischer-Tropsch) de la production d'huile de base, fraction d'hydrocarbures aliphatiques linéaires, ramifiés et cycliques en C40-70 |
| 866259-61-2 | N,N-dicoco-2-hydroxy-acetamide | N,N-Di(alkyl de coco)-2-hydroxyacétamide |
| 928771-01-1 | Alkanes, C10-20 - branched and linear | Alcanes en C10-20, ramifiés ou linéaires |
| 944747-28-8 | Fatty acids, C18-unsatd., dimers, polymers, with bisphenol A, diethylenetriamine, epichlorohydrin, N1, N1-1,2-ethanediylbis[1,3-propanediamine], tall-oil fatty acids and triethylenetetramine | Dimères d'acides gras insaturés en C18, polymérisés avec du 4,4′-(propane-2,2-diyl)bisphénol, de la 3-azapentane-1,5-diamine, du 1-chloro-2,3-époxypropane, de la N,N-éthane-1,2-diylbis[propane-1,3-diamine], des acides gras de tallöl et de la 3,6 diazaoctane-1,8-diamine |
| 1000817-22-0 | Fatty acids, C8-18 and C18-unsatd, reaction products with diethanolamine and propylene oxide | Acides gras en C8-18 et en C18 insaturés, produits de la réaction avec du 2,2′ aminobiséthanol et du 1,2-époxypropane |
| 1001320-38-2 | Carbamic acid, [(butylthio) thioxomethyl]-,butyl ester | [(Butylthio) thioxométhyl]-carbamate de butyle |
| 1013910-41-2 | Oxirane, 2-ethyl-, polymer with oxirane, mono-C12-14-sec-alkyl ethers | 2-Éthyloxirane polymérisé avec de l'oxirane, oxydes mono(sec-alkyl(C12-14)iques) |
| 1022990-65-3 | Oxirane, 2-ethyl-, polymer with oxirane, mono-C11-15-sec-alkyl ethers | 2-éthyloxirane polymérisé avec de l'oxirane, oxydes mono-sec-alkyliques en C11-15 |
| 1174918-46-7 | Alkanes, C14-16-branched and linear | Alcanes en C14-16 linéaires et ramifiés |
| 1224429-82-6 | Phosphoric acid, mixed esters with polyethylene glycol and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanol, ammonium salts | Acide phosphorique, esters mixtes avec du polyéthylèneglycol et du 3,3,4,4,5,5,6,6,7,7,8,8,8-tridécafluoro-1-octanol, sels ammoniacaux |
| 1437280-84-6 | Alkanes, C9-C13-branched and linear | Alcanes en C9-C13 linéaires et ramifiés |
| 1437280-85-7 | Alkanes, C18-C24-branched and linear | Alcanes en C18-C24 linéaires et ramifiés |
| 1437281-01-0 | Alkanes, C15-C19-branched and linear | Alcanes en C15-C19 linéaires et ramifiés |
| 1437281-03-2 | Alkanes, C12-C15-branched and linear | Alcanes en C12-C15 linéaires et ramifiés |
| 1437281-04-3 | Alkanes, C9-C12-branched and linear | Alcanes en C9-C12 linéaires et ramifiés |
| 1538409-50-5 | Poly(oxy-1,2-ethanediyl), α-[2-[tetrahydro-1 (2H)-pyrimidinyl) ethyl]-ω-hydroxy-, N-tallow alkyl derivs., di-Me sulfate-quaternized | α-[2-[tétrahydro-(2H)-pyrimidin-1-yl)ethyle]-ω-hydroxypoly(oxyéthane-1,2-diyle), dérivés N-(alkyle de suif), quaternarisés avec du sulfate de diméthyle |
| Confidential Accession Number (see footnote 17) | Masked name | Nom maquillé |
|---|---|---|
| 13811-5 | 2-Propenoic acid, 2-methyl-, methyl ester, telomer with alkyl 2-propenoate, tert-dodecanethiol, ethenylbenzene, oxiranylmethyl 2-methyl-2-propenoate and 1,2-propanediol mono(2-methyl-2-propenoate), reaction products with 2,2′-thiobis[ethanol], lactates (salts) | 2-Méthyl-2-propènoate de méthyle télomérisé avec le 2-propènoate d'alkyle, le tert-dodécanethiol, l'éthénylbenzène, le 2-méthyl-2-propènoate d'oxiranylméthyle et le mono(2-méthyl-2-propènoate) de propane-1,2-diol, produits de réaction avec le 2,2′-thiodiéthanol, lactates (sels) |
| 13697-8 | The reaction product of dihydro-undecyl-heteromonocycleethanamine, with oxirane, mono[(C12-14-alkyloxy)methyl] derivs. and 2-hydroxypropanoic acid | Le produit de réaction de la dihydro-undécyl-hétéromonocycleéthanamine, avec les dérivés mono[(C12-14-alkyloxy)méthyliques d'oxirane et l'acide 2-hydroxypropanoïque |
| 17963-8 | Amines, alkyl, compounds with 2-mercapto-dialkyl-1,3,2-dioxaphosphorinane 2-oxide (1:1) | Alcanamines, composés avec du 2-oxyde de 2 mercapto-dialkyl-1,3,2-dioxaphosphinane (1/1) |
| 18735-6 | 1-substituted Propane, 3-(triethoxysilyl)-, reaction products with polyethylene glycol mono-(branched tridecyl) ether | Propane substitué en position 1, 3-(triéthoxysilyl)-, produits de la réaction avec de l'éther tridécylique monoramifié de polyéthylèneglycol |
| 13568-5 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 2(methylamino)ethanol, N-(1,3-dimethylbutylidene)-N′-[2-[(1,3-dimethylbutylidene)amino]ethyl]-1,2-ethanediamine and 2-hydroxypropanoic acid | 4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, le 2-(méthylamino)éthanol, la N-(1,3-diméthylbutylidène)-N′-{2-[(1,3-diméthylbutylidène)amino]éthyl}éthane-1,2-diamine et l'acide 2-hydroxypropanoïque |
| 13668-6 | Polymer of 4,4′-(1-methylethylidene)bisphenol polymer with (chloromethyl)oxirane, 4,4′-(1-methylidene)bisphenol, alkylphenols, alkanolamines and alkylamines, lactic acid salt of | Polymère du 4,4′-(1-méthyléthylidène)diphénol polymérisé avec le (chlorométhyl)oxirane, le 4,4′-(1-méthylidène)diphénol, des alkylphénols, des alcanolamines et des alkylamines, sel de l'acide lactique |
| 13680-0 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with chloromethyloxirane, 4,4′-(1methylethylidene)bisphenol, hexahydro-1,3-isobenzofurandione, α,α′-[(1-methylethylidene)di4,1-phenylene]bis(ω-hydroxy)poly(oxy-1,2-ethanediyl), sulfamic acid, 2(methylamino)ethanol, N,N-dimethyl-1,3-alkanediamine and 2-aminoethanol | 4,4′-(1-Méthyléthylidène)diphéhol polymérisé avec le chlo rométhyloxirane, le 4,4′-(1méthyléthylidène)diphénol, l'hexahydro-1,3-isobenzofurandione, l'α,α′-[(1-méthyléthylidène)di-4,1-phénylène]bis(ω-hydroxy)poly(oxyéthane-1,2-diyl), l'acide sulfamique, le 2-(méthylamino)éthanol, la N,N-diméthylalcane-1,3-diamine et le 2-aminoéthanol |
| 13702-4 | Phenol, 4,4′-(1-methylethylidene)bis-, polymer with (chloromethyl)heteromonocycle, 1,3-propanediamine, 2-methyl-N,N-dimethyl-1,5-pentanediamine, neodecanoic acid, hetermonocyclicmethyl ester, capped with 2,2′-iminobisethanol, salt with 2-hydroxypropanoic acid | 4,4′-(1-Méthyléthylidène)bisphénol polymérisé avec le (chlorométhyl)hétéromonocycle, la propane-1,3-diamine, la 2-méthyl-N,N-diméthylpentane-1,5-diamine, le néodécanoate d'hétérmonocycliqueméthyle, terminé avec le 2,2′-iminobiséthanol, sel avec l'acide 2-hydroxypropanoïque |
| 14236-7 | (Chloromethyl)oxirane, polymer with 4,4′-(1-methylethylidene)bis[phenol] and N,N-dialkyl-1-octadecanamine, acetates (salts) | (Chlorométhyl)oxirane polymérisé avec le 4,4′-(1-méthyléthylidène)diphénol et la N,N-dialkyloctadécan-1-amine, acétates (sels) |
| 15099-6 | Propanoic acid, 2-hydroxy-, (2S)-, compds. with bisphenol A-epichlorohydrin polymer dodecylphenol Ph ether-polyamine-N,N-dimethyl-1, 3-propanediamine-2-(methylamino) ethanol reaction products | Acide lactique, (2S)-, composés avec un polymère de bisphénol A et d'épichlorhydrine, de l'oxyde de dodécylphénol et de phényle, une polyamine, de la N,N-diméthylpropane-1,3-diamine, produits de la réaction avec du 2-(méthylamino)éthanol |
| 16285-4 | Oxirane, alkyl-, homopolymer, 3-aminopropyl 4-dodecylphenyl ether | Alkyloxirane, homopolymérisé, éther 4-dodécylphényl 3-aminopropylique |
| 17772-6 | Polymer of aliphatic amine, epichlorohydrin, oxalic acid and urea | Polymère d'une amine aliphatique, l'épichlorhydrine, l'acide oxalique et l'urée |
| 14857-7 | 1,3-Diisocyanatoalkylbenzene, polymer with α,α′-[(methylimino)di-2,1-ethanediyl]bis[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)], acetates (salts) | 1,3-Diisocyanatoalkylbenzène polymérisé avec l'α,α′[(méthylimino)diéthane-1,2-diyl]bis[ω-hydroxypoly[oxy(méthyléthane-1,2-diyl)], acétates (sels) |
| 14971-4 | 4,4′-(1-Methylethylidene)bisphenol, polymer with (chloromethyl)oxirane, and 2(dimethylamino)ethanol-blocked polyalkylenepolyphenylene isocyanate, lactates (salts) | 4,4′-Isopropylidènebisphénol polymérisé avec du (chlorométhyl)oxirane et de l'isocyanate de polyalkylènepolyphénylène séquencé avec du 2 (diméthylamino)éthanol, lactates (sels) |
| 18253-1 | 1-Alkanol, polyfluoro-, reaction products with phosphorus oxide (P2O5), ammonium salts | polyfluoroalcan-1-ol, produits de réaction avec le pentoxyde de diphosphore (P2O5), sels d'ammonium, |
| 15232-4 | Poly[oxy(1,2-propanediyl)], α-(3-aminopropyl)-ω-hydroxy-, alkyl ethers | α-(3-Aminopropyl)-ω-hydroxypoly[oxy(propane-1,2-diyl)], éthers alkyliques |
| 18475-7 | Alkanediol, reaction products with phosphorus oxide (P2O5), polyfluoro-1-alkanol,-ammonium salts | Alcanediol, produits de la réaction avec de l'oxyde de phosphore (P2O5), polyfluoro 1-alcanol, sels ammoniacaux |
| CAS RN | Name of the substance | Nom de la substance |
|---|---|---|
| 95-31-8 | 2-Benzothiazolesulfenamide, N-(1,1-dimethylethyl)- | N-tert-Butylbenzothiazole-2-sulfénamide |
| 95-33-0 | 2-Benzothiazolesulfenamide, N-cyclohexyl- | N-Cyclohexylbenzothiazole-2-sulfénamide |
| 120-78-5 | Benzothiazole, 2,2′-dithiobis- | Disulfure de di(benzothiazol-2-yle) |
| 149-30-4 | 2(3H)-Benzothiazolethione | Benzothiazole-2-thiol |
| 1321-69-3 | Naphthalenesulfonic acid, sodium salt | Naphtalènesulfonate de sodium |
| 2492-26-4 | 2(3H)-Benzothiazolethione, sodium salt | Sulfure de sodium et de benzothiazol-2-yle |
| 3147-75-9 | Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)- | 2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3tétraméthylbutyl)phénol |
| 3846-71-7 | Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)- | 2-Benzotriazol-2-yl-4,6-di-tert-butylphénol |
| 3896-11-5 | Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-6-(1,1-dimethylethyl)-4-methyl- | Bumétrizole |
| 4221-80-1 | Benzoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2,4-bis(1,1-dimethylethyl)phenyl ester | 3,5-Di-tert-butyl-4-hydroxybenzoate de 2,4-di-tert-butylphényle |
| 4979-32-2 | 2-Benzothiazolesulfenamide, N,N-dicyclohexyl- | N,N-Dicyclohexylbenzothiazole-2-sulfénamide |
| 7726-95-6 | Bromine | Brome |
| 21564-17-0 | Thiocyanic acid, (2-benzothiazolylthio)methyl ester | Thiocyanate de (benzothiazol-2-ylthio)méthyle |
| 23128-74-7 | Benzenepropanamide, N,N′-1,6-hexanediylbis[3,5-bis(1,1-dimethylethyl)-4-hydroxy- | N,N′-Hexane-1,6-diylbis[3-(3,5-di-tert-butyl-4-hydroxyphénylpropionamide] |
| 25167-32-2 | Benzenesulfonic acid, oxybis[dodecyl-, disodium salt | 2,2′(ou 3,3′)-Oxybis[5(ou 2)-dodécylbenzènesulfonate] de disodium |
| 25322-17-2 | Naphthalenesulfonic acid, dinonyl- | Acide dinonylnaphtalènesulfonique |
| 25619-56-1 | Naphthalenesulfonic acid, dinonyl-, barium salt | Bis(dinonylnaphtalènesulfonate) de baryum |
| 25638-17-9 | Naphthalenesulfonic acid, butyl-, sodium salt | Butylnaphtalènesulfonate de sodium |
| 29385-43-1 | 1H-Benzotriazole, 4(or 5)-methyl- | Méthyl-1H-benzotriazole |
| 36437-37-3 | Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1-dimethylethyl)-6-(1-methylpropyl)- | 2-(2H-Benzotriazol-2-yl)-4-(tert-butyl)-6-(secbutyl)phénol |
| 36443-68-2 | Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-5-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester | Bis[3-(5-tert-butyl-4-hydroxy-m-tolyl)propionate] d'éthylènebis(oxyéthylène) |
| 60223-95-2 | Naphthalenedisulfonic acid, dinonyl- | Acide dinonylnaphtalènedisulfonique |
| 70321-86-7 | Phenol, 2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)- | 2-(2H-Benzotriazol-2-yl)-4,6-bis(1-méthyl-1-phényléthyl)phénol |
| 80584-90-3 | 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-4-methyl- | N,N-Bis(2-éthylhexyl)-4-méthyl-1H-benzotriazole-1-méthylamine |
| 80595-74-0 | 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-5-methyl- | N,N-Bis(2-éthylhexyl)-5-méthyl-1H-benzotriazole-1-méthylamine |
| 94270-86-7 | 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-ar-methyl- | N,N-Bis(2-éthylhexyl)-ar-méthyl-1H-benzotriazole-1-méthanamine |
| CAS RN | Name of the substance | Nom de la substance |
|---|---|---|
| 50-27-1 | Estra-1,3,5(10)-triene-3,16,17-triol, (16α,17β)- | Oestriol |
| 50-28-2 | Estra-1,3,5(10)-triene-3,17-diol (17β)- | Estra-1,3,5(10)-triène-3,17-diol (17β)- |
| 57-11-4 | Octadecanoic acid | Acide stéarique |
| 57-88-5 | Cholest-5-en-3-ol (3β)- | Cholestérol |
| 58-93-5 | 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide | Hydrochlorothiazide |
| 61-73-4 | Phenothiazin-5-ium, 3,7-bis(dimethylamino)-, chloride | Chlorure de méthylthioninium |
| 67-20-9 | 2,4-Imidazolidinedione, 1-[[(5-nitro-2-furanyl)methylene]amino]- | Nitrofurantoïne |
| 67-43-6 | Glycine, N,N-bis[2-[bis(carboxymethyl)amino]ethyl]- | Acide N-carboxyméthyliminobis(éthylènenitrilo)tétraacétique |
| 67-68-5 | Methane, sulfinylbis- | Diméthylsulfoxyde |
| 68-12-2 | Formamide, N,N-dimethyl- | N,N-Diméthylformamide |
| 74-93-1 | Methanethiol | Méthanethiol |
| 75-08-1 | Ethanethiol | Éthanethiol |
| 75-33-2 | 2-Propanethiol | Propane-2-thiol |
| 75-75-2 | Methanesulfonic acid | Acide méthanesulfonique |
| 75-77-4 | Silane, chlorotrimethyl- | Chlorotriméthylsilane |
| 75-79-6 | Silane, trichloromethyl- | Trichloro(méthyl)silane |
| 77-58-7 | Stannane, dibutylbis[(1-oxododecyl)oxy]- | Dilaurate de dibutylstannane |
| 77-90-7 | 1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, tributyl ester | O-Acétylcitrate de tributyle |
| 78-04-6 | 1,3,2-Dioxastannepin-4,7-dione, 2,2-dibutyl- | Maléate de dibutylstannane |
| 78-06-8 | 6H-1,3,2-Oxathiastannin-6-one, 2,2-dibutyldihydro- | 2,2-Dibutyldihydro-6H-1,3,2-oxathiastannin-6-one |
| 78-70-6 | 1,6-Octadien-3-ol, 3,7-dimethyl- | Linalol |
| 79-11-8 | Acetic acid, chloro- | Acide chloroacétique |
| 79-14-1 | Acetic acid, hydroxy- | Acide glycolique |
| 79-34-5 | Ethane, 1,1,2,2-tetrachloro- | 1,1,2,2-Tétrachloroéthane |
| 79-36-7 | Acetyl chloride, dichloro- | Chlorure de dichloroacétyle |
| 79-92-5 | Bicyclo[2.2.1]heptane, 2,2-dimethyl-3-methylene- | Camphène |
| 80-07-9 | Benzene, 1,1′-sulfonylbis[4-chloro- | Bis(4-chlorophényl)sulfone |
| 80-46-6 | Phenol, 4-(1,1-dimethylpropyl)- | p-(1,1-Diméthylpropyl)phénol |
| 80-62-6 | 2-Propenoic acid, 2-methyl-, methyl ester | Méthacrylate de méthyle |
| 83-44-3 | Cholan-24-oic acid, 3,12-dihydroxy-, (3α,5β,12α)- | Acide 3α,12α-dihydroxy-5β-cholan-24-oïque |
| 83-86-3 | myo-Inositol, hexakis(dihydrogen phosphate) | Acide phytique |
| 84-65-1 | 9,10-Anthracenedione | Anthraquinone |
| 85-43-8 | 1,3-Isobenzofurandione, 3a,4,7,7a-tetrahydro- | Anhydride 1,2,3,6-tétrahydrophtalique |
| 87-29-6 | 2-Propen-1-ol, 3-phenyl-, 2-aminobenzoate | Anthranilate de cinnamyle |
| 87-69-4 | Butanedioic acid, 2,3-dihydroxy- [R-(R,R)]- | Acide (++)-tartrique |
| 88-89-1 | Phenol, 2,4,6-trinitro- | Acide picrique |
| 89-78-1 | Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1α,2β,5α)- | Menthol |
| 89-82-7 | Cyclohexanone, 5-methyl-2-(1-methylethylidene)-, (R)- | p-Menth-4(8)-én-3-one |
| 90-43-7 | [1,1′-Biphenyl]-2-ol | Biphényl-2-ol |
| 91-17-8 | Naphthalene, decahydro- | Décahydronaphtalène |
| 92-69-3 | [1,1′-Biphenyl]-4-ol | Biphényl-4-ol |
| 92-84-2 | 10H-Phenothiazine | Phénothiazine |
| 92-88-6 | [1,1′-Biphenyl]-4,4′-diol | Biphényle-4,4′-diol |
| 94-13-3 | Benzoic acid, 4-hydroxy-, propyl ester | 4-Hydroxybenzoate de propyle |
| 94-18-8 | Benzoic acid, 4-hydroxy-, phenylmethyl ester | 4-Hydroxybenzoate de benzyle |
| 94-26-8 | Benzoic acid, 4-hydroxy-, butyl ester | 4-Hydroxybenzoate de butyle |
| 94-36-0 | Peroxide, dibenzoyl | Peroxyde de dibenzoyle |
| 94-60-0 | 1,4-Cyclohexanedicarboxylic acid, dimethyl ester | Cyclohexane-1,4-dicarboxylate de diméthyle |
| 95-14-7 | 1H-Benzotriazole | Benzotriazole |
| 95-47-6 | Benzene, 1,2-dimethyl- | o-Xylène |
| 95-49-8 | Benzene, 1-chloro-2-methyl- | 2-Chlorotoluène |
| 95-63-6 | Benzene, 1,2,4-trimethyl- | 1,2,4-Triméthylbenzène |
| 96-05-9 | 2-Propenoic acid, 2-methyl-, 2-propenyl ester | Méthacrylate d'allyle |
| 96-14-0 | Pentane, 3-methyl- | 3-Méthylpentane |
| 96-26-4 | 2-Propanone, 1,3-dihydroxy- | 1,3-Dihydroxyacétone |
| 96-37-7 | Cyclopentane, methyl- | Méthylcyclopentane |
| 96-48-0 | 2(3H)-Furanone, dihydro- | γ-Butyrolactone |
| 96-49-1 | 1,3-Dioxolan-2-one | Carbonate d'éthylène |
| 97-00-7 | Benzene, 1-chloro-2,4-dinitro- | 1-Chloro-2,4-dinitrobenzène |
| 97-63-2 | 2-Propenoic acid, 2-methyl-, ethyl ester | Méthacrylate d'éthyle |
| 97-65-4 | Butanedioic acid, methylene- | Acide itaconique |
| 97-77-8 | Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetraethyl- | Disulfirame |
| 97-90-5 | 2-Propenoic acid, 2-methyl-, 1,2-ethanediyl ester | Diméthacrylate d'éthylène |
| 97-99-4 | 2-Furanmethanol, tetrahydro- | Alcool tétrahydrofurfurylique |
| 98-29-3 | 1,2-Benzenediol, 4-(1,1-dimethylethyl)- | 4-tert-Butylpyrocatéchol |
| 98-73-7 | Benzoic acid, 4-(1,1-dimethylethyl)- | Acide 4-tert-butylbenzoïque |
| 98-83-9 | Benzene, (1-methylethenyl)- | 2-Phénylpropène |
| 98-86-2 | Ethanone, 1-phenyl- | Acétophénone |
| 99-08-1 | Benzene, 1-methyl-3-nitro- | 3-Nitrotoluène |
| 99-62-7 | Benzene, 1,3-bis(1-methylethyl)- | 1,3-Diisopropylbenzène |
| 99-97-8 | Benzenamine, N,N,4-trimethyl- | N,N-Diméthyl-p-toluidine |
| 100-18-5 | Benzene, 1,4-bis(1-methylethyl)- | 1,4-Diisopropylbenzène |
| 100-20-9 | 1,4-Benzenedicarbonyl dichloride | Dichlorure de téréphtaloyle |
| 100-21-0 | 1,4-Benzenedicarboxylic acid | Acide téréphtalique |
| 100-42-5 | Benzene, ethenyl- | Styrène |
| 101-02-0 | Phosphorous acid, triphenyl ester | Phosphite de triphényle |
| 101-72-4 | 1,4-Benzenediamine, N-(1-methylethyl)-N′-phenyl- | N-Isopropyl-N′-phényl-p-phénylènediamine |
| 102-06-7 | Guanidine, N,N′-diphenyl- | 1,3-Diphénylguanidine |
| 102-77-2 | Morpholine, 4-(2-benzothiazolylthio)- | 2-(Morpholinothio)benzothiazole |
| 103-09-3 | Acetic acid, 2-ethylhexyl ester | Acétate de 2-éthylhexyle |
| 104-43-8 | Phenol, 4-dodecyl- | p-Dodécylphénol |
| 104-93-8 | Benzene, 1-methoxy-4-methyl- | 4-Méthylanisole |
| 105-08-8 | 1,4-Cyclohexanedimethanol | Cyclohexane-1,4-diméthanol |
| 105-11-3 | 2,5-Cyclohexadiene-1,4-dione, dioxime | p-Benzoquinone-dioxime |
| 105-59-9 | Ethanol, 2,2′-(methylimino)bis- | 2,2′-Méthyliminodiéthanol |
| 105-76-0 | 2-Butenedioic acid (Z)-, dibutyl ester | Maléate de dibutyle |
| 105-83-9 | 1,3-Propanediamine, N-(3-aminopropyl)-N-methyl- | N,N-Bis(3-aminopropyl)méthylamine |
| 106-20-7 | 1-Hexanamine, 2-ethyl-N-(2-ethylhexyl)- | Bis(2-éthylhexyl)amine |
| 106-23-0 | 6-Octenal, 3,7-dimethyl- | Citronellal |
| 106-42-3 | Benzene, 1,4-dimethyl- | p-Xylène |
| 106-50-3 | 1,4-Benzenediamine | p-Phénylènediamine |
| 106-91-2 | 2-Propenoic acid, 2-methyl-, oxiranylmethyl ester | Méthacrylate de 2,3-époxypropyle |
| 106-98-9 | 1-Butene | But-1-ène |
| 107-01-7 | 2-Butene | But-2-ène |
| 107-12-0 | Propanenitrile | Propiononitrile |
| 107-19-7 | 2-Propyn-1-ol | Prop-2-yn-1-ol |
| 107-71-1 | Ethaneperoxoic acid, 1,1-dimethylethyl ester | Peracétate de tert-butyle |
| 108-01-0 | Ethanol, 2-(dimethylamino)- | 2-Diméthylaminoéthanol |
| 108-05-4 | Acetic acid ethenyl ester | Acétate de vinyle |
| 108-30-5 | 2,5-Furandione, dihydro- | Anhydride succinique |
| 108-38-3 | Benzene, 1,3-dimethyl- | m-Xylène |
| 108-77-0 | 1,3,5-Triazine, 2,4,6-trichloro- | 2,4,6-Trichloro-1,3,5-triazine |
| 108-87-2 | Cyclohexane, methyl- | Méthylcyclohexane |
| 108-95-2 | Phenol | Phénol |
| 108-98-5 | Benzenethiol | Benzènethiol |
| 109-08-0 | Pyrazine, methyl- | 2-Méthylpyrazine |
| 109-16-0 | 2-Propenoic acid, 2-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester | Diméthacrylate de 2,2′-éthylènedioxydiéthyle |
| 109-28-4 | 9-Octadecenamide, N-[3-(dimethylamino)propyl]-, (Z)- | N-[3-(Diméthylamino)propyl]oléamide |
| 109-55-7 | 1,3-Propanediamine, N,N-dimethyl- | 3-Aminopropyldiméthylamine |
| 109-65-9 | Butane, 1-bromo- | 1-Bromobutane |
| 109-69-3 | Butane, 1-chloro- | 1-Chlorobutane |
| 109-70-6 | Propane, 1-bromo-3-chloro- | 1-Bromo-3-chloropropane |
| 109-74-0 | Butanenitrile | Butyronitrile |
| 110-05-4 | Peroxide, bis(1,1-dimethylethyl) | Peroxyde de di-tert-butyle |
| 110-86-1 | Pyridine | Pyridine |
| 110-97-4 | 2-Propanol, 1,1′-iminobis- | 1,1′-Iminodipropan-2-ol |
| 111-66-0 | 1-Octene | Oct-1-ène |
| 112-18-5 | 1-Dodecanamine, N,N-dimethyl- | Dodécyldiméthylamine |
| 112-35-6 | Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]- | 2-[2-(2-Méthoxyéthoxy)éthoxy]éthanol |
| 112-36-7 | Ethane, 1,1′-oxybis[2-ethoxy- | Oxyde de bis(2-éthoxyéthyle) |
| 112-62-9 | 9-Octadecenoic acid (Z)-, methyl ester | Oléate de méthyle |
| 112-73-2 | Butane, 1,1′-[oxybis(2,1-ethanediyloxy)]bis- | Oxyde de bis(2-butoxyéthyle) |
| 115-11-7 | 1-Propene, 2-methyl- | 2-Méthylpropène |
| 115-27-5 | 4,7-Methanoisobenzofuran-1,3-dione, 4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro- | Anhydride 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ène-2,3-dicarboxylique |
| 117-39-5 | 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy- | 3,3′,4′,5,7-Pentahydroxyflavone |
| 118-55-8 | Benzoic acid, 2-hydroxy-, phenyl ester | Salicylate de phényle |
| 118-79-6 | Phenol, 2,4,6-tribromo- | 2,4,6-Tribromophénol |
| 119-36-8 | Benzoic acid, 2-hydroxy-, methyl ester | Salicylate de méthyle |
| 119-84-6 | 2H-1-Benzopyran-2-one, 3,4-dihydro- | 3,4-Dihydrocoumarine |
| 120-32-1 | Phenol, 4-chloro-2-(phenylmethyl)- | Clorofène |
| 120-47-8 | Benzoic acid, 4-hydroxy-, ethyl ester | 4-Hydroxybenzoate d'éthyle |
| 120-61-6 | 1,4-Benzenedicarboxylic acid, dimethyl ester | Téréphtalate de diméthyle |
| 121-54-0 | Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride | Chlorure de benzethonium |
| 121-79-9 | Benzoic acid, 3,4,5-trihydroxy-, propyl ester | 3,4,5-Trihydroxybenzoate de propyle |
| 122-32-7 | 9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester | Trioléate de 1,2,3-propanetriyle |
| 122-69-0 | 2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester | Cinnamate de cinnamyle |
| 122-99-6 | Ethanol, 2-phenoxy- | 2-Phénoxyéthanol |
| 123-51-3 | 1-Butanol, 3-methyl- | 3-Méthylbutan-1-ol |
| 123-79-5 | Hexanedioic acid, dioctyl ester | Adipate de dioctyle |
| 124-17-4 | Ethanol, 2-(2-butoxyethoxy)-, acetate | Acétate de 2-(2-butoxyéthoxy)éthyle |
| 124-18-5 | Decane | Décane |
| 124-22-1 | 1-Dodecanamine | Dodécylamine |
| 124-28-7 | 1-Octadecanamine, N,N-dimethyl- | Dimantine |
| 124-63-0 | Methanesulfonyl chloride | Chlorure de méthanesulfonyle |
| 124-68-5 | 1-Propanol, 2-amino-2-methyl- | 2-Amino-2-méthylpropanol |
| 125-46-2 | 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl- | 2,6-Diacétyl-1,2,3,9b-tétrahydro-7,9-dihydroxy-8,9b-diméthyldibenzofurane-1,3-dione |
| 126-00-1 | Benzenebutanoic acid, 4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl- | Acide 4,4-bis(4-hydroxyphényl)valérique |
| 127-65-1 | Benzenesulfonamide, N-chloro-4-methyl-, sodium salt | Tosylchloramide sodique |
| 127-91-3 | Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene- | Pin-2(10)-ène |
| 128-04-1 | Carbamodithioic acid, dimethyl-, sodium salt | Diméthyldithiocarbamate de sodium |
| 129-17-9 | Ethanaminium, N-[4-[[4-(diethylamino)phenyl](2,4disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, hydroxide, inner salt, sodium salt | Hydrogéno[4-[4-(diéthylamino)-2′,4′-disulfonatobenzhydrylidène]cyclohexa-2,5-dién-1-ylidène]diéthylammonium, sel de sodium |
| 131-17-9 | 1,2-Benzenedicarboxylic acid, di-2-propenyl ester | Phtalate de diallyle |
| 131-53-3 | Methanone, (2-hydroxy-4-methoxyphenyl)(2hydroxyphenyl)- | Dioxybenzone |
| 131-55-5 | Methanone, bis(2,4-dihydroxyphenyl)- | 2,2′,4,4′-Tétrahydroxybenzophénone |
| 131-56-6 | Methanone, (2,4-dihydroxyphenyl)phenyl- | 2,4-Dihydroxybenzophénone |
| 131-57-7 | Methanone, (2-hydroxy-4-methoxyphenyl)phenyl- | Oxybenzone |
| 135-19-3 | 2-Naphthalenol | 2-Naphtol |
| 135-37-5 | Glycine, N-(carboxymethyl)-N-(2-hydroxyethyl)-, disodium salt | 2-Hydroxyéthyliminodi(acétate) de disodium |
| 135-57-9 | Benzamide, N,N′-(dithiodi-2,1-phenylene)bis- | N,N′-Dithiodi-o-phénylènedibenzamide |
| 136-30-1 | Carbamodithioic acid, dibutyl-, sodium salt | Dibutyldithiocarbamate de sodium |
| 139-13-9 | Glycine, N,N-bis(carboxymethyl)- | Acide nitrilotriacétique |
| 140-10-3 | 2-Propenoic acid, 3-phenyl-, (E)- | Acide trans-cinnamique |
| 140-67-0 | Benzene, 1-methoxy-4-(2-propenyl)- | 4-Allylanisole |
| 142-16-5 | 2-Butenedioic acid (Z)-, bis(2-ethylhexyl) ester | Maléate de bis(2-éthylhexyle) |
| 142-83-6 | 2,4-Hexadienal, (E,E)- | Hexa-2,4-diénal |
| 143-28-2 | 9-Octadecen-1-ol, (Z)- | (Z)-Octadéc-9-énol |
| 149-44-0 | Methanesulfinic acid, hydroxy-, monosodium salt | Hydroxyméthanesulfinate de sodium |
| 149-57-5 | Hexanoic acid, 2-ethyl- | Acide 2-éthylhexanoïque |
| 287-92-3 | Cyclopentane | Cyclopentane |
| 288-32-4 | 1H-Imidazole | Imidazole |
| 301-10-0 | Hexanoic acid, 2-ethyl-, tin(2++) salt | Bis(2-éthylhexanoate) d'étain |
| 314-13-6 | 1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethyl[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt | 6,6′-[3,3′-Diméthyl-(1,1′-biphényl-4,4′diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphtalènedisulfonate) de tétrasodium |
| 330-54-1 | Urea, N′-(3,4-dichlorophenyl)-N,N-dimethyl- | Diuron |
| 396-01-0 | 2,4,7-Pteridinetriamine, 6-phenyl- | Triamtérène |
| 513-35-9 | 2-Butene, 2-methyl- | 2-Méthylbut-2-ène |
| 520-36-5 | 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)- | 5,7-dihydroxy-2-(hydroxy4-phényl)-4H-1-benzopyran-4-one |
| 540-72-7 | Thiocyanic acid, sodium salt | Thiocyanate de sodium |
| 546-80-5 | Bicyclo[3.1.0]hexan-3-one, 4-methyl-1-(1-methylethyl)-, [1S-(1α,4α,5α)]- | 1-Isopropyl-4-méthylbicyclo[3.1.0]hexan-3-one |
| 552-89-6 | Benzaldehyde, 2-nitro- | 2-Nitrobenzaldéhyde |
| 556-63-8 | Formic acid, lithium salt | Formiate de lithium |
| 563-80-4 | 2-Butanone, 3-methyl- | 3-Méthylbutanone |
| 590-18-1 | 2-Butene, (Z)- | (Z)-But-2-ène |
| 593-56-6 | Hydroxylamine, O-methyl-, hydrochloride | Chlorure de méthoxyammonium |
| 597-82-0 | Phosphorothioic acid, O,O,O-triphenyl ester | Thiophosphate de O,O,O-triphényle |
| 616-45-5 | 2-Pyrrolidinone | 2-Pyrrolidone |
| 624-64-6 | 2-Butene, (E)- | (E)-But-2-ène |
| 624-92-0 | Disulfide, dimethyl | Disulfure de diméthyle |
| 628-96-6 | 1,2-Ethanediol, dinitrate | Dinitrate d'éthylène |
| 629-59-4 | Tetradecane | Tétradécane |
| 646-06-0 | 1,3-Dioxolane | 1,3-Dioxolane |
| 683-18-1 | Stannane, dibutyldichloro- | Dichlorure de dibutylstannane |
| 753-73-1 | Stannane, dichlorodimethyl- | Dichlorure de diméthylstannane |
| 756-79-6 | Phosphonic acid, methyl-, dimethyl ester | Méthylphosphonate de diméthyle |
| 818-08-6 | Stannane, dibutyloxo- | Oxyde de dibutylstannane |
| 822-06-0 | Hexane, 1,6-diisocyanato- | Diisocyanate d'hexaméthylène |
| 868-77-9 | 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester | Méthacrylate de 2-hydroxyéthyle |
| 924-42-5 | 2-Propenamide, N-(hydroxymethyl)- | N-(Hydroxyméthyl)acrylamide |
| 931-36-2 | 1H-Imidazole, 2-ethyl-4-methyl- | 2-Éthyl-4-méthylimidazole |
| 947-04-6 | Azacyclotridecan-2-one | Dodécane-12-lactame |
| 982-57-0 | Butanedioic acid, mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester, monosodium salt | Ester mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophényl)propylique] de l'acide butanedioïque, sel monosodique |
| 989-38-8 | Xanthylium, 9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethyl-, chloride | Chlorure de 9-[2-(éthoxycarbonyl)phényl]3,6-bis(éthylamino)-2,7-diméthylxanthylium |
| 993-16-8 | Stannane, trichloromethyl- | Trichlorométhylstannane |
| 999-97-3 | Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)- | 1,1,1,3,3,3-Hexaméthyldisilazane |
| 1064-48-8 | 2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[(4-nitrophenyl)azo]-6-(phenylazo)-, disodium salt | 4-Amino-5-hydroxy-3-(4-nitrophénylazo)-6-(phénylazo)naphtalène-2,7-disulfonate de sodium |
| 1067-33-0 | Stannane, bis(acetyloxy)dibutyl- | Di(acétate) de dibutylstannane |
| 1067-53-4 | 2,5,7,10-Tetraoxa-6-silaundecane, 6-ethenyl-6-(2-methoxyethoxy)- | Tris(2-méthoxyéthoxy)vinylsilane |
| 1072-63-5 | 1H-Imidazole, 1-ethenyl- | 1-Vinylimidazole |
| 1118-46-3 | Stannane, butyltrichloro- | Trichlorure de butylstannane |
| 1185-55-3 | Silane, trimethoxymethyl- | Triméthoxy(méthyl)silane |
| 1185-81-5 | Stannane, dibutylbis(dodecylthio)- | Dibutylbis(dodécylthio)stannane |
| 1222-05-5 | Cyclopenta[g]-2-benzopyran, 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl- | 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexaméthylindéno[5,6-c]pyrane |
| 1241-94-7 | Phosphoric acid, 2-ethylhexyl diphenyl ester | Phosphate de 2-éthylhexyle et de diphényle |
| 1304-28-5 | Barium oxide (BaO) | Oxyde de baryum, obtenu par calcination de la withérite |
| 1306-38-3 | Cerium oxide (CeO2) | Dioxyde de cérium |
| 1309-64-4 | Antimony oxide (Sb2O3) | Trioxyde de diantimoine |
| 1311-10-0 | Strontium hydroxide (Sr(OH)2), octahydrate | Octahydrate d'hydroxyde de strontium (Sr(OH)2) |
| 1317-35-7 | Manganese oxide (Mn3O4) | Tétraoxyde de trimanganèse |
| 1330-20-7 | Benzene, dimethyl- | Xylène, mélange d'isomères, pur |
| 1506-02-1 | Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- | 1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one |
| 1562-00-1 | Ethanesulfonic acid, 2-hydroxy-, monosodium salt | 2-Hydroxyéthanesulfonate de sodium |
| 1569-02-4 | 2-Propanol, 1-ethoxy- | 1-Éthoxypropan-2-ol |
| 1633-05-2 | Carbonic acid, strontium salt (1:1) | Carbonate de strontium |
| 1634-04-4 | Propane, 2-methoxy-2-methyl- | Oxyde de tert-butyle et de méthyle |
| 1638-22-8 | Phenol, 4-butyl- | 4-Butylphénol |
| 1806-26-4 | Phenol, 4-octyl- | p-Octylphénol |
| 1936-15-8 | 1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-(phenylazo)-, disodium salt | 7-Hydroxy-8-phénylazonaphtalène-1,3-disulfonate de disodium |
| 1962-75-0 | 1,4-Benzenedicarboxylic acid, 1,4-dibutyl ester | téréphtalate de dibutyle, |
| 1987-50-4 | Phenol, 4-heptyl- | 4-Heptylphénol |
| 2173-57-1 | Naphthalene, 2-(2-methylpropoxy)- | Oxyde d'isobutyle et de 2-naphtyle |
| 2216-51-5 | Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1α,2β,5α)]- | 2-Menthol |
| 2315-67-5 | Ethanol, 2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- | 2-[4-(1,1,3,3-Tétraméthylbutyl)phénoxy]éthanol |
| 2386-87-0 | 7-Oxabicyclo[4.1.0]heptane-3-carboxylic acid, 7-oxabicyclo[4.1.0]hept-3-ylmethyl ester | 7-Oxabicyclo[4.1.0]heptane-3-carboxylate de 7-oxabicyclo[4.1.0]hept-3-ylméthyle |
| 2432-99-7 | Undecanoic acid, 11-amino- | Acide 11-aminoundécanoïque |
| 2440-22-4 | Phenol, 2-(2H-benzotriazol-2-yl)-4-methyl- | 2-(2H-Benzotriazol-2-yl)-p-crésol |
| 2463-53-8 | 2-Nonenal | Non-2-énal |
| 2530-83-8 | Silane, trimethoxy[3-(oxiranylmethoxy)propyl]- | [3-(2,3-Époxypropoxy)propyl]triméthoxysilane |
| 2530-85-0 | 2-Propenoic acid, 2-methyl-, 3-(trimethoxysilyl)propyl ester | Méthacrylate de 3-triméthoxysilylpropyle |
| 2530-87-2 | Silane, (3-chloropropyl)trimethoxy- | 3-Chloropropyltriméthoxysilane |
| 2610-05-1 | 1,3-Naphthalenedisulfonic acid, 6,6′-[(3,3′-dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4-amino-5-hydroxy-, tetrasodium salt | 1-naphtalénol, 2-méthyl-, 1-acétate |
| 2650-18-2 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, diammonium salt | Diammonio(éthyl)[4-({4-[éthyl(3-sulfonatobenzyl)amino]phényl}(2-sulfonatophényl)méthylène)cyclohexa-2,5-dién-1-ylidène](3-sulfonatobenzyl)ammonium |
| 2680-03-7 | 2-Propenamide, N,N-dimethyl- | N,N-Diméthylacrylamide |
| 2768-02-7 | Silane, ethenyltrimethoxy- | Triméthoxyvinylsilane |
| 2781-10-4 | Stannane, dibutylbis[(2-ethyl-1-oxohexyl)oxy]- | Bis(2-éthylhexanoate) de dibutylétain |
| 2855-13-2 | Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl- | 3-Aminométhyl-3,5,5-triméthylcyclohexylamine |
| 2935-90-2 | Propanoic acid, 3-mercapto-, methyl ester | 3-Mercaptopropionate de méthyle |
| 2996-92-1 | Silane, trimethoxyphenyl- | Triméthoxyphénylsilane |
| 3081-01-4 | 1,4-Benzenediamine, N-(1,4-dimethylpentyl)-N′-phenyl- | N-(1,4-Diméthylpentyl)-N′-phénylbenzène-1,4-diamine |
| 3164-85-0 | Hexanoic acid, 2-ethyl-, potassium salt | 2-Éthylhexanoate de potassium |
| 3248-91-7 | Benzenamine, 4-[(4-amino-3-methylphenyl)(4-imino-3-methyl-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, monohydrochloride | 4-[(4-Amino-m-tolyl)(4-imino-3-méthylcyclohexa-2,5-dién-1-ylidène)méthyl]-o-toluidine, monochlorhydrate |
| 3268-49-3 | Propanal, 3-(methylthio)- | 3-(Méthylthio)propionaldéhyde |
| 3302-10-1 | Hexanoic acid, 3,5,5-trimethyl- | Acide 3,5,5-triméthylhexanoïque |
| 3322-93-8 | Cyclohexane, 1,2-dibromo-4-(1,2-dibromoethyl)- | 1,2-Dibromo-4-(1,2-dibromoéthyl)cyclohexane |
| 3520-42-1 | Xanthylium, 3,6-bis(diethylamino)-9-(2,4-disulfophenyl)-, hydroxide, inner salt, sodium salt | Hydrogéno-3,6-bis(diéthylamino)-9-(2,4-disulfonatophényl)xanthylium, sel de sodium |
| 3648-18-8 | Stannane, dioctylbis[(1-oxododecyl)oxy]- | Dilaurate de dioctylétain |
| 3669-02-1 | Distannoxane, 1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]- | 1,1,3,3,-Tétrabutyl-1,3-bis[(1-oxododécyl)oxy]distannoxane |
| 3864-99-1 | Phenol, 2-(5-chloro-2H-benzotriazol-2-yl)-4,6-bis(1,1-dimethylethyl)- | 2,4-Di-tert-butyl-6-(5-chlorobenzotriazol-2-yl)phénol |
| 3926-62-3 | Acetic acid, chloro-, sodium salt | Chloroacétate de sodium |
| 3982-87-4 | Phosphine sulfide, tris(2-methylpropyl)- | Sulfure de triisobutylphosphine |
| 4065-45-6 | Benzenesulfonic acid, 5-benzoyl-4-hydroxy-2-methoxy- | Sulisobenzone |
| 4067-16-7 | 3,6,9,12-Tetraazatetradecane-1,14-diamine | 3,6,9,12-Tétraazatétradécaméthylènediamine |
| 4191-73-5 | Benzoic acid, 4-hydroxy-, 1-methylethyl ester | 4-Hydroxybenzoate d'isopropyle |
| 4198-19-0 | 2,7-Naphthalenedisulfonic acid, 3,3′-[(3,3′dimethoxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[4,5-dihydroxy-, tetrasodium salt | 3,3′-{[3,3′-Diméthoxy(1,1′-biphényl)-4,4′diyl]bis(azo)}bis(4,5-dihydroxynaphtalène-2,7-disulfonate) de tétrasodium |
| 4247-02-3 | Benzoic acid, 4-hydroxy-, 2-methylpropyl ester | 4-Hydroxybenzoate d'isobutyle |
| 4253-22-9 | Stannane, dibutylthioxo- | Dibutylthioxostannane |
| 4403-90-1 | Benzenesulfonic acid, 2,2′-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-methyl-, disodium salt | 2,2′-(9,10-Dioxoanthracène-1,4-diyldiimino)bis(5-méthylsulfonate de disodium |
| 4424-06-0 | Bisbenzimidazo[2,1-b:2′,1′i]benzo[lmn][3,8]phenanthroline-8,17-dione | Bisbenzimidazo[2,1-b:2′,1′-i]benzo[lmn][3,8]phénanthroline-8,17-dione |
| 4712-55-4 | Phosphonic acid, diphenyl ester | Phosphonate de diphényle |
| 4719-04-4 | 1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol | 2,2′,2″-(Hexahydro-1,3,5-triazine-1,3,5-triyl)triéthanol |
| 5026-74-4 | Oxiranemethanamine, N-[4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)- | p-(2,3-Époxypropoxy)-N,N-bis(2,3-époxypropyl)aniline |
| 5039-78-1 | Ethanaminium, N,N,N-trimethyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, chloride | Chlorure de [2(méthacryloyloxy)éthyl]triméthylammonium |
| 5124-30-1 | Cyclohexane, 1,1′-methylenebis[4-isocyanato- | Diisocyanate de 4,4′-méthylènedicyclohexyle |
| 5141-20-8 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](4-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, hydroxide, inner salt, disodium salt | Dihydrogéno(éthyl)(4-{p-[éthyl(msulfonatobenzyl)amino]-p′sulfonatobenzhydrylène}cyclohexa-2,5-dién-1ylidène)(m-sulfonatobenzyl)ammonium, sel de disodium |
| 5146-66-7 | 2,6-Octadienenitrile, 3,7-dimethyl- | 3,7-Diméthylocta-2,6-diènenitrile |
| 5153-25-3 | Benzoic acid, 4-hydroxy-, 2-ethylhexyl ester | 4-Hydroxybenzoate de 2-éthylhexyle |
| 5165-97-9 | 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propenyl)amino]-, monosodium salt | 2-Méthyl-2-[(1-oxoallyl)amino]propanesulfonate de sodium |
| 5392-40-5 | 2,6-Octadienal, 3,7-dimethyl- | Citral |
| 5435-64-3 | Hexanal, 3,5,5-trimethyl- | 3,5,5-Triméthylhexanal |
| 5466-77-3 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, 2-ethylhexyl ester | 4-Méthoxycinnamate de 2-éthylhexyle |
| 5847-55-2 | Stannane, dibutylbis[(1-oxooctadecyl)oxy]- | Dibutylbis(stéaroyloxy)stannane |
| 5989-27-5 | Cyclohexene, 1-methyl-4-(1-methylethenyl)-, (R)- | (R)-p-Mentha-1,8-diène |
| 6104-30-9 | Urea, N,N″-(2-methylpropylidene)bis- | N,N″-(Isobutylidène)diurée |
| 6197-30-4 | 2-Propenoic acid, 2-cyano-3,3-diphenyl-, 2-ethylhexyl ester | Octocrylène |
| 6259-76-3 | Benzoic acid, 2-hydroxy-, hexyl ester | Salicylate d'hexyle |
| 6362-79-4 | 1,3-Benzenedicarboxylic acid, 5-sulfo-, monosodium salt | Hydrogéno-5-sulfoisophtalate de sodium |
| 6373-74-6 | Benzenesulfonic acid, 5-[(2,4-dinitrophenyl)amino]-2-(phenylamino)-, monosodium salt | 2-Anilino-5-(2,4-dinitroanilino)benzènesulfonate de sodium |
| 6419-19-8 | Phosphonic acid, [nitrilotris(methylene)]tris- | Acide nitrilotriméthylènetriphosphonique |
| 6422-86-2 | 1,4-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester | Téréphtalate de bis(2-éthylhexyle) |
| 6528-34-3 | Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]N-(2-methoxyphenyl)-3-oxo- | 2-[(4-Méthoxy-2-nitrophényl)azo]-N-(2-méthoxyphényl)-3-oxobutyramide |
| 6728-26-3 | 2-Hexenal, (E)- | trans-Hex-2-énal |
| 6731-36-8 | Peroxide, (3,3,5-trimethylcyclohexylidene)bis[(1,1dimethylethyl) | Diperoxyde de di-tert-butyle et de 3,3,5-triméthylcyclohexylidène |
| 6739-62-4 | Benzoic acid, 2-[[2-amino-6-[[4′-[(3-carboxy-4-hydroxyphenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-5-hydroxy-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt | 2-[[2-Amino-6-[[4′-[(3-carboxylato-4hydroxyphényl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]-5-hydroxy-7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium |
| 6834-92-0 | Silicic acid (H2SiO3), disodium salt | Métasilicate de disodium |
| 6842-15-5 | 1-Propene, tetramer | Prop-1-ène tétramérisé |
| 6864-37-5 | Cyclohexanamine, 4,4′-methylenebis[2-methyl- | 2,2′-Diméthyl-4,4′-méthylènebis(cyclohexylamine) |
| 7381-01-3 | Dodecanoic acid, 2-sulfoethyl ester, sodium salt | Laurate de sodium et de 2-sulfonatoéthyle |
| 7398-69-8 | 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride | Chlorure de diallyldiméthylammonium |
| 7488-55-3 | Sulfuric acid, tin(2++) salt (1:1) | Sulfate d'étain |
| 7492-66-2 | 2,6-Octadiene, 1,1-diethoxy-3,7-dimethyl- | 1,1-Diéthoxy-3,7-diméthylocta-2,6-diène |
| 7563-33-9 | Butanoic acid, 3-methyl-, ammonium salt | Isovalérate d'ammonium |
| 7601-89-0 | Perchloric acid, sodium salt | Perchlorate de sodium |
| 7631-95-0 | Molybdate (MoO42-), disodium, (ß-4)- | Molybdate de disodium |
| 7637-07-2 | Borane, trifluoro- | Trifluorure de bore |
| 7646-78-8 | Stannane, tetrachloro- | Tétrachlorure d'étain |
| 7647-15-6 | Sodium bromide (NaBr) | Bromure de sodium |
| 7699-43-6 | Zirconium, dichlorooxo- | Oxydichlorure de zirconium |
| 7719-09-7 | Thionyl chloride | Dichlorure de thionyle |
| 7722-64-7 | Permanganic acid (HMnO4), potassium salt | Permanganate de potassium |
| 7757-74-6 | Disulfurous acid, disodium salt | Anhydrosulfite disodique |
| 7757-86-0 | Phosphoric acid, magnesium salt (1:1) | Hydrogénoorthophosphate de magnésium |
| 7758-02-3 | Potassium bromide (KBr) | Bromure de potassium |
| 7758-09-0 | Nitrous acid, potassium salt | Nitrite de potassium |
| 7758-19-2 | Chlorous acid, sodium salt | Chlorite de sodium |
| 7773-01-5 | Manganese chloride (MnCl2) | Dichlorure de manganèse |
| 7775-14-6 | Dithionous acid, disodium salt | Dithionite de sodium |
| 7775-27-1 | Peroxydisulfuric acid ([(HO)S(O)2]2O2), disodium salt | Peroxodisulfate de disodium |
| 7783-47-3 | Tin fluoride (SnF2) | Difluorure d'étain |
| 7785-87-7 | Sulfuric acid, manganese(2++) salt (1:1) | Sulfate de manganèse |
| 7789-23-3 | Potassium fluoride (KF) | Fluorure de potassium |
| 7791-07-3 | Sodium perchlorate, monohydrate | Monohydrate de perchlorate de sodium |
| 7791-25-5 | Sulfuryl chloride | Dichlorure de sulfuryle |
| 7803-51-2 | Phosphine | Phosphine |
| 8012-00-8 | C.I. Pigment Yellow 41 | Pyrochlore, jaune d'antimoine et de plomb |
| 8068-05-1 | Lignin, alkali | Thiolignine |
| 9003-36-5 | Formaldehyde, polymer with (chloromethyl)oxirane and phenol | Formaldéhyde polymérisé avec le (chlorométhyl)oxirane et le phénol |
| 9006-27-3 | Poly(oxy-1,2-ethanediyl), α-(1-oxododecyl)-ω-methoxy- | α-Lauroyl-ω-méthoxypoly(oxyéthylène) |
| 9017-01-0 | Benzene, 1,3-diisocyanatomethyl-, homopolymer | Diisocyanate de m-tolylidène, homopolymérisé |
| 9046-10-0 | Poly[oxy(methyl-1,2-ethanediyl)], α-(2-aminomethylethyl)-ω-(2-aminomethylethoxy)- | α-[2-(Aminométhyl)éthyl]-ω-[2(aminométhyl)éthoxy]poly[oxy(méthyléthylène)] |
| 10025-70-4 | Strontium chloride (SrCl2), hexahydrate | chlorure de strontium, 6-hydrate |
| 10026-06-9 | Stannane, tetrachloro-, hydrate (1:5) | Hydrate de tétrachlorostannane (5/1) |
| 10042-84-9 | Glycine, N,N-bis(carboxymethyl)-, sodium salt | 2,2′,2″-Nitrilotriacétate de sodium |
| 10102-40-6 | Molybdate (MoO42-), sodium, hydrate (1:2:2), (T-4)- | Dihydrate de (T 4) molybdate(MoO42-) de disodium |
| 10117-38-1 | Sulfurous acid, dipotassium salt | Sulfite de potassium |
| 10213-10-2 | Tungstate (WO42-), disodium, dihydrate, (T-4)- | Dihydrate de (T-4)-tungstate (WO42-) de disodium |
| 10377-60-3 | Nitric acid, magnesium salt | Nitrate de magnésium |
| 10476-85-4 | Strontium chloride (SrCl2) | Chlorure de strontium |
| 10584-98-2 | 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 4,4-dibutyl-10-ethyl-7-oxo-, 2-ethylhexyl ester | 4,4-Dibutyl-10-éthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle |
| 11070-44-3 | 1,3-Isobenzofurandione, tetrahydromethyl- | Anhydride tétrahydrométhylphtalique |
| 12040-43-6 | Silicic acid, aluminum magnesium sodium salt | Acide silicique, sel d'aluminium, de magnésium et de sodium |
| 12058-66-1 | Stannate (SnO32-), disodium | Trioxyde d'étain et de disodium |
| 12070-12-1 | Tungsten carbide (WC) | Carbure de tungstène |
| 12125-03-0 | Stannate (SnO32-), dipotassium, trihydrate | Trihydrate de stannate (SnO32-) de dipotassium |
| 12142-33-5 | Stannate (SnO32-), dipotassium | Trioxyde d'étain et de dipotassium |
| 12222-00-3 | Cuprate(4-), [µ-[[4,4′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[3-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium | [µ-[[4,4′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[3-hydroxynaphtalène-2,7disulfonato]](8-)]]dicuprate(4-) de tétrasodium |
| 13311-84-7 | Propanamide, 2-methyl-N-[4-nitro-3(trifluoromethyl)phenyl]- | 2-méthyl-N-[4-nitro-3(trifluorométhyl)phényl]propanamide |
| 13323-62-1 | Stannane, dibutylbis[(1-oxo-9-octadecenyl)oxy]-, (Z,Z)- | Dibutylbis(octadéc-9(Z)-énoyloxy)stannane |
| 13446-34-9 | Manganese chloride (MnCl2), tetrahydrate; | Tétrahydrate de chlorure de manganèse (MnCl2) |
| 13455-21-5 | Potassium fluoride dihydrate | Dihydrate de fluorure de potassium |
| 13466-08-5 | Sodium bromide dihydrate | Dihydrate de bromure de sodium |
| 13472-45-2 | Tungstate (WO42-), disodium, (ß-4)- | Tungstate de disodium |
| 13473-26-2 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-4,5,6,7-tetrachloro-3′,6′-dihydroxy- | 2′,4′,5′,7′-Tétrabromo-4,5,6,7-tétrachloro-3′,6′-dihydroxyspiro[isobenzofurane-1(3H),9′[9H]xanthène]-3-one |
| 13475-82-6 | Heptane, 2,2,4,6,6-pentamethyl- | 2,2,4,6,6-Pentaméthylheptane |
| 13520-92-8 | Zirconium, dichlorooxo-, octahydrate | Octahydrate d'oxyde de dichlorozirconium |
| 13752-51-7 | Morpholine, 4-[(4-morpholinylthio)thioxomethyl]- | 4-[(Morpholinothio)thioxométhyl]morpholine |
| 13775-53-6 | Aluminate(3-), hexafluoro-, trisodium, (OC-6-11)- | Hexafluoroaluminate de trisodium |
| 14025-21-9 | Zincate(2-), [[N,N′-1,2-ethanediylbis[N-(carboxymethyl)glycinato]](4-)-N,N′,O,O′,ON,ON′]-, disodium, (OC-6-21)- | ({N,N′-Éthylènediylbis[N(carboxylatométhyl)glycinato(4-)]}N,N′,O,O′,ON,ON′)zincate(2-) de disodium |
| 14254-22-9 | Stannane, butoxydibutylchloro- | Butoxydibutylchlorostannane |
| 14901-07-6 | 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)- | 4-(2,6,6-Triméthylcyclohex-1-én-1-yl)-but-3-én-2-one |
| 15546-11-9 | 2,7,9-Trioxa-8-stannatrideca-4,11-dien-13-oic acid, 8,8-dibutyl-3,6,10-trioxo-, methyl ester, (Z,Z)- | (Z,Z)-8,8-Dibutyl-3,6,10-trioxo-2,7,9-trioxa-8-stannatridéca-4,11-dién-13-oate de méthyle |
| 15546-12-0 | 5,7,12-Trioxa-6-stannaoctadeca-2,9-dienoic acid, 6,6-dibutyl-14-ethyl-4,8,11-trioxo-, 2-ethylhexyl ester | 6,6-Dibutyl-14-éthyl-4,8,11-trioxo-5,7,12-trioxa-6-stannaoctadéca-2,9-diénoate de 2-éthylhexyle |
| 15546-16-4 | 5,7,12-Trioxa-6-stannahexadeca-2,9-dienoic acid, 6,6-dibutyl-4,8,11-trioxo-, butyl ester, (Z,Z)- | (Z,Z)-6,6-Dibutyl-4,8,11-trioxo-5,7,12-trioxa-6-stannahexadéca-2,9-diénoate de butyle |
| 15571-58-1 | 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dioctyl-7-oxo-, 2-ethylhexyl ester | 10-Éthyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle |
| 15625-89-5 | 2-Propenoic acid, 2-ethyl-2-[[(1-oxo-2propenyl)oxy]methyl]-1,3-propanediyl ester | Diacrylate de 2-éthyl-2-[[(1oxoallyl)oxy]méthyl]propane-1,3-diyle |
| 15630-89-4 | Carbonic acid disodium salt, compd. with hydrogen peroxide (H2O2) (2:3) | Carbonate de disodium, composé avec le peroxyde d'hydrogène(2:3) |
| 16056-95-4 | Strontium chloride (SrCl2), dihydrate; | Dihydrate de chlorure de strontium (SrCl2) |
| 16091-18-2 | 1,3,2-Dioxastannepin-4,7-dione, 2,2-dioctyl- | Maléate de dioctylstannane |
| 16409-43-1 | 2H-Pyran, tetrahydro-4-methyl-2-(2-methyl-1-propenyl)- | Tétrahydro-4-méthyl-2-(2-méthylprop-1-ényl)pyrane |
| 16423-68-0 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-, disodium salt | 2-(2,4,5,7-Tétraiodo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium |
| 16470-24-9 | Benzenesulfonic acid, 2,2′-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt | 4,4′-Bis[[4-[bis(2-hydroxyéthyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]stilbène-2,2′-disulfonate] de tétrasodium |
| 16731-55-8 | Disulfurous acid, dipotassium salt | Bisulfite de dipotassium |
| 17372-87-1 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy-, disodium salt | 2-(2,4,5,7-Tétrabromo-6-oxydo-3-oxoxanthén-9yl)benzoate de disodium |
| 17589-24-1 | 1,3-Diazetidine-2,4-dione, 1,3-bis[4-[(4-isocyanatophenyl)methyl]phenyl]- | Diisocyanate de 2,4-dioxo-1,3-diazétidine-1,3-diylbis[p-phénylèneméthylène-p-phénylène] |
| 17796-82-6 | 1H-Isoindole-1,3(2H)-dione, 2-(cyclohexylthio)- | N-(Cyclohexylthio)phtalimide |
| 18127-01-0 | Benzenepropanal, 4-(1,1-dimethylethyl)- | 3-(4-tert-Butylphényl)propionaldéhyde |
| 18172-67-3 | Bicyclo[3.1.1]heptane, 6,6-dimethyl-2-methylene-, (1S)- | (-)-Pin-2(10)-ène |
| 18282-10-5 | Tin oxide (SnO2) | Dioxyde d'étain |
| 18480-07-4 | Strontium hydroxide (Sr(OH)2) | Hydroxyde de strontium |
| 19438-60-9 | 1,3-Isobenzofurandione, hexahydro-5-methyl- | Anhydride hexahydro-4-méthylphtalique |
| 19766-89-3 | Hexanoic acid, 2-ethyl-, sodium salt | 2-Éthylhexanoate de sodium |
| 20325-40-0 | [1,1′-Biphenyl]-4,4′-diamine, 3,3′-dimethoxy-, dihydrochloride | Dichlorure de 3,3′-diméthoxybiphényl-4,4′-ylènediammonium |
| 20603-88-7 | Manganese chloride (MnCl2), dihydrate | Dihydrate de chlorure de manganèse (MnCl2) |
| 21145-77-7 | Ethanone, 1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- | 1-(5,6,7,8-Tétrahydro-3,5,5,6,8,8-hexaméthyl-2naphtyl)éthan-1-one |
| 22205-30-7 | Stannane, bis(dodecylthio)dioctyl- | Bis(dodécylthio)dioctylstannane |
| 22373-78-0 | Monensin, monosodium salt | Monensin, sel monosodique |
| 22464-99-9 | Hexanoic acid, 2-ethyl-, zirconium salt | Acide 2-éthylhexanoïque, sel de zirconium |
| 22673-19-4 | Tin, dibutylbis(2,4-pentanedionato-O,O′)-, (OC-6-11)- | Dibutylbis(pentane-2,4-dionato-O,O′)stannane |
| 25155-25-3 | Peroxide, [1,3(or 1,4)-phenylenebis(1-methylethylidene)]bis[(1,1-dimethylethyl) | Peroxyde de [1,3(ou et de 1,4)-phénylènebis(1-méthyléthylidène)]bis[tert-butyle] |
| 25167-67-3 | Butene | Butène |
| 25167-70-8 | Pentene, 2,4,4-trimethyl- | 2,4,4-Triméthylpentène |
| 25168-21-2 | 2-Butenoic acid, 4,4′-[(dibutylstannylene)bis(oxy)]bis[4-oxo-, diisooctyl ester, (Z,Z)- | 4,4′-[(Dibutylstannylène)bis(oxy)]bis[4-oxoisocrotonate] de diisooctyle |
| 25168-22-3 | Stannane, dibutylbis[(1-oxoneodecyl)oxy]- | Dibutylbis[(1-oxonéodécyl)oxy]stannane |
| 25168-24-5 | Acetic acid, 2,2′-[(dibutylstannylene)bis(thio)]bis-, diisooctyl ester | 2,2′-[(Dibutylstannylène)bis(thio)]diacétate de diisooctyle |
| 25214-63-5 | 1,2-Ethanediamine, polymer with methyloxirane | Éthane-1,2-diamine polymérisée avec le méthyloxirane |
| 25214-70-4 | Formaldehyde, polymer with benzenamine | Formaldéhyde polymérisé avec l'aniline |
| 25321-09-9 | Benzene, bis(1-methylethyl)- | Diisopropylbenzène |
| 25340-17-4 | Benzene, diethyl- | Diéthylbenzène |
| 25584-83-2 | 2-Propenoic acid, monoester with 1,2-propanediol | Acide acrylique, monoester avec le propane-1,2-diol |
| 25686-28-6 | Benzene, 1,1′-methylenebis[4-isocyanato-, homopolymer | Diisocyanate de 4,4′-méthylènediphényle homopolymérisé |
| 25723-16-4 | Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) | α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (3:1) avec le propylidynetriméthanol |
| 26401-86-5 | Acetic acid, 2,2′,2″-[(octylstannylidyne)tris(thio)]tris-, triisooctyl ester | 2,2′,2″-[(Octylstannylidyne)tris(thio)]triacétate de triisooctyle |
| 26401-97-8 | Acetic acid, 2,2′-[(dioctylstannylene)bis(thio)]bis-, diisooctyl ester | 2,2′-[(Dioctylstannylène)bis(thio)]diacétate de diisooctyle |
| 26472-00-4 | 4,7-Methano-1H-indene, 3a,4,7,7a-tetrahydrodimethyl- | Méthylcyclopentadiène |
| 26658-42-4 | 1,2-Ethanediamine, N-(2-aminoethyl)-N′-[2-[(2-aminoethyl)amino]ethyl]-, polymer with (chloromethyl)oxirane | 3,6,9-Triazaundécane-1,11-diamine polymérisée avec le (chlorométhyl)oxirane |
| 26761-45-5 | Neodecanoic acid, oxiranylmethyl ester | Néodécanoate de 2,3-époxypropyle |
| 27029-41-0 | 1,3-Propanediamine, N,N-dimethyl-, polymer with (chloromethyl)oxirane | N,N-Diméthylpropane-1,3-diamine polymérisée avec le (chlorométhyl)oxirane |
| 27107-89-7 | 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-, 2-ethylhexyl ester | 10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle |
| 27247-96-7 | Nitric acid, 2-ethylhexyl ester | Nitrate de 2-éthylhexyle |
| 27344-41-8 | Benzenesulfonic acid, 2,2′-([1,1′-biphenyl]-4,4′-diyldi-2,1-ethenediyl)bis-, disodium salt | 2,2′-([1,1′-Biphényl]-4,4′diyldivinylène)bis(benzènesulfonate) de disodium |
| 27813-02-1 | 2-Propenoic acid, 2-methyl-, monoester with 1,2-propanediol | Acide méthacrylique, monoester avec le propane-1,2-diol |
| 28407-37-6 | Cuprate(4-), [µ-[[3,3′-[(3,3′-dihydroxy[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[5-amino-4-hydroxy-2,7-naphthalenedisulfonato]](8-)]]di-, tetrasodium | [µ-[[3,3′-[(3,3′-Dihydroxy[1,1′-biphényl]-4,4′diyl)bis(azo)]bis[5-amino-4-hydroxynaphtalène-2,7-disulfonato]](8-)]]dicuprate(4-) de tétrasodium |
| 28472-97-1 | Nonanedioic acid, diisodecyl ester | Azélate de diisodécyle |
| 28883-73-0 | Poly(oxy-1,2-ethanediyl), α,α′[(octadecylimino)di-2,1-ethanediyl]bis[ω-hydroxy-, hydrochloride | α,α′-{[(Octadécyl)imino]diéthylène}bis[ω-hydroxypoly(oxyéthylène)], chlorhydrate |
| 28961-43-5 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-[(1-oxo-2-propenyl)oxy]-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) | α-Hydro-ω-(acryloyloxy)poly(oxyéthylène), éther (3:1) avec le propylidynetriméthanol |
| 30499-70-8 | 1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with (chloromethyl)oxirane | 2-Éthyl-2-(hydroxyméthyl)propane-1,3-diol polymérisé avec le (chlorométhyl)oxirane |
| 31107-36-5 | 1,3-Diazetidin-2-one, 1,3-bis[4-[(4isocyanatophenyl)methyl]phenyl]-4-[[4-[(4-isocyanatophenyl)methyl]phenyl]imino]- | Diisocyanate de 4-[[p-(pisocyanatobenzyl)phényl]imino]-2-oxo-1,3-diazétidine-1,3-diylbis(p-phénylèneméthylène-p-phénylène) |
| 31394-54-4 | Isoheptane | Isoheptane |
| 32388-55-9 | Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-, [3R-(3α,3aβ,7β,8aα)]- | [3R-(3α,3aβ,7β,8aα)]-1-(2,3,4,7,8,8a-Hexahydro-3,6,8,8-tétraméthyl-1H-3a,7-méthanoazulén-5-yl)éthan-1-one |
| 32492-61-8 | Poly(oxy-1,2-ethanediyl), α,α′-[(1-methylethylidene)di4,1-phenylene]bis[ω-hydroxy- | α,α′-(Isopropylidènedi-p-phénylène)bis[ωhydroxypoly(oxyéthylène)] |
| 33145-10-7 | Phenol, 2,2′-(2-methylpropylidene)bis[4,6-dimethyl- | 2,2′-(2-Méthylpropylidène)bis[4,6-xylénol] |
| 34041-09-3 | Hexanoic acid, 2-ethyl-, molybdenum salt | Acide 2-éthylhexanoïque, sel de molybdène |
| 35176-06-8 | Ethanol, 2,2′-iminobis-, polymer with methyloxirane | 2,2′-Iminodiéthanol polymérisé avec le méthyloxirane |
| 36631-30-8 | 1,2,4-Benzenetricarboxylic acid, 1,2,4-triisodecyl ester | Benzène-1,2,4-tricarboxylate de triisodécyle |
| 37353-75-6 | Poly[oxy(methyl-1,2-ethanediyl)], α,α′-[(1-methylethylidene)di-4,1-phenylene]bis[ω-hydroxy- | α,α′-(Isopropylidènedi-p-phénylène)bis{ωhydroxypoly[oxy(méthyléthylène)]} |
| 37640-57-6 | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, compd. with 1,3,5-triazine-2,4,6-triamine (1:1) | 1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, composé avec la 1,3,5-triazine-2,4,6-triamine (1:1) |
| 37853-59-1 | Benzene, 1,1′-[1,2ethanediylbis(oxy)]bis[2,4,6-tribromo- | 1,1′-(Éthane-1,2-diylbisoxy)bis(2,4,6-tribromobenzène) |
| 37971-36-1 | 1,2,4-Butanetricarboxylic acid, 2-phosphono- | Acide 2-phosphonobutane-1,2,4-tricarboxylique |
| 40530-60-7 | Carbonic acid, 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]ethyl ethyl ester | Carbonate d'éthyle et de 2-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy]éthyle |
| 41272-40-6 | Methanaminium, N-[4-[[4-(dimethylamino)phenyl]phenylmethylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate | Acétate de [4-[α-[4(diméthylamino)phényl]benzylidène]cyclohexa-2,5-dién-1-ylidène]diméthylammonium |
| 42978-66-5 | 2-Propenoic acid, (1-methyl-1,2ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] ester | Diacrylate de (1-méthyléthane-1,2diyl)bis[oxy(méthyléthylène)] |
| 44992-01-0 | Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2propenyl)oxy]-, chloride | Chlorure de [2-(acryloyloxy)éthyl]triméthylammonium |
| 50586-59-9 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) | α-Hydro-ω-hydroxypoly(oxyéthylène), éther (3:1) avec le 2-éthyl-2-(hydroxyméthyl)propane-1,3-diol |
| 52408-84-1 | Poly[oxy(methyl-1,2-ethanediyl)], α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxo-2-propenyl)oxy]- | α,α′,α″-Propane-1,2,3-triyltris{ω(acryloyloxy)poly[oxy(méthyléthylène)]} |
| 52625-13-5 | Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with D-glucitol (6:1) | α-Hydro-ω-hydroxypoly[oxy(méthyléthylène)], éther (6:1) avec le D-glucitol |
| 53148-32-6 | Hexanoic acid, 2-ethyl-, 1,4-cyclohexanediylbis(methylene) ester | Bis(2-éthylhexanoate) de cyclohexane-1,4-diylbisméthylène |
| 53306-54-0 | 1,2-Benzenedicarboxylic acid, bis(2-propylheptyl) ester | Phtalate de bis(2-propylheptyle) |
| 53988-10-6 | 2H-Benzimidazole-2-thione, 1,3-dihydro-4(or 5)-methyl- | 1,3-Dihydro-4(ou-5)-méthyl-2H-benzimidazole-2-thione |
| 54076-97-0 | Ethanaminium, N,N,N-trimethyl-2-[(1-oxo-2-propenyl)oxy]-, chloride, homopolymer | Chlorure de [2-(acryloyl)oxy]triméthylammonium homopolymérisé |
| 54423-67-5 | Neononanoic acid, ethenyl ester | Néononanoate de vinyle |
| 54464-57-2 | Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- | 1-(1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one |
| 54464-59-4 | Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthalenyl)- | 1-(1,2,3,4,5,6,7,8-Octahydro-2,3,5,5-tétraméthyl-2-naphtyl)éthan-1-one |
| 54849-38-6 | Acetic acid, 2,2′,2″-[(methylstannylidyne)tris(thio)]tris-, triisooctyl ester | 2,2′,2″-[(Méthylstannylidyne)tris(thio)]triacétate de triisooctyle |
| 57018-52-7 | 2-Propanol, 1-(1,1-dimethylethoxy)- | 1-tert-Butoxypropan-2-ol |
| 57219-64-4 | Zirconium, [µ-[carbonato(2-)-O:O′]]dihydroxydioxodi- | [µ-[Carbonéato(2-)-O:O′]]dihydroxydioxodizirconium |
| 57583-34-3 | 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-, 2-ethylhexyl ester | 10-Éthyl-4-[[2-[(2-éthylhexyl)oxy]-2-oxoéthyl]thio]-4-méthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle |
| 57583-35-4 | 8-Oxa-3,5-dithia-4-stannatetradecanoic acid, 10-ethyl-4,4-dimethyl-7-oxo-, 2-ethylhexyl ester | 10-Éthyl-4,4-diméthyl-7-oxo-8-oxa-3,5-dithia-4-stannatétradécanoate de 2-éthylhexyle |
| 61791-39-7 | 1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs. | 4,5-Dihydro-1H-imidazole-1-éthanol, dérivés de 2-nortallöl alkyles |
| 63500-71-0 | 2H-Pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl)- | 2-Isobutyl-4-méthyltétrahydro-2H-pyran-4-ol |
| 64742-10-5 | Extracts (petroleum), residual oil solvent | Extraits au solvant (pétrole), huile résiduelle |
| 65997-17-3 | Glass, oxide, chemicals | Verre aux oxydes, produits chimiques |
| 66418-17-5 | Cuprate(3-), [µ-[4-[[4′-[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3′-dihydroxy[1,1′-biphenyl]-4yl]azo]-3-hydroxy-2,7-naphthalenedisulfonato(7-)]]di-, trisodium | [µ-[4-[[4′-[(6-Amino-1-hydroxy-3-sulfo-2-naphtyl)azo]3,3′-dihydroxy[1,1′-biphényl]-4-yl]azo]-3-hydroxynaphtalène-2,7-disulfonato(7-)]]dicuprate(3-) de trisodium |
| 67762-79-2 | 2,5-Furandione, dihydro-, monopolybutenyl derivs. | Anhydride succinique, dérivés mono[poly(butényliques)] |
| 67800-94-6 | 1,3-Benzenediamine, ar-methyl-, polymer with methyloxirane and oxirane | Benzène-1,3-diamine, ar-méthylée, polymérisée avec le méthyloxirane et l'oxirane |
| 67989-23-5 | 1,2,4-Benzenetricarboxylic acid, decyl octyl ester | Acide benzène-1,2,4-tricarboxylique, ester de décyle et d'octyle |
| 68092-47-7 | Benzoic acid, 3-methyl-, barium salt | m-Toluate de baryum |
| 68131-73-7 | Amines, polyethylenepoly- | Amines, polyéthylènepoly- |
| 68155-66-8 | Ethanone, 1-(1,2,3,5,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- | 1-(1,2,3,5,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one |
| 68155-67-9 | Ethanone, 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)- | 1-(1,2,3,4,6,7,8,8a-Octahydro-2,3,8,8-tétraméthyl-2-naphtyl)éthan-1-one |
| 68186-85-6 | C.I. Pigment Green 50 | Spinelle vert de titanite de cobalt |
| 68186-90-3 | C.I. Pigment Brown 24 | Rutile couleur chamois de chrome, d'antimoine et de titane |
| 68187-10-0 | C.I. Pigment Brown 34 | Spinelle brun de ferrite de nickel |
| 68299-15-0 | Stannane, dioctylbis[(1-oxoneodecyl)oxy]- | Bis(néodécanoyloxy)dioctylstannane |
| 68412-21-5 | Neodecanoic acid, rare earth salts | Acide néodécanoïque, sels de terres rares |
| 68439-70-3 | Amines, C12-16-alkyldimethyl | Amines, alkyle en C12-16 diméthyles |
| 68479-98-1 | Benzenediamine, ar,ar-diethyl-ar-methyl- | Diéthylméthylbenzènediamine |
| 68514-09-0 | Sulfite liquors and Cooking liquors, spent, oxidized | Lessives de sulfite et lessives de cuisson usées, oxydées |
| 68515-50-4 | 1,2-Benzenedicarboxylic acid, dihexyl ester, branched and linear | Phtalates de dihexyle ramifié et linéaire |
| 68515-51-5 | 1,2-Benzenedicarboxylic acid, di-C6-10-alkyl esters | Phtalates de dialkyles en C6-10 |
| 68515-73-1 | D-Glucopyranose, oligomeric, decyl octyl glycosides | Éthers décyliques et octyliques du D-glucose, oligomères |
| 68526-83-0 | Alcohols, C7-9-iso-, C8-rich | Alcools en C7-9, iso-, riches en C8 |
| 68609-97-2 | Oxirane, mono[(C12-14-alkyloxy)methyl] derivs. | Oxirane, dérivés mono[(alcoolates en C12-14)méthyle] |
| 68855-45-8 | Phenol, dodecyl-, sulfurized, calcium salts | Phénol, dodécyl-, sulfurisé, sels de calcium |
| 68891-38-3 | Poly(oxy-1,2-ethanediyl), α-sulfo-ω-hydroxy-, C12-14-alkyl ethers, sodium salts | α-Sulfo-ω-hydroxypoly(oxyéthylène), éthers C12-14-alkyliques, sels de sodium |
| 68928-76-7 | Stannane, dimethylbis[(1-oxoneodecyl)oxy]- | Diméthylbis[(1-oxonéodécyl)oxy]stannane |
| 68938-03-4 | Octene, hydroformylation products, low-boiling | Octène, produits d'hydroformylation, fraction à bas point d'ébullition |
| 68990-67-0 | Quillaja saponaria, ext. | Extrait de Quillaja saponaria |
| 70210-32-1 | Benzenesulfonic acid, 3-(benzoylamino)-4-hydroxy-5-[[1-[[[4′-[[2-[[2-hydroxy-5(methylsulfonyl)phenyl]azo]-1,3-dioxobutyl]amino]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]amino]carbonyl]-2-oxopropyl]azo]-, monosodium salt | 3-Benzamido-4-hydroxy-5-[[1-[[4′-[[2-[[2-hydroxy-5-(méthylsulfonyl)phényl]azo]-1,3-dioxobutyl]amino]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]carbamoyl]-2-oxopropyl]azo]benzènesulfonate de sodium |
| 70714-66-8 | Phosphonic acid, [[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-, ammonium salt | Acide [[(phosphonométhyl)imino]bis[éthylènenitrilobis(méthylène)]]tétraphosphonique, sel d'ammonium |
| 71566-41-1 | Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, trisodium salt | 2-[[2-Amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfonato-1-naphtyl)azo]-3,3′-diméthoxy[1,1′-biphényl]-4-yl]azo]7-sulfonato-1-naphtyl]azo]-5-nitrobenzoate de trisodium |
| 71617-10-2 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, 3-methylbutyl ester | p-Méthoxycinnamate d'isopentyle |
| 71631-15-7 | C.I. Pigment Black 30 | Spinelle noir de chromite de fer et de nickel |
| 71868-10-5 | 1-Propanone, 2-methyl-1-[4-(methylthio)phenyl]2-(4-morpholinyl)- | 2-Méthyl-1-[4-(méthylthio)phényl]-2-(morpholin-4-yl)propan-1-one |
| 71873-63-7 | Cuprate(4-), [µ-[7-[[3,3′-dihydroxy-4′-[(4-hydroxy-2-sulfobenzo[a]phenazin-3-yl)azo][1,1′-biphenyl]-4-yl]azo]-8-hydroxy-1,3,6-naphthalenetrisulfonato(8-)]]di-, tetrasodium | [µ-[7-[[3,3′-Dihydroxy-4′-[(4-hydroxy-2sulfobenzo[a]phénazin-3-yl)azo][1,1′-biphényl]-4yl]azo]-8-hydroxynaphtalène-1,3,6trisulfonato(8-)]]dicuprate(4-) de tétrasodium |
| 72903-27-6 | 1,4-Cyclohexanedicarboxylic acid, 1,4-diethyl ester | Ester 1,4-diéthylique de l'acide cyclohexane-1,4-dicarboxylique |
| 73913-06-1 | Manganese chloride (MnCl2), hydrate | Hydrate de chlorure de manganèse (MnCl2) |
| 75782-86-4 | Alcohols, C12-13 | Alcools en C12-13 |
| 75782-87-5 | Alcohols, C14-15 | Alcools en C14-15 |
| 75880-28-3 | Propanol, [(1-methyl-1,2-ethanediyl)bis(oxy)]bis-, polymer with 1-isocyanato-2-[(4-isocyanatophenyl)methyl]benzene and 1,1′-methylenebis[4-isocyanatobenzene] | (Propylènedioxy)dipropanol polymérisé avec le diisocyanate de 2,4′-méthylènediphényle et le diisocyanate de 4,4′-méthylènediphényle |
| 75980-60-8 | Phosphine oxide, diphenyl(2,4,6-trimethylbenzoyl)- | Oxyde de diphényl(2,4,6-triméthylbenzoyl)phosphine |
| 84896-44-6 | Propanoic acid, 3,3′-[(dibutylstannylene)bis(thio)]bis-, diisotridecyl ester | 3,3′-[(Dibutylstanylène)bis(thio)]dipropionate de diisotridécyle |
| 84989-41-3 | 2-Oxetanone, 3-C12-16-alkyl-4-C13-17-alkylidene derivs. | Oxétan-2-one, dérivés 3-C12-16-alkyl-4-C13-17-alkylidéniques |
| 85017-91-0 | Strontium chloride (SrCl2), hydrate | Hydrate de chlorure de strontium (SrCl2) |
| 85117-41-5 | Benzene, mono-C10-14-alkyl derivs., fractionation bottoms | Benzène, dérivés mono-C10-14-alkyliques, produits de queue de fractionnement |
| 87735-26-0 | 3,5,7,9-Tetraoxa-4,8-disila-6-stannaundecane, 6,6-dibutyl-4,4,8,8-tetraethoxy- | 6,6-Dibutyl-4,4,8,8-tétraéthoxy-3,5,7,9-tétraoxa-4,8-disila-6-stannaundécane |
| 94279-36-4 | 1,2,4-Benzenetricarboxylic acid, tri-C9-11 alkyl esters | Mélange de benzène-1,2,4-tricarboxylates de trialkyle en C9-11 |
| 97488-98-7 | Oils, fish, oxidized, bisulfited, sodium salts | Huiles de poisson oxydées, bisulfitées, sels de sodium |
| 101200-51-5 | Benzoic acid, 2-[[2-amino-5-hydroxy-6-[[4′-[(2-hydroxy-6-sulfo-1-naphthalenyl)azo]-3,3′-dimethoxy[1,1′-biphenyl]-4-yl]azo]-7-sulfo-1-naphthalenyl]azo]-5-nitro-, disodium salt | Sel disodique de l'acide 2-{2-amino-5-hydroxy-6-[4′-(2-hydroxy-6-sulfo-1-naphtylazo)-3,3′-diméthoxybiphényl-4-ylazo]-7-sulfo-1-naphtylazo}-5-nitrobenzoïque |
| 111850-24-9 | Phenol, 2,6-bis(1-methylpropyl)-4-[(4-nitrophenyl)azo]- | 2,6-Bis(1-méthylpropyl)-4-[(4-nitrophényl)azo]phénol |
| 117527-94-3 | Amines, C12_14-tert-alkyl, compds. with 1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenol 1-[[2-hydroxy-4(or 5)-nitrophenyl]azo]-2-naphthalenol chromium complexes | tert-Alkylamines en C12-14, composés avec des complexes de chrome du 1-[(2-hydroxy-3-nitro-5-tert-pentylphényl)azo]-2-naphtol et du 1-[(2-hydroxy-4(ou 5)-nitrophényl)azo]-2-naphtol |
| 118832-72-7 | Acetic acid, [[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]-, C10-14-isoalkyl esters | Esters C10-14-alkyliques de l'acide ({[3,5-bis(tert-butyl)-4-hydroxyphényl]méthyl}thio)acétique |
| 119313-12-1 | 1-Butanone, 2-(dimethylamino)-1-[4-(4-morpholinyl)phenyl]-2-(phenylmethyl)- | 2-(Diméthylamino)-1-[4-(morpholin-4-yl)phényl]-2-(phénylmethyl)butan-1-one |
| 121246-28-4 | 1,3,5-Triazine-2,4,6-triamine, N,N′,N″-tris[4-[(1,4-dimethylpentyl)amino]phenyl]- | N,N′,N″-Tris[4-[(1,4diméthylpentyl)amino]phényl]mélamine |
| 125997-21-9 | Phosphoryl chloride, polymer with 1,3-benzenediol, phenyl ester | Chlorure de phosphoryle polymérisé avec le résorcinol, éther phénylique |
| 206770-18-5 | 1,2,4-Benzenetricarboxylic acid, mixed 2-ethylhexyl and stearyl triesters | Triesters mixtes 2-éthylhexyliques et stéaryliques de l'acide benzène-1,2,4-tricarboxylique |
| 207683-20-3 | Sodium perchlorate hydrate | Hydrate de perchlorate de sodium |
| 474919-59-0 | 1,2-Cyclohexanedicarboxylic acid, 1,2-dinonyl ester, branched and linear | Cyclohexane-1,2-dicarboxylates de dinonyle (ramifiés ou linéaires) |
| 866625-93-6 | Benzotriazole, 1(or 2)-[1-(cyclohexyloxy)heptyl]methyl- | 1(ou 2)-[1-(Cyclohexyloxy)heptyl]méthylbenzotriazole |
| 1163775-81-2 | 1,2,4-Benzenetricarboxylic acid, mixed lauryl and octyl triesters | Mélange de triesters dodécyliques et/ou octyliques de l'acide benzène-1,2,4-tricarboxylique |
| Confidential Accession Number | Masked name | Nom maquillé |
|---|---|---|
| 13827-3 | Phosphonic acid, dibutyl ester, reaction products with alkyl substituted ethanol | Phosphonate de dibutyle, produits de réaction avec de l'éthanol substitué avec un alkyle |
| CAS RN | Substance name | Nom de la substance |
|---|---|---|
| 52-01-7 | Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, γ-lactone, (7α,17α)- | Spironolactone |
| 53-43-0 | Androst-5-en-17-one, 3-hydroxy-, (3β)- | Prastérone |
| 57-85-2 | Androst-4-en-3-one, 17-(1-oxopropoxy)-, (17β)- | Propionate de testostérone |
| 60-13-9 | Benzeneethanamine, α-methyl-, sulfate (2:1) | sulfate d'amphétamine |
| 60-31-1 | Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, chloride | Chlorure d'acétylcholine |
| 66-40-0 | Ethanaminium, N,N,N-triethyl- | tétraéthylammonium |
| 68-05-3 | Ethanaminium, N,N,N-triethyl-, iodide | Iodure de tétraéthylammonium |
| 73-31-4 | Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- | N-(2-(5-méthoxyindole-3-yl)éthyl)acetamide |
| 79-17-4 | Hydrazinecarboximidamide | aminoguanidine |
| 83-43-2 | Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6α,11β)- | Méthylprednisolone |
| 85-19-8 | Methanone, (5-chloro-2-hydroxyphenyl)phenyl- | 5-chloro-2-hydroxybenzophénone |
| 85-70-1 | 1,2-Benzenedicarboxylic acid, 2-butoxy-2-oxoethyl butyl ester | Phtalate de butoxycarbonylméthyle et de butyle |
| 87-18-3 | Benzoic acid, 2-hydroxy-, 4-(1,1-dimethylethyl)phenyl ester | Salicylate de 4-tert-butylphényle |
| 91-68-9 | Phenol, 3-(diethylamino)- | 3-Diéthylaminophénol |
| 94-43-9 | Mercury, (benzoato-O)phenyl- | benzoate de phénylmercure |
| 94-51-9 | 1-Propanol, 3,3′-oxybis-, 1,1′-dibenzoate | dibenzoate de 3,3′-oxydipropyle |
| 95-84-1 | Phenol, 2-amino-4-methyl- | 2-Amino-p-crésol |
| 97-18-7 | Phenol, 2,2′-thiobis[4,6-dichloro- | Bithionol |
| 99-57-0 | Phenol, 2-amino-4-nitro- | 2-Amino-4-nitrophénol |
| 102-29-4 | 1,3-Benzenediol, monoacetate | Acétate de 3-hydroxyphényle |
| 102-98-7 | Mercurate(2-), [orthoborato(3-)-κO]phenyl-, hydrogen (1:2) | [orthoborato(3-)-O]phénylmercurate(2-) de dihydrogéno |
| 104-98-3 | 2-Propenoic acid, 3-(1H-imidazol-4-yl)- | Acide 3-imidazol-4-ylacrylique |
| 116-38-1 | Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1) | chlorure de d'édrophonium |
| 122-11-2 | Benzenesulfonamide, 4-amino-N-(2,6-dimethoxy-4-pyrimidinyl)- | sulfadiméthoxine |
| 123-78-4 | 4-Octadecene-1,3-diol, 2-amino-, (2S,3R,4E)- | 2-aminooctadec-4-ène-1,3-diol |
| 130-95-0 | Cinchonan-9-ol, 6′-methoxy-, (8α,9R)- | Quinine |
| 132-69-4 | 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, hydrochloride (1:1) | 3-[[1-benzyl-1H-indazole-3-yl]oxy]-N,N-diméthylpropylamine, monochlorhydrate |
| 137-88-2 | Pyridinium, 1-[(4-amino-2-propyl-5- pyrimidinyl)methyl]-2-methyl-, chloride, hydrochloride (1:1:1) | Pyridinium, 1-[(4-amino-2-propyl-5-pyrimidinyl)méthyl]-2-méthyl-, chlorure, chlorhydrate (1:1:1) |
| 141-02-6 | 2-Butenedioic acid (E)-, bis(2-ethylhexyl) ester | Fumarate de bis(2-éthylhexyle) |
| 141-86-6 | 2,6-Pyridinediamine | Pyridine-2,6-diyldiamine |
| 141-94-6 | 5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl- | Héxétidine |
| 142-55-2 | 2-hydroxypropyl laurate | laurate de 2-hydroxypropyle |
| 145-13-1 | Pregn-5-en-20-one, 3-hydroxy-, (3β)- | prégnenolone |
| 148-01-6 | Benzamide, 2-methyl-3,5-dinitro- | dinitolmide |
| 148-79-8 | 1H-Benzimidazole, 2-(4-thiazolyl)- | Thiabendazole |
| 153-61-7 | 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)- | céfalotine |
| 293-51-6 | Cyclotetrasiloxane | Cyclotétrasiloxane |
| 303-98-0 | 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)- | Coenzyme Q-10 |
| 306-94-5 | Naphthalene, octadecafluorodecahydro- | Perflunafène |
| 317-34-0 | 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compd. with 1,2-ethanediamine (2:1) | Aminophylline |
| 330-95-0 | Urea, N,N′-bis(4-nitrophenyl)-, compd. with 4,6-dimethyl-2(1H)-pyrimidinone (1:1) | 1,3-Bis(4-nitrophényl)urée--4,6-diméthylpyrimidin-2-ol (1:1) |
| 362-74-3 | Adenosine, N-(1-oxobutyl)-, cyclic 3′,5′-(hydrogen phosphate) 2′-butanoate | bucladesine |
| 404-86-4 | 6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)- | Capsaïcine |
| 500-38-9 | 1,2-Benzenediol, 4,4′-(2,3-dimethyl-1,4-butanediyl)bis- | 4,4′-(2,3-diméthyltétraméthylene)dipyrocatéchol |
| 501-30-4 | 4H-Pyran-4-one, 5-hydroxy-2-(hydroxymethyl)- | 5-hydroxy-2-hydroxyméthyl-4-pyrone |
| 508-02-1 | Olean-12-en-28-oic acid, 3-hydroxy-, (3β)- | Acide 3β-hydroxyoléan-12-én-28-oïque |
| 518-40-1 | Benzoic acid, 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthen-9-yl)- | Acide 2-(6-hydroxy-4,5-diiodo-3-oxo-3H-xanthén-9-yl)benzoïque |
| 522-48-5 | 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, monohydrochloride | Tétryzoline, chlorhydrate |
| 522-51-0 | Quinolinium, 1,1′-(1,10-decanediyl)bis[4-amino-2-methyl-, dichloride | cotarmine de déqualinium |
| 530-43-8 | Hexadecanoic acid, (2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl ester | palmitate de chloramphénicol |
| 538-02-3 | Cyclopentaneethanamine, N,α-dimethyl-, hydrochloride | cyclopentamine, chlorhydrate |
| 546-46-3 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3) | Dicitrate de trizinc |
| 556-38-7 | Pentanoic acid, zinc salt | Divalérate de zinc |
| 557-61-9 | 1-Octacosanol | Octacosan-1-ol |
| 576-55-6 | Phenol, 2,3,4,5-tetrabromo-6-methyl- | 3,4,5,6-Tétrabromo-o-crésol |
| 594-45-6 | Ethanesulfonic acid | Acide éthanesulfonique |
| 603-85-0 | Phenol, 2-amino-3-nitro- | 2-amino-3-nitrophénol |
| 611-75-6 | Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride | bromhexine, chlorhydrate |
| 660-27-5 | Acetic acid, dichloro-, compd. with N-(1-methylethyl)-2-propanamine (1:1) | Dichloroacétate de diisopropylammonium |
| 719-59-5 | Methanone, (2-amino-5-chlorophenyl)phenyl- | 2-Amino-5-chlorobenzophénone |
| 820-66-6 | 1-Octadecanaminium, N-(carboxymethyl)-N,N-dimethyl-, hydroxide, inner salt | (Carboxylatométhyl)diméthyl(octadécyl)ammonium |
| 832-01-9 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, methyl ester | p-méthoxycinnamate de méthyle |
| 865-44-1 | Iodine chloride (ICl3) | Trichlorure d'iode |
| 866-82-0 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, copper(2++) salt (1:2) | Citrate de dicuivre |
| 1093-16-9 | Spiro[naphthalene-2(1H),2′-oxirane]-1-propanol, α-ethenyloctahydro-α,5,5,8a-tetramethyl- | α-Vinyloctahydro-α,5,5,8a-tétraméthyl-spiro[naphtalène-2(1H),2′-oxirane]propan-1-ol |
| 1109-11-1 | 2,4,6,8,10,12,14,16-Heptadecaoctaenoic acid, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, ethyl ester, (2E,4E,6E,8E,10E,12E,14E,16E)- | 8′-apo-.bêta.-carotène-8′-oate d'éthyle |
| 1112-38-5 | Phosphorothioic acid, O,O-dimethyl ester | Phosphorothioate d'O,O-diméthyle |
| 1314-84-7 | Zinc phosphide (Zn3P2) | Diphosphure de trizinc |
| 1315-04-4 | Antimony sulfide (Sb2S5) | Pentasulfure de diantimoine |
| 1317-26-6 | Aluminum magnesium hydroxide (AlMg2(OH)7), monohydrate | magaldrate |
| 1319-53-5 | Malachite (Cu2(CO3)(OH)2) | malachite |
| 1322-14-1 | 10-Undecenoic acid, calcium salt | Diundéc-10-énoate de calcium |
| 1335-26-8 | Magnesium peroxide | Peroxyde de magnésium |
| 1337-20-8 | Chlorophyllins, copper potassium sodium | chlorophyllines, cuivre, potassium et sodium |
| 1399-80-0 | Benzenedimethanaminium, ar-dodecyl-ar,N,N,N,N′,N′,N′-heptamethyl-, dichloride, mixt. with ar-dodecyl-ar,N,N,N-tetramethylbenzenemethanaminium chloride | Benzènediméthanaminium, ar-dodécyl-ar,N,N,N,N′,N′,N′-heptaméthyl-, dichlorure, mélange avec le chlorure d'ar-dodécyl-ar,N,N,N-tétraméthylbenzèneméthanaminium |
| 1405-89-6 | Bacitracin zinc | Bacitracine zincique |
| 1463-95-2 | Pyridinium, 2-[2-[(5-bromo-2-pyridinyl)amino]ethenyl]-1-ethyl-6-methyl-, iodide (1:1) | iodure de 2-[2-[(5-bromo-2-pyridyl)amino]vinyl]-1-éthyl-6-méthylpyridinium |
| 1553-41-9 | 5,8,11,14,17-Eicosapentaenoic acid | acide 5Z,8Z,11Z,14Z,17Z-eicosapentaénoïque |
| 1570-64-5 | Phenol, 4-chloro-2-methyl- | 4-Chloro-o-crésol |
| 1641-17-4 | Methanone, (2-hydroxy-4-methoxyphenyl)(4-methylphenyl)- | mexénone |
| 1778-02-5 | Pregn-5-en-20-one, 3-(acetyloxy)-, (3β)- | acétate de prégnenolone |
| 1929-30-2 | 2-Propenoic acid, 3-(4-methoxyphenyl)-, ethyl ester | p-méthoxycinnamate d'éthyle |
| 1976-28-9 | 3-Pyridinecarboxylic acid, aluminum salt (3:1) | trinicotinate d'aluminium |
| 2016-45-7 | 1-Hexadecanamine, N,N-dimethyl-, hydrochloride (1:1) | chlorure de hexadécyldiméthylammonium |
| 2040-10-0 | Ethanone, 1-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]- | 4′-tert-Butyl-2′,6′-diméthylacétophénone |
| 2136-71-2 | Ethanol, 2-(hexadecyloxy)- | 2-(hexadécyloxy)éthanol |
| 2180-18-9 | Acetic acid, manganese salt | Acide acétique, sel de manganèse |
| 2197-63-9 | 1-Hexadecanol, hydrogen phosphate | Hydrogénophosphate de dihexadécyle |
| 2224-49-9 | Dodecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | Acide laurique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1) |
| 2315-66-4 | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- | 3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]- |
| 2370-64-1 | Dodecanoic acid, 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl ester | laurate de 17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yle |
| 2380-86-1 | 1H-Indol-6-ol | 6-hydroxyindole |
| 2420-29-3 | 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol | 3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol |
| 2487-40-3 | 6H-Purin-6-one, 1,2,3,7-tetrahydro-2-thioxo- | 1,2,3,7-Tétrahydro-2-thioxo-6H-purin-6-one |
| 2565-36-8 | Ethanol, 2,2′-[methylenebis(oxy)]bis- | 2,2′-[méthylènebis(oxy)]biséthanol |
| 2568-33-4 | 1, 3-Butanediol, 3-methyl | 1,3-butanediol, 3-méthyl- |
| 2638-43-9 | 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tetramethylbutyl)phenoxy]- | 3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-[4-(1,1,3,3-tétraméthylbutyl)phénoxy]- |
| 2748-88-1 | Pyridinium, 4-methyl-1-tetradecyl-, chloride | Chlorure de 4-méthyl-1-tétradécylpyridinium |
| 2784-94-3 | Ethanol, 2,2′-[[4-(methylamino)-3nitrophenyl]imino]bis- | 2,2′-[[4-(Méthylamino)-3-nitrophényl]imino]diéthanol |
| 2835-98-5 | Phenol, 2-amino-5-methyl- | 6-amino-m-cresol |
| 2835-99-6 | Phenol, 4-amino-3-methyl- | 4-Amino-m-crésol |
| 2919-66-6 | Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-16-methylene- | acétate de mélengestrol |
| 2944-65-2 | Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, iron(2+) salt (1:1) | [R-(R*,R*)]-tartrate de fer |
| 3069-40-7 | Silane, trimethoxyoctyl- | Triméthoxyoctylsilane |
| 3184-65-4 | Phenol, 4-chloro-2-(phenylmethyl)-, sodium salt | 2-Benzyl-4-chlorophénolate de sodium |
| 3251-56-7 | Phenol, 2-methoxy-4-nitro- | 2-Méthoxy-4-nitrophénol |
| 3305-68-8 | 9-Octadecen-1-ol, phosphate (3:1), (9Z,9′Z,9″Z)- | phosphate de trioléyle |
| 3374-30-9 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl(phenylmethyl)amino]phenyl](5-hydroxy-2,4-disulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-, hydroxide, inner salt, calcium salt (2:1) | Bis[hydrogéno(benzyl)[4-[[4-(benzyléthylamino)phényl](5-hydroxy-2,4-disulfonatophényl)méthylène]cyclohexa-2,5-dién-1-ylidène](éthyl)ammonium], sel de calcium |
| 3397-16-8 | L-Glutamic acid, N-(1-oxooctadecyl)- | acide N-(1-oxooctadécyl)-L-glutamique |
| 3520-90-9 | 3,6,9,12,15,18,21-Heptaoxatricosan-1-ol, 23-(4-octylphenoxy)- | 3,6,9,12,15,18,21-heptaoxatricosan-1-ol, 23-(4-octylphénoxy)- |
| 3521-84-4 | D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3′-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-triiodobenzoate] (2:1) (salt) | adipiodone, sel de dimeglumine |
| 3564-09-8 | 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[2-(2,4,5-trimethylphenyl)diazenyl]-, sodium salt (1:2) | 3-hydroxy-4-[(2,4,5-triméthylphényl)azo]naphtalène-2,7-disulfonate de disodium |
| 3599-32-4 | 1H-Benz[e]indolium, 2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidene]-1,3,5-heptatrienyl]-1,1-dimethyl-3-(4-sulfobutyl)-, hydroxide, inner salt, sodium salt | 2-{7-[1,3-Dihydro-1,1-diméthyl-3-(4-sulfobutyl)-2H-benz[e]indol-2-ylidène]hepta-1,3,5-triényl}-1,1-diméthyl-3-(4-sulfobutyl)-1H-benz[e]indolium, hydroxyde, sel interne, sel de sodium |
| 3697-42-5 | 2,4,11,13-Tetraazatetradecanediimidamide, N,N″-bis(4-chlorophenyl)-3,12-diimino-, hydrochloride (1:2) | chlorhexidine, dichlorhydrate |
| 4316-73-8 | Glycine, N-methyl-, monosodium salt | Sarcosinate de sodium |
| 4372-02-5 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 4′,5′-dibromo-3′,6′-dihydroxy-, sodium salt (1:2) | 2-(4,5-dibromo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium |
| 4478-97-1 | 3,6,9,12,15-Pentaoxahentriacontan-1-ol | 3,6,9,12,15-pentaoxahentriacontan-1-ol |
| 4618-23-9 | Benzoic acid, 2,3,4,5-tetrachloro-6-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, disodium salt | Acide 2,3,4,5-tétrachloro-6-(2,4,5,7-tétrabromo-6-hydroxy-3-oxo-3H-xanthén-9-yl)benzoïque, sel disodique |
| 4861-19-2 | Urea, phosphate (1:1) | Phosphate d'urée |
| 4991-65-5 | 1,3-Benzoxathiol-2-one, 6-hydroxy- | tioxolone |
| 5353-26-4 | 3,6,9,12-Tetraoxatriacont-21-en-1-ol, (Z)- | 3,6,9,12-tétraoxatriacont-21-én-1-ol, (Z)- |
| 5697-02-9 | 1-naphthalenol, 2-methyl-, acetate | 1-naphtalénol, 2-méthyl-, 1-acétate |
| 5725-96-2 | Methanamine, N-hydroxy-N-methyl- | N-Hydroxydiméthylamine |
| 5836-69-1 | Phosphinic amide, P,P-dibutyl-N,N-dipropyl- | Amide phosphinique, P,P-dibutyl-N,N-dipropyl- |
| 5858-61-7 | 2,7-Naphthalenedisulfonic acid, 3-[[4-(acetylamino)phenyl]azo]-4-hydroxy-, disodium salt | 3-[[4-(acétylamino)phényl]azo]-4-hydroxynaphtalène-2,7-disulfonate de disodium |
| 5863-51-4 | Benzenemethanaminium, N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt | Hydrogéno[4-[(2-chlorophényl)[4-[éthyl(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium |
| 5905-52-2 | Propanoic acid, 2-hydroxy-, iron(2+) salt (2:1) | dilactate de fer |
| 6159-41-7 | 10-Undecenoic acid, potassium salt (1:1) | Acide 10-undécénoïque, sel de potassium (1:1) |
| 6182-11-2 | Octadecanoic acid, 1-methyl-1,2-ethanediyl ester | Distéarate de propylène |
| 6219-67-6 | 1,3-Benzenediamine, 4-methoxy-, sulfate | Sulfate de 4-méthoxybenzène-1,3-diamine |
| 6219-69-8 | 1,3-Benzenediamine, 4-ethoxy-, sulfate | 1,3-benzènediamine, 4-éthoxy-, sulfate |
| 6273-99-0 | Mercury, [.mu.-[orthoborato(2-)-κO:κO′]]diphenyldi- | [.mu.-[orthoborato(2-)-O:O′]]diphényldimercure |
| 6358-53-8 | 2-Naphthalenol, 1-[(2,5-dimethoxyphenyl)azo]- | 1-[(2,5-Diméthoxyphényl)azo]napht-2-ol |
| 6371-76-2 | 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(phenylazo)-, calcium salt (2:1) | Bis[3-hydroxy-4-(phénylazo)-2-naphtoate] de calcium |
| 6371-96-6 | Butanamide, 2-[(4-methoxy-2-nitrophenyl)azo]-N-(2-methylphenyl)-3-oxo- | 2-[(4-Méthoxy-2-nitrophényl)azo]-3-oxo-N-(o-tolyl)butyramide |
| 6505-30-2 | Benzenemethanaminium, N-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylene]-3-methyl-2,5-cyclohexadien-1-ylidene]-N-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt | Hydrogéno[4-[[4-(diéthylamino)phényl][4-[éthyl[(3-sulfonatobenzyl)amino]-o-tolyl]méthylène]-3-méthylcyclohexa-2,5-dién-1-ylidène](éthyl)(3-sulfonatobenzyl)ammonium, sel de sodium |
| 6548-12-5 | Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo-, inner salt, barium salt (1:1) | dihydrogéno(éthyl)[4-[[4-[éthyl(3-sulfonatobenzyl)amino]phényl](2-sulfonatophényl)methylène]cyclohexa-2,5-diène-1-ylidène](3-sulfonatobenzyl)ammonium, sel de baryum |
| 6640-03-5 | 1-Tetradecanol, hydrogen phosphate | Hydrogénophosphate de ditétradécyle |
| 6966-09-2 | Cyclohexanone, 2-(1-piperidinylmethyl)-, hydrochloride (1:1) | Cyclohexanone, 2-(1-pipéridinylméthyl)-, chlorhydrate (1:1) |
| 7091-57-8 | 8-Quinolinol, benzoate (salt) | acide benzoïque, composé avec quinoléine-8-ol (1:1) |
| 7147-34-4 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-ethylhexyl)ester | 2-hydroxypropane-1,2,3-tricarboxylate de tris(2-éthylhexyle) |
| 7211-53-2 | Docosanoic acid, potassium salt (1:1) | Sel de potassium de l'acide docosanoïque (1:1) |
| 7230-93-5 | Dodecanoic acid, aluminum salt (3:1) | trilaurate d'aluminium |
| 7360-38-5 | Hexanoic acid, 2-ethyl-, 1,2,3-propanetriyl ester | 2-ethylhexanoate de propane-1,2,3-triyle |
| 7446-27-7 | Phosphoric acid, lead(2++) salt (2:3) | Bis(orthophosphate) de triplomb |
| 7492-68-4 | Carbonic acid, copper salt | acide carbonique, sel de cuivre |
| 7651-99-2 | Phosphonic acid, [1,2-ethanediylbis[nitrilobis (methylene)]]tetrakis-, pentasodium salt | [Éthylènebis(nitrilobisméthylène)]tétrakisphosphonate pentasodique |
| 7704-67-8 | Erythromycin, thiocyanate (salt) | thiocyanate d'érythromycine |
| 7773-03-7 | Sulfurous acid, monopotassium salt | Hydrogénosulfite de potassium |
| 7789-46-0 | Iron bromide (FeBr2) | Dibromure de fer |
| 7790-44-5 | Stibine, triiodo- | Triiodure d'antimoine |
| 8007-56-5 | Aqua regia | Acide nitrochlorhydrique |
| 9022-75-7 | Poly[oxy[hydroxymethyl)-1,2-ethanediyl]], α-dodecyl-ω-hydroxy- | Poly[oxy[hydroxyméthyl)-1,2-éthanediyl]], α-dodécyl-oméga-hydroxy- |
| 9050-93-5 | β-D-Glucan, (1→3)-, carboxymethyl ether, sodium salt | β-D-glucane, (1→3)-, éther carboxyméthylique, sel sodique |
| 9065-63-8 | Oxirane, methyl-, polymer with oxirane, butyl ether | Oxirane, méthyl-, polymérisé avec l'oxirane, éther butylique |
| 10031-23-9 | Radium bromide (RaBr2) | bromure de radium |
| 10031-59-1 | Sulfuric acid, thallium salt | Sulfate de thallium |
| 10101-63-0 | Lead iodide (PbI2) | Diiodure de plomb |
| 10124-48-8 | Mercury amide chloride (Hg(NH2)Cl) | Chlorure d'aminomercure |
| 10124-49-9 | Sulfuric acid, iron salt | Acide sulfurique, sel de fer |
| 10139-47-6 | Zinc iodide (ZnI2) | Iodure de zinc |
| 10161-34-9 | Estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17β)- | 17-acétate de 17.bêta.-hydroxyestra-4,9,11-triène-3-one |
| 10192-46-8 | Boric acid (H3BO3), zinc salt (2:3) | Acide borique (H3BO3), sel de zinc (2:3) |
| 10233-14-4 | 9-Octadecenoic acid (Z)-, 2-[2-(2-hydroxyethoxy)ethoxy]ethyl ester | Oléate de 2-[2-(2-hydroxyéthoxy)éthoxy]éthyle |
| 10279-59-1 | Phosphoric acid, aluminum sodium salt (8:2:3) | Acide phosphorique, sel d'aluminium et de sodium (8:2:3) |
| 10294-31-2 | Gold iodide (AuI) | Monoiodure d'or |
| 10294-70-9 | Tin iodide (SnI2) | Diiodure d'étain |
| 10305-76-7 | Phosphoric acid, aluminum sodium salt (8:3:1), tetrahydrate | Acide phosphorique, sel d'aluminium et de sodium (8:3:1), tétrahydrate |
| 10326-21-3 | Chloric acid, magnesium salt | Chlorate de magnésium |
| 10361-76-9 | Peroxymonosulfuric acid, potassium salt (1:2) | Acide peroxymonosulfurique, sel de potassium (1:2) |
| 10476-84-3 | Octadecanoic acid, manganese salt (1:?) | Acide octadécanoïque, sel de manganèse (1:?) |
| 10476-86-5 | Strontium iodide (SrI2) | Iodure de strontium |
| 11092-32-3 | Aluminum oxide (AlO2) | oxyde d'aluminium |
| 11108-73-9 | Uranium alloy, base, U,Nb,Zr (Mulberry) | Alliage d'uranium, base, U, Nb, Zr (Mulberry) |
| 12018-01-8 | Chromium oxide (CrO2) | Dioxyde de chrome |
| 12122-15-5 | Nickel carbonate hydroxide (Ni5(CO3)2(OH)6) | Hydroxyde de carbonate de nickel (Ni5(CO3)2(OH)6) |
| 12217-41-3 | C.I. Basic Blue 22 | Basic Blue 22 du C.I. |
| 12217-43-5 | 9,10-Anthracenedione, 1-amino-4-[[4-[(dimethylamino)methyl]phenyl]amino]- | 1-amino-4-[[4-[(diméthylamino)méthyl]phényl]amino]anthraquinone |
| 12221-52-2 | C.I. Basic Red 22 | C.I. rouge basique 22 |
| 12222-04-7 | C.I. Direct Blue 199 | Direct Blue 199 du C.I. |
| 12640-40-3 | Bismuth oxide | oxyde de bismuth |
| 12651-23-9 | Titanium hydroxide | hydroxyde de titane |
| 12684-19-4 | Lead iodide | Iodure de plomb |
| 13103-75-8 | Benzenamine, N,N-dimethyl-4-(2-pyridinylazo)- | N,N-Diméthyl-4-(2-pyridylazo)aniline |
| 13408-62-3 | Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)- | Ferrate(3-), hexakis(cyano-κC)-, (OC-6-11)- |
| 13429-07-7 | 2-Propanol, 1-(2-methoxypropoxy)- | 1-(2-méthoxypropoxy)propane-2-ol |
| 13557-75-0 | Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt (1:1) | laurate de sodium et de 2-(1-carboxylatoéthoxy)-1-méthyl-2-oxoéthyle |
| 13682-92-3 | Aluminum, (glycinato-N,O)dihydroxy-, (ß-4)- | Glycinate de dihydroxyaluminium |
| 13779-98-1 | Plumbane, tetraiodo- | Plumbane, tétraiodo- |
| 14452-57-4 | Magnesium peroxide (Mg(O2)) | Dioxyde de magnésium |
| 14465-68-0 | 9,12,15-Octadecatrienoic acid, 1,1′,1″-(1,2,3-propanetriyl) ester, (9Z,9′Z,9″Z,12Z,12′Z,12″Z,15Z,15′Z,15″Z)- | tris[(9Z,12Z,15Z)-octadéca-9,12,15-triénoate] de propane-1,2,3-triyle |
| 14639-25-9 | 2-Pyridinecarboxylic acid, chromium(3+) salt (3:1) | Acide 2-pyridinecarboxylique, sel de chrome (3+) (3:1) |
| 15454-75-8 | Zinc, bis(5-oxo-L-prolinato-κN1,κO2)-, (T-4)- | bis(5-oxo-L-prolinato-N1,O2)zinc |
| 15763-02-7 | Butanedioic acid, 2-hydroxy-, 1,4-dioctyl ester | 2-hydroxybutanedioate de 1,4-dioctyle |
| 15792-51-5 | Benzenesulfonic acid, 2,5-dichloro-4-[4,5-dihydro-3-methyl-5-oxo-4-[[3-[(phenylamino)sulfonyl]phenyl]azo]-1H-pyrazol-1-yl]-, monosodium salt | 4-[4-[[3-(anilinosulfonyl)phényl]azo]-4,5-dihydro-3-méthyl-5-oxo-1H-pyrazole-1-yl]-2,5-dichlorobenzènesulfonate de sodium |
| 15876-39-8 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one,2′,4′,5′,7′-tetrabromo-3′,6′-dihydroxy, aluminum salt (3:2) | tris[2-(2,4,5,7-tétrabromo-6-oxydo-3-oxoxanthène-9-yl)benzoate] de dialuminium |
| 15905-86-9 | Nitric acid, uranium salt | Acide nitrique, sel d'uranium |
| 16040-38-3 | Phosphoric acid, lead salt | Acide phosphorique, sel de plomb |
| 16057-43-5 | Ethanol,2{2-(octadecyloxy)ethoxy}- | Éthanol, 2{2-(octadécyloxy)éthoxy}- |
| 16508-79-5 | 2-Naphthalenecarboxylic acid, 3-hydroxy-4-(2-phenyldiazenyl)-, barium salt (2:1) | Acide 3-hydroxy-4-(2-phényldiazényl)-2-naphtalènecarboxylique, sel de baryum (2:1) |
| 16508-80-8 | Benzoic acid, 2-(2,4,5,7-tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-, aluminum salt (1:?) | acide 2-(2,4,5,7-tétrabromo-3,6-dihydroxyxanthène-9-yl)benzoïque, sel d'aluminium |
| 16561-29-8 | Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester | Tétradécanoate de (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acétyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-décahydro-4a,7b-dihydroxy-3-(hydroxyméthyl)-1,1,6,8-tétraméthyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulén-9-yle |
| 16693-53-1 | Glycine, N-methyl-N-(1-oxododecyl)-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | N-Méthyl-N-(1-oxododécyl)glycine, composé avec le 2,2′,2″-nitrilotri(éthanol) (1:1) |
| 16824-78-5 | Phenol, 2,4,6-trinitro-, calcium salt | Phénol, 2,4,6-trinitro-, sel de calcium |
| 17026-85-6 | 1-Hexadecanol, 1-(dihydrogen phosphate), potassium salt (1:?) | 1-hexadécanol, 1-(dihydrogen phosphate), potassium salt (1:?) |
| 17121-12-9 | 1,3,5,7,2,4,6,8-Tetroxatetraphosphocane, 2,4,6,8-tetrahydroxy-,2,4,6,8-tetraoxide,ion(4-) | 1,3,5,7,2,4,6,8-tétroxatétraphosphocane, 2,4,6,8-tétrahydroxy-,2,4,6,8-tétraoxyde, ionique (-4) |
| 17375-37-0 | Carbonic acid, manganese salt | acide carbonique, sel de manganèse |
| 17619-86-2 | Ethanol, 2-amino-, sulfite (salt) | Éthanol, 2-amino-, sulfite (sel) |
| 17672-22-9 | Phenol, 2-amino-6-methyl- | Phénol, 2-amino-6-méthyl- |
| 17879-97-9 | Benzenepropanoic acid, 3-amino-α-ethyl-2,4,6-triiodo-, (R)- | Acide (R)-3-amino-α-éthyl-2,4,6-triiodobenzènepropanoïque |
| 17949-65-4 | Zinc, bis(2-pyridinecarboxylato-κN1,κO2-, (T-4)- | picolinate de zinc |
| 18089-54-8 | Silanol, methyl- | Silanol, méthyl- |
| 18358-13-9 | 2-Propenoic acid, 2-methyl-, ion(1-) | Acide 2-méthyl-2-propénoïque ionique (1-) |
| 18507-89-6 | 3-Quinolinecarboxylic acid, 6-(decyloxy)-7-ethoxy-4-hydroxy-, ethyl ester | 6-décyloxy-7-éthoxy-4-hydroxy-3-quinoleinate d'éthyle |
| 18917-91-4 | Aluminum, tris(2-hydroxypropanoato-O1,O2)- | Trilactate d'aluminium |
| 20636-48-0 | 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(4-nonylphenoxy)- | 3,6,9,12-tétraoxatétradécan-1-ol, 14-(4-nonylphénoxy)- |
| 20858-25-7 | 3,6,9,12-Tetraoxatetracosanoic acid | Acide 3,6,9,12-tétraoxatétracosanoïque |
| 20882-75-1 | 9H-Xanthen-9-one, 1,2,8-trihydroxy-6-methoxy- | 9H-xanthén-9-one, 1,2,8-trihydroxy-6-méthoxy- |
| 21034-17-3 | Oxazolium, 3,4-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide | iodure de 3,4-dimethyl-2-[2-(phénylamino)vinyl]oxazolium |
| 21109-95-5 | Barium sulfide (BaS) | Sulfure de baryum |
| 21127-45-7 | 3,6,9,12,15-Pentaoxaheptacosanoic acid | Acide 3,6,9,12,15-pentaoxaheptacosanoïque |
| 21245-01-2 | Benzoic acid, 4-(dimethylamino)-, 3-methylbutyl ester | Padimate |
| 21542-96-1 | 1-Docosanamine, N,N-dimethyl- | N,N-diméthyldocosylamine |
| 22204-24-6 | 2-naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]pyrimidine (1:1) | acide 4,4′-méthylènebis[3-hydroxy-2-naphtoïque], composé avec (E)-1,4,5,6-tétrahydro-1-méthyl-2-[2-(2-thiényl)vinyl]pyrimidine (1:1) |
| 22366-99-0 | 9,10-Anthracenedione, 1-[(3-aminopropyl)amino]-4-(methylamino)- | 1-[(3-aminopropyl)amino]-4-(méthylamino)anthraquinone |
| 22801-45-2 | 9-Octadecenoic acid (9Z)-, 2-octyldodecyl ester | oléate de 2-octyldodécyle |
| 23059-38-3 | Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester, cis- | cis-1,4-Diméthylcyclohexanecarboxylate de méthyle |
| 23250-42-2 | Cyclohexanecarboxylic acid, 1,4-dimethyl-, methyl ester (trans) | trans-1,4-Diméthylcyclohexanecarboxylate de méthyle |
| 24292-52-2 | 2-Propen-1-one, 1-[4-[[6-O-(6-deoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (E)- | 1-[4-[[6-O-(6-Désoxy-α-2-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-méthoxyphényl]-3-(3-hydroxy-4-méthoxyphényl)prop-2-én-1-one |
| 24545-86-6 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-dinitro- | 3′,6′-dihydroxy-4′,5′-dinitrospiro[isobenzofuranne-1(3H),9′-[9H]xanthène]-3-one |
| 24905-87-1 | Ethanol, 2-[(4-amino-3-nitrophenyl)amino]- | 2-(4-amino-3-nitroanilino)éthanol |
| 25136-75-8 | 2-Propen-1-aminium, N,N-dimethyl-N-2-propenyl-, chloride, polymer with 2-propenamide and 2-propenoic acid | Chlorure de diallyldiméthylammonium polymérisé avec l'acrylamide et l'acide acrylique |
| 25482-78-4 | Peroxymonosulfuric acid, potassium salt | Acide peroxymonosulfurique, sel de potassium |
| 25709-83-5 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy- | Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,5′-tribromo-3′,6′-dihydroxy- |
| 25709-84-6 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy- | Spiro[isobenzofuran-1(3H),9′-[9H]xanthén]-3-one, 2′,4′,7′-tribromo-3′,6′-dihydroxy- |
| 25852-45-3 | Poly(oxy-1,2-ethanediyl), α-phosphono-ω-(dodecyloxy)- | α-Phosphono-ω-(dodécyloxy)poly(oxyéthylène) |
| 25999-20-6 | Benzoic acid, 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyltetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]tetrahydro-3-methyl-2-furanyl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methyl-, monosodium salt | acide benzoïque, [[éthyl-5 (éthyl-5 tétrahydrohydroxy-5 méthyl-6 2H-pyrannyl-2)-5 tétrahydrométhyl-3 furannyl-2]-7 hydroxy-4 diméthyl-3,5 oxononyl-6]-6 hydroxy-2 méthyl-3, sel monosodique, [2R-[2α[2S* (3R*,4S*,5S*,7R*),3S*,5S*],5α,6.bêta.]]- |
| 26264-02-8 | 3,6,9,12-Tetraoxatetradecan-1-ol, 14-(nonylphenoxy)- | 14-(nonylphénoxy)-3,6,9,12-tétraoxatétradécane-1-ol |
| 26538-44-3 | 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-, [3S-(3R,7S)]- | Zéranol |
| 26545-51-7 | Benzamide, N,N-diethylmethyl- | Benzamide, N,N-diéthylméthyl- |
| 26658-83-3 | 2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-(dimethylamino)ethyl 2-methyl-2-propenoate | 2-méthyl-2-propénoate de butyle, polymérisé avec le 2-méthyl-2-propénoate de 2-(diméthylamino)éthyle |
| 26915-12-8 | Benzenamine, ar-methyl- | Toluidine |
| 26920-62-7 | 1-Docosanaminium, N-(carboxymethyl)-N,N-dimethyl-, inner salt | (carboxylatométhyl)docosyldiméthylammonium |
| 27177-03-3 | 3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(nonylphenoxy)- | 20-(nonylphénoxy)-3,6,9,12,15,18-hexaoxaicosane-1-ol |
| 27177-07-7 | 3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(octylphenoxy)- | 3,6,9,12,15,18,21,24,27-nonaoxanonacosan-1-ol, 29-(octylphénoxy)- |
| 27636-82-4 | 2,4-imidazolidinedione, (hydroxymethyl)-5,5-dimethyl- | 2,4-imidazolidinedione, (hydroxyméthyl)-5,5-diméthyl- |
| 27640-89-7 | 13-Docosenoic acid, (13Z)-13-docosen-1-yl ester, (13Z)- | (Z)-docos-13-énoate de (Z)-docos-13-ényle |
| 28212-44-4 | Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-(4-nonylphenoxy)- | α-(Carboxyméthyl)-ω-(p-nonylphénoxy)poly(oxyéthylène) |
| 28261-54-3 | Pyrrolidinone | Pyrrolidinone |
| 28602-69-9 | Diphosphoric acid, ammonium manganese(2+) salt (2:2:3) | Acide diphosphorique, sel d'ammonium et de manganèse(2+) (2:2:3) |
| 28855-27-8 | Benzenemethanaminium, ar-dodecyl-ar,N,N,N-tetramethyl-, chloride | chlorure de (dodécylméthylbenzyl)triméthylammonium |
| 30599-15-6 | 1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with oxirane | 2,2-Bis(hydroxyméthyl)propane-1,3-diol polymérisé avec l'oxirane |
| 31282-04-9 | D-Streptamine, O-6-amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene-(1.fwdarw.2-3)-O-β-D-talopyranosyl-(1.fwdarw.5)-2-deoxy-N3-methyl- | hygromycine B |
| 31512-74-0 | Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] | Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)] |
| 31692-79-2 | Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy- | Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy- |
| 31846-06-7 | Cyclohexanol, 3-(1,1-dimethylethyl)-, acetate | Acétate de 3-tert-butylcyclohexanyle |
| 32310-26-2 | Androstene | Androstène |
| 33239-19-9 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo-, sodium salt (1:2) | 2-(4,5-diiodo-6-oxydo-3-oxoxanthène-9-yl)benzoate de disodium |
| 33907-46-9 | Octadecanoic acid, hydroxy-, 2-hydroxyethyl ester | Hydroxyoctadécanoate de 2-hydroxyéthyle |
| 33907-47-0 | Octadecanoic acid, hydroxy-, monoester with 1,2-propanediol | acide hydroxyoctadécanoïque, monoester avec propane-1,2-diol |
| 34452-51-2 | Acetic acid, mercapto-, monopotassium salt | Mercaptoacétate de potassium |
| 34464-38-5 | Isodecane | isodécane |
| 34769-44-3 | 1,3(2H,9bH)-Dibenzofurandione, 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-, sodium salt (1:1) | 2,6-diacétyl-7,9-dihydroxy-8,9b-diméthyldibenzofuranne-1,3(2H,9bH)-dione, sel de monosodium |
| 34965-01-0 | Pyrrolidine, 1-[2-(dodecyloxy)ethyl]-, hydrochloride | Pyrrolidine, 1-[2-(dodécyloxy)éthyl]-, chlorhydrate |
| 35602-69-8 | Cholest-5-en-3-ol (3β)-, 3-octadecanoate | sterate de cholest-5-ène-3-β-yle |
| 36284-86-3 | Octadecanamide, N-(2-hydroxy-1,1-dimethylethyl)- | Octadécanamide, N-(2-hydroxy-1,1-diméthyléthyl)- |
| 37220-90-9 | Silicic acid, lithium magnesium salt | Acide silicique, sel de lithium et de magnésium |
| 37222-66-5 | Potassium peroxymonosulfate sulfate (K5(HSO5)2(HSO4)(SO4)) | Sulfate de peroxymonosulfate de potassium (K5(HSO5)2(HSO4)(SO4)) |
| 37286-92-3 | Benzenesulfonic acid, ethenyl-, homopolymer, calcium salt | Acide éthénylbenzènesulfonique, homopolymère, sel de calcium |
| 38480-64-7 | 1-Dodecanesulfonic acid, ion(1-) | Acide 1-dodécanesulfonique, ionique (1-) |
| 38577-97-8 | Spiro[isobenzofuran-1(3H),9′-[9H]xanthen]-3-one, 3′,6′-dihydroxy-4′,5′-diiodo- | 3′,6′-Dihydroxy-4′,5′-diiodospiro[isobenzofurane-1(3H),9′-[9H]xanthène]-3-one |
| 38621-51-1 | Octadecanoic acid, 12-hydroxy-, monoester with 1,2-propanediol | Acide hydroxyoctadécanoïque, monoester avec le propane-1,2-diol |
| 38866-20-5 | Morpholinium, 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)amino]propyl]-4-methyl-, methyl sulfate (1:1) | sulfate de 4-[3-[(9,10-dihydro-4-hydroxy-9,10-dioxoanthryl)amino]propyl]-4-méthylmorpholinium et de méthyle |
| 38886-21-4 | Phenol, 2-methoxynitro- | Phénol, 2-méthoxynitro- |
| 38975-03-0 | 3,6,9,12,15-Pentaoxaheptacosanoic acid, sodium salt | Acide 3,6,9,12,15-pentaoxaheptacosanoïque, sel sodique |
| 39322-04-8 | Chromium potassium oxide | Oxyde de chrome et de potassium |
| 39456-59-2 | Phosphoric acid, mixt. with sodium fluoride (NaF) | Acide phosphorique, mélange avec le fluorure de sodium (NaF) |
| 40160-92-7 | Poly(oxy-1,2-ethanediyl), α-(3-pentadecylphenyl)-ω-hydroxy- | α-(3-Pentadécylphényl)-ω-hydroxypoly(oxyéthane-1,2-diyl) |
| 40188-41-8 | Octanenitrile, 3,7-dimethyl- | 3,7-Diméthyloctanonitrile |
| 40738-57-6 | 2-Propenoic acid, ethenylidene ester, homopolymer | 2-propénoate d'éthénylidène, homopolymère |
| 40754-59-4 | Butanedioic acid, 2-sulfo-, 4-[2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl] ester, sodium salt (1:2) | 2-sulfonatosuccinate de disodium et de 4-[2-[2-[2-(dodécyloxy)éthoxy]éthoxy]éthyle |
| 41080-66-4 | Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-[(1-oxooctadecyl)oxy]- | Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-[(1-oxooctadécyl)oxy]- |
| 41669-40-3 | Tetradecanoic acid, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | Myristate de tris(2-hydroxyéthyl)ammonium |
| 41927-88-2 | Sodium iodide (Na123I) | Iodure de sodium (Na123I) |
| 42131-25-9 | Isononanoic acid, isononyl ester | Isononanoate d'isononyle |
| 42766-91-6 | Poly (oxy-1, 2-ethanediyl), α-[(3b, 5a)-cholestan-3-yl]-ω-hydroxy- | Poly(oxy-1, 2-éthanediyle), α-[(3b, 5a)-cholestan-3-yl]-oméga-hydroxy- |
| 45267-19-4 | Tetradecanamide, N-[3-(dimethylamino)propyl]- | N-[3-(Diméthylamino)propyl]myristamide |
| 49625-21-0 | Butanoic acid, 4-[[4-[[[(4-methoxy-2-nitrophenyl)amino]carbonyl]amino]benzoyl]amino]-2-oxo- | Acide 4-[[4-[[[(4-méthoxy-2-nitrophényl)amino]carbonyl]amino]benzoyl]amino]-2-oxobutanoïque |
| 50545-60-3 | Phenol, methyl-, tetrabromo deriv. | Phénol, méthyl-, dérivés tétrabromés |
| 50610-28-1 | Ethanol, 2-[(4-amino-2-chloro-5-nitrophenyl)amino]- | 2-[(4-amino-2-chloro-5-nitrophényl)amino]éthanol |
| 50643-20-4 | Poly (oxy-1,2-ethanediyl), α-hexadecyl-ω-hydroxy-, phosphate | Poly(oxy-1,2-éthanediyle), α-hexadécyl-oméga-hydroxy-, phosphate |
| 50800-85-6 | Indium chloride (111InCl3) | Chlorure d'indium (111InCl3) |
| 50982-74-6 | Ethanol, 2-(4-amino-3-nitrophenoxy)- | Éthanol, 2-(4-amino-3-nitrophénoxy)- |
| 50994-40-6 | 1,4-Benzenediamine, sulfate (1:?) | 1,4-benzènediamine, sulfate (1:?) |
| 51023-21-3 | 1H-Imidazolol, ethyldihydro[(9Z)-9-octadecen-1-yl]- | 1H-imidazolol, éthyldihydro[(9Z)-9-octadécèn-1-yl]- |
| 51192-09-7 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with 1,2,3-propanetriol mono-9-octadecenoate (2:1), (Z)- | α-Hydro-ω-hydroxypoly(oxyéthylène), éther (2:1) avec le monooléate du glycérol |
| 51311-89-8 | Antimony iodide | Iodure d'antimoine |
| 51365-71-0 | 1,2-Benzenedicarboxamide, N,N′-dioctadecyl- | 1,2-benzènedicarboxamide, N,N′-dioctadécyl- |
| 51513-58-7 | 6,10-Dodecadienal, 3,7,11-trimethyl-, (6E)- | 6,10-Dodécadiénal, 3,7,11-triméthyl-, (6E)- |
| 51781-21-6 | 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1) | 5-[3-[(tert-butyl)amino]-2-hydroxypropoxy]-3,4-dihydro-2-quinolone, monochlorhydrate |
| 51810-70-9 | Zinc phosphide | phosphure de zinc |
| 51852-65-4 | Poly(oxy-1,2-ethanediyl), α-[2-hydroxy-3-[(1-oxooctadecyl)oxy]propyl]-ω-hydroxy- | Poly(oxy-1,2-éthanediyle), α-[2-hydroxy-3-[(1-oxooctadécyl)oxy]propyl]-oméga-hydroxy- |
| 52467-63-7 | 1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride | Chlorure de N,N-dihexadécyl-N-méthyl-1-hexadécanaminium |
| 52557-98-9 | Bicyclo[2.2.1]heptane-2-carboxylic acid, 3,3-dimethyl- | Acide 3,3-diméthylbicyclo[2.2.1]heptane-2-carboxylique |
| 52793-97-2 | N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]benzenaminim, methyl | sulfate de méthyle et de N,N,N-triméthyl-4-[(4,7,7-triméthyl-3-oxobicyclo[2.2.1]hept-2-ylidène)méthyl]anilinium |
| 52845-07-5 | Isoeicosane | Isoeicosane |
| 53171-04-3 | 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxododecyl)oxy]-, chloride | 1-propanaminium, 2-hydroxy-N,N,N-triméthyl-3-[(1-oxododécyl)oxy]-, chlorure |
| 54182-58-0 | Aluminum, hexadeca-.mu.-hydroxytetracosahydroxy[.mu.8-[[1,3,4,6-tetra-O-sulfo-β-D-fructofuranosyl α-D-glucopyranoside tetrakis(sulfato-κO′)](8-)]]hexadeca- | sucralfate |
| 54422-45-6 | N-[2-hydroxy-1-(hydroxymethyl)heptadecyl]-9-octadecenamide | 9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)- |
| 54590-52-2 | Benzenesulfonic acid, 4-dodecyl-, compd. with 1-amino-2-propanol (1:1) | Acide p-dodécylbenzènesulfonique, composé avec le 1-aminopropan-2-ol (1:1) |
| 55134-13-9 | Salinomycin, 4-methyl-, (4S)- | narasine |
| 55297-96-6 | Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (1:1) (salt) | acide acétique, [[(diéthylamino)-2 éthyl]thio]-, ester d'éthényldécahydro-6 hydroxy-5 tétraméthyl-4,6,9,10 oxo-1 propano-3a,9 3aH-cyclopentacyclo-octényl-8, [3aS-(3aα,4.bêta.,5α,6α,8.bêta.,9α,9a.bêta.,10S*)]-, (E)-butènedioate-2 (1:1) (sel) |
| 55837-20-2 | 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, rel- | 4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, rel- |
| 55840-13-6 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate | acide propanetricarboxylique-1,2,3, hydroxy-2, ester avec le mono-octadécanoate de propanetriol-1,2,3 |
| 55852-15-8 | Propanoic acid, 2-hydroxy-, compd. with N-[3-(dimethylamino)propyl]-16-methylheptadecanamide (1:1) | Acide lactique, composé (1:1) préparé avec le N-[3-(diméthylamino)propyl]-16-méthylheptadécanamide |
| 55852-84-1 | Bacitracin, methylenebis[2-hydroxybenzoate] | Méthylènedisalicylate de la bacitracine |
| 55901-20-7 | D2-Proline, 5-oxo-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | 5-Oxo-D2-proline, composé avec le 2,2′,2″-nitrilotriéthanol (1:1) |
| 55940-73-3 | Benzoic acid, 2-hydroxy-, oxybis(methyl-2,1-ethanediyl) ester | disalicylate d'oxydipropylène |
| 56038-13-2 | α-D-Galactopyranoside, 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl 4-chloro-4-deoxy- | 4-chloro-4-désoxy-α-D-galactose de 1,6-dichloro-1,6-didésoxy-.bêta.-D-fructofurannosyle |
| 56235-92-8 | Butanedioic acid, hydroxy-, bis(2-ethylhexyl) ester | malate de bis(2-éthylhexyle) |
| 56554-41-7 | 9,12,15-Octadecatrienoic acid, 2,3-dihydroxypropyl ester | 9-octadécénamide, N-[2-hydroxy-1-(hydroxyméthyl)heptadécyl]-, (9Z)- |
| 56639-51-1 | Aluminum, hydroxybis(tetradecanoato-κO)- | hydroxybis(myristato-O)aluminium |
| 56827-95-3 | 1-Hexadecanol, phosphate (3:1) | Phosphate de trihexadécyle |
| 57072-40-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, chromium(3+) salt (1:?) | acide citrique, sel de chrome |
| 57524-53-5 | Ethanol, 2-[(4-methoxy-2-nitrophenyl)amino]- | Éthanol, 2-[(4-méthoxy-2-nitrophényl)amino]- |
| 57834-50-1 | Benzoic acid, 4-[[[[4-(ethoxycarbonyl)phenyl]amino]methylene]amino]-, ethyl ester | p-({[p-(Éthoxycarbonyl)anilino]méthylène}amino)benzoate d'éthyle |
| 57934-97-1 | 2-Cyclohexene-1-carboxylic acid, 2-ethyl-6,6-dimethyl-, ethyl ester | 2-Éthyl-6,6-diméthylcyclohex-2-ène-1-carboxylate d'éthyle |
| 57963-76-5 | 4a(2H)-Naphthalenol, octahydro-4,4,8a-trimethyl-,trans- | 4a(2H)-naphtalénol, octahydro-4,4,8a-triméthyl-, trans- |
| 57963-77-6 | cis-1,1,10-Trimethyl-9-decahydronaphthol | cis-1,1,10-triméthyl-9-décahydronaphtol |
| 58855-36-0 | Ethanol, 2,2′-iminobis-, compd. with α-sulfo-ω-(dodecyloxy)poly(oxy-1,2-ethanediyl) (1:1) | Éthanol, 2,2′-iminobis-, composé avec l'α-sulfo-oméga-(dodécyloxy)poly(oxy-1,2-éthanediyle) (1:1) |
| 59056-93-8 | Ethanone, 1-[(2R,3S)-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl]-, rel- | rel-1-[(2R,3S)-1,2,3,4,5,6,7,8-Octahydro-2,3,8,8-tétraméthylnaphtalén-2-yl]éthanone |
| 59070-56-3 | Poly(oxy-1,2-ethanediyl), α,α′.,α″-1,2,3-propanetriyltris[ω-hydroxy-, monododecanoate | Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris[oméga-hydroxy]-, monododécanoate |
| 59219-71-5 | Hexanoic acid, 3,5,5-trimethyl-, 3,5,5-trimethylhexyl ester | 3,5,5-Triméthylhexanoate de 3,5,5-triméthylhexyle |
| 59587-08-5 | 1,3-Dioxolo[4,5-g]quinoline-7-carboxylic acid, 5-ethyl-5,8-dihydro-8-oxo-, sodium salt (1:1) | 5-éthyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoléine-7-carboxylate de sodium |
| 59599-53-0 | Benzoic acid, 2-hydroxy-, 2-(2-hydroxy-1-methylethoxy)-1-methylethyl ester | 2-hydroxybenzoate de 2-(2-hydroxy-1-méthyléthoxy)-1-méthyléthyle |
| 59599-58-5 | Benzenesulfonic acid, 4-tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | Acide 4-tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotris[éthanol] (1:1) |
| 59792-81-3 | Aluminum, tris(5-oxo-L-prolinato-κN1,κO2)- | tris(5-oxo-L-prolinato-N1,O2)aluminium |
| 59820-63-2 | 2-[3-(methylamino)-4-nitrophenoxy]ethanol | 2-[3-(méthylamino)-4-nitrophénoxy]éthanol |
| 59970-10-4 | 3,6,9,12-Tetraoxatriacontan-1-ol | 3,6,9,12-tétraoxatriacontan-1-ol |
| 60031-93-8 | Cyclohexanemethanol, 4-ethenyl-α,α,4-trimethyl-3-(1-methylethenyl)-, acetate, [1R-(1α,3α,4β)]- | Acétate de [1R-(1α,3α,4β)]-3-isopropyl-α,α,4-triméthyl-4-vinylcyclohexaneméthanol |
| 60270-33-9 | Docosanamide, N-[3-(dimethylamino)propyl]- | N-[3-(diméthylamino)propyl]docosanamide |
| 60684-33-5 | 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl- | 2,5-cyclohexadiène-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaén-1-yl)-5,6-diméthoxy-3-méthyl- |
| 60778-99-6 | Sulfuric acid, aluminum magnesium salt | Sulfates mixtes d'aluminium et de magnésium |
| 60908-77-2 | Isohexadecane | Isohexadécane |
| 61692-77-1 | 2-Butenoic acid, 2-methyl-, 2-methylbutyl ester, (2Z)- | 2-méthylisocrotonate de 2-méthylbutyle |
| 61693-08-1 | Heptadecane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadecamethyl- | Heptadécane, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16-hexadécaméthyl- |
| 61702-44-1 | 1,4-Benzenediamine, 2-chloro-, sulfate (1:1) | sulfate de 2-chloro-p-phénylénédiamine |
| 61790-62-3 | Fatty acids, coco, reaction products with N,N-dimethyl-1,3-propanediamine | Acides gras de coco, produits de réaction avec la N,N-diméthylpropane-1,3-diamine |
| 61886-59-7 | Benzenesulfonic acid, tridecyl-, compd. with 2,2′,2″-nitrilotris[ethanol] (1:1) | Acide tridécylbenzènesulfonique, composé avec le 2,2′,2″-nitrilotriéthanol (1:1) |
| 62152-14-1 | 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, ammonium salt (1:1), homopolymer | Acide 2-méthyl-2-[(1-oxo-2-propén-1-yl)amino]-1-propanesulfonique, sel d'ammonium (1:1), homopolymère |
| 62406-73-9 | 6,10-Dioxaspiro[4.5]decane, 8,8-dimethyl-7-(1-methylethyl)- | 6,10-dioxaspiro[4.5]décane,8,8-diméthyl-7-(-1-méthyléthyl)- |
| 62625-14-3 | Phenol, 2-amino-6-chloro-4-nitro-, monohydrochloride | 2-Amino-6-chloro-4-nitrophénol , monochlorhydrate |
| 63084-98-0 | Phenol, 4-amino-, sulfate (2:1) (salt) | Sulfate de bis[(4-hydroxyphényl)ammonium] |
| 63089-86-1 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with D-glucitol (6:1), tetra-9-octadecenoate, (all-Z)- | α-Hydro-ω-hydroxypoly(oxyéthylène), éther (6:1) avec le D-glucitol, tétraoléate |
| 64924-67-0 | 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-, monohydrobromide, rel- | 4(3H)-quinazolinone, 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxy-2-pipéridinyl]-2-oxopropyl]-, monobromhydrate, rel- |
| 65235-31-6 | 4-[(2-hydroxyethyl)amino]-3-nitrophenol | 4-[(2-hydroxyéthyl)amino]-3-nitrophénol |
| 65389-08-4 | Indium-111In, tris(8-quinolinolato-κN1,κO8)- | Indium-111In, tris(8-quinolinolato-κN1,κO8)- |
| 65405-96-1 | Nickel, [.mu.-[carbonato(2-)-κO:κO′]]dihydroxydi- | [.mu.-[carbonato(2-)-O:O′]]dihydroxydinickel |
| 65710-07-8 | D-Streptamine, o-4-amino-4-deoxy-α-D-glucopyranosyl-(1→8)-o-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-α-D-allo-octadialdo-1,5:8,4-dipyranosyl-(1→4)-2-deoxy-, sulfate (salt) | sulfate d'apramycine |
| 66095-81-6 | Ethanol, 2-[(2-methoxy-4-nitrophenyl)amino]- | 2-[(2-méthoxy-4-nitrophényl)amino]éthanol |
| 66575-29-9 | 1H-Naphtho[2,1-b]pyran-1-one, 5-(acetyloxy)-3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-, [3R-(3-α,4a-β,5-β,6-β,6a-α,10-α,10a-β,10b-α)]- | colforsine |
| 66671-82-7 | 1,4-Benzenediamine, 2-methoxy-, sulfate (1:1) | Sulfate de 2-méthoxybenzène-1,4-diammonium |
| 67783-98-6 | Formaldehyde, polymer with 4,4′-(1-methylethylidene)bis[phenol] and 2-methylphenol | Formaldéhyde polymérisé avec le 4,4′-isopropylidènediphénol et l'o-crésol |
| 67784-88-7 | Glycerides, palm-oil mono- and di-, hydrogenated, ethoxylated | Mono- et diglycérides d'huile de palme, hydrogénées, éthoxylées |
| 67846-16-6 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate | Sulfate d'éthyldiméthyl[3-[(1-oxooctadécyl)amino]propyl]ammonium et d'éthyle |
| 67874-65-1 | Propanoic acid, 3-mercapto-, 2,3-dihydroxypropyl ester | 3-Mercaptopropionate de 2,3-dihydroxypropyle |
| 67914-69-6 | 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- | 4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d'éthyle, rel- |
| 68015-98-5 | 1,3-Benzenediamine, 4-ethoxy-, sulfate (1:1) | Sulfate de 4-éthoxybenzène-1,3-diammonium |
| 68187-29-1 | 2-Glutamic acid, N-coco acyl derivs., compds. with triethanolamine (1:1) | Acide 2-glutamique, dérivés N-acyles de coco, composés avec la triéthanolamine (1:1) |
| 68239-79-2 | Phenol, 3-(ethylamino)-4-methyl-, sulfate (2:1) (salt) | Sulfate de bis[éthyl(4-hydroxy-o-tolyl)ammonium] |
| 68239-83-8 | 1,4-Benzenediamine, 2-nitro-, sulfate (1:1) | Sulfate de 2-nitrobenzène-1,4-diammonium |
| 68239-84-9 | Phenol, 3-(diethylamino)-, sulfate (2:1) (salt) | Sulfate de bis[(diéthylhydroxyphényl)ammonium] |
| 68391-32-2 | 2-Naphthalenaminium, 8-[(4-amino-3-nitrophenyl)azo]-7-hydroxy-N,N,N-trimethyl-, chloride | Chlorure de [8-[(4-amino-3-nitrophényl)azo]-7-hydroxy-2-naphtyl]triméthylammonium |
| 68413-33-2 | Quaternary ammonium compounds, bis(2-hydroxy-C>10-alkyl)dimethyl, chlorides | Chlorures de bis(2-hydroxy-C>G10-alkyl)diméthylammonium quaternaire |
| 68475-50-3 | Aluminum, tris[5-amino-4-hydroxy-3-(phenylazo)-2,7-naphthalenedisulfonato(2-)]di- | Tris[5-amino-4-hydroxy-3-(phénylazo)naphtalène-2,7-disulfonato(2-)]dialuminium |
| 68479-64-1 | Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) | 2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle] |
| 68552-95-4 | Fatty acids, vegetable-oil, ethoxylated | Acides gras d'huile végétale, éthoxylés |
| 68607-24-9 | Quaternary ammonium compounds, C20-22-alkyltrimethyl, chlorides | Composés de l'ion ammonium quaternaire, alkyle en C20-22 triméthyles, chlorures |
| 68797-65-9 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate | Sulfate de N-éthyl-3-docosanamido-N,N-diméthylpropan-1-aminium et d'éthyle |
| 68814-13-1 | 1-Hexadecanol, phosphate | Hexadécan-1-ol, phosphate |
| 68889-49-6 | 9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, polymer with α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) | Trioléate de propane-1,2,3-triyle polymérisé avec l'α-hydro-ω-hydroxypoly(oxyéthylène) |
| 68890-92-6 | Poly(oxy-1,2-ethanediyl), α-(3-carboxy-1-oxosulfopropyl)-ω-hydroxy-, ethers with lanolin alcs., disodium salts | α-(3-Carboxysulfopropionyl)-ω-hydroxypoly(oxyéthylène), éthers avec des alcools de lanoline, sels disodiques |
| 68910-56-5 | Quaternary ammonium compounds, di-C12-15-alkyldimethyl, chlorides | Composés de l'ion ammonium quaternaire, dialkyle en C12-15 diméthyles, chlorures |
| 68915-25-3 | Keratins, lauroyl | Kératines, dérivés lauroyliques |
| 68929-04-4 | 1H-Imidazolium, 1-[2-(2-carboxyethoxy)ethyl]-1-(2-carboxyethyl)-4,5-dihydro-2-undecyl-, hydroxide, disodium salt | Hydroxyde de disodium et de 1-[2-(2-carboxyéthoxy)éthyl]-1-(2-carboxyéthyl)-4,5-dihydro-2-undécyl-1H-imidazolium |
| 68935-40-0 | 1H-Indene-2-propanoic acid, 2,3-dihydro-1-oxo-5,6-bis(phenylmethoxy)-2-propyl- | Acide 2,3-dihydro-1-oxo-5,6-bis(phénylméthoxy)-2-propyl-1H-indène-2-propanoïque |
| 68953-59-3 | Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N′-bis(hydrogenated tallow acyl) derivs., Me sulfates (salts) | Bis(2-aminoéthyl)(2-hydroxyéthyl)méthylammonium, dérivés N,N′-diacylés de suif hydrogéné, sulfates mixtes de méthyle (sels) |
| 68953-68-4 | Aluminum, chloro propylene glycol complexes | Aluminium, complexes chloro de propylèneglycol |
| 69537-38-8 | 1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-[(1-oxodocosyl)oxy]-, chloride (1:1) | chlorure de 2-hydroxy-3-[(1-oxodocosyl)oxy]propyltriméthylammonium |
| 70131-69-0 | Silsesquioxanes, Phenyl | Phénylsilsesquioxanes |
| 70729-68-9 | Heptanoic acid, oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ester | Diheptanoate d'oxybis(éthane-2,1-diyloxyéthane-2,1-diyle) |
| 70729-87-2 | Isooctadecanoic acid, compd. with N,N-dimethyl-1-dodecanamine (1:1) | Acide isooctadécanoïque, composé avec le N,N-diméthyldodécylamine (1:1) |
| 70914-02-2 | Glycerides, C14-18 and C16-18-unsatd. mono- and di-, ethoxylated | Mono- et diglycérides en C14-18 et en C16-18 insaturés, éthoxylés |
| 71060-72-5 | Quaternary ammonium compounds, tri-C14-18-alkylmethyl, chlorides | Chlorures de tri-C14-18-alkylméthylammonium quaternaire |
| 71329-50-5 | Guar gum, 2-hydroxypropyl 2-hydroxy-3-(trimethylammonio)propyl ether, chloride | Gomme de guar, éthers 2-hydroxypropylique et 2-hydroxy-3-(triméthylammonio)propylique, chlorure |
| 71463-34-8 | 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, hydrogen sulfate (salt), monosodium salt | 1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, hydrogénosulfate (sel), sel monosodique |
| 71735-79-0 | 13-Oxabicyclo[10.1.0]trideca-4,8-diene, trimethyl- | Triméthyl-13-oxabicyclo[10.1.0]tridéca-4,8-diène |
| 71812-38-9 | Sorbitan, isooctadecanoate (2:3) | Sorbitane, isooctadécanoate (2:3) |
| 71850-81-2 | 1-Propanaminium, N-(carboxymethyl)-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]-N,N-dimethyl-, hydroxide, inner salt, [R-(Z)]- | [R-(Z)]-N-(Carboxyméthyl)-3-[(12-hydroxy-1-oxooctadéc-9-ényl)amino]-N,N-diméthylpropan-1-aminium, hydroxyde, sel interne |
| 71957-08-9 | Cobalt, bis(D-gluconato-κO1,κO2)-,(T-4)- | bis(D-gluconato-O1,O2)cobalt |
| 72175-39-4 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), octadecanoate (2:3) | Octadécanoate (2:3) d'α-hydro-ω-hydroxypoly(oxyéthane-1,2-diyl) éther avec le méthyl-D-glucopyranoside (4:1) |
| 72230-86-5 | Terpenes and Terpenoids, cedarwood-oil, Texan, hydroxy, acetates | Esters de l'acide acétique avec les alcools terpéniques tirés de l'essence du bois de cèdre du Texas |
| 72484-69-6 | Oxirane, methyl-, polymer with oxirane, mono(2-decyltetradecyl) ether | Oxirane, méthyl-, polymérisé avec l'oxirane, éther mono(2-décyltétradécylique) |
| 73231-34-2 | Acetamide, 2,2-dichloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]- | Acétamide, 2,2-dichloro-N-[(1S,2R)-1-(fluorométhyl)-2-hydroxy-2-[4-(méthylsulfonyl)phényl]éthyl]- |
| 73296-86-3 | Isooctadecanoic acid, ester with oxybis[propanediol] | Acide isooctadécanoïque, ester avec l'oxybis[propanediol] |
| 73772-45-9 | 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxodecyl)amino]-, hydroxide, inner salt | Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxodécyl)amino]propylammonium |
| 73772-46-0 | 1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3-[(1-oxooctyl)amino]-, hydroxide, inner salt | Hydroxyde de (carboxyméthyl)diméthyl-3-[(1-oxooctyl)amino]propylammonium |
| 74610-55-2 | Tylosin, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt) | Tylosine, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (sel) |
| 75018-70-1 | Ethanesulfonic acid, 2-[[[[(3α,5β,7α,12α,20S)-3,7,12-trihydroxy-20-methylpregnan-21-yl]seleno-75Se]acetyl]amino]- | Acide éthanesulfonique, 2-[[[[(3α,5bêta,7α,12α,20S)-3,7,12-trihydroxy-20-méthylprégnan-21-yl]séléno-75Se]acétyl]amino]- |
| 75911-79-4 | Bicyclo[3.2.1]octan-8-ol, 1,5-dimethyl-, acetate | Acétate de 1,5-diméthylbicyclo[3.2.1]oct-8-yle |
| 77851-07-1 | 2-Cyclohexene-1-carboxylic acid, 2,3,6,6-tetramethyl-, ethyl ester | 2,3,6,6-Tétraméthylcyclohex-2-ène-1-carboxylate d'éthyle |
| 77923-28-5 | Cyclododecane, (2-methoxyethoxy)- | (2-Méthoxyéthoxy)cyclododécane |
| 78509-74-7 | 1-(hexadecyloxy)octadecan-2-ol) | 1-(hexadécyloxy)octadécan-2-ol) |
| 78616-98-5 | Dodecanoic acid, 2-aminoethyl ester | Dodécanoate de 2-aminoéthyle |
| 79120-33-5 | Litharge (PbO) | Litharge (PbO) |
| 79702-63-9 | Butanedioic acid, 2-sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecen-1-yl]amino]ethyl] ester, sodium salt (1:2) | 2-Sulfonatosuccinate de disodium et de (Z)-[2-[(1-oxooctadéc-9-ényl)amino]éthyle] |
| 80435-42-3 | Iron alloy, base, Fe 63-74,Cr 12.0-15.0,Ni 12.0-15.0, W 1.50-3.00,Mn 0-1.00,Si 0.30-0.80,C 0.35-0.50, Mo 0.20-0.50,P 0-0.045,S 0-0.030 (UNS S66009) | Alliage de fer, base, Fe 63-74, Cr 12,0-15,0, Ni 12,0-15,0, W 1,50-3,00, Mn 0-1,00, Si 0,30-0,80, C 0,35-0,50, Mo 0,20-0 50, P 0-0,045, S 0-0,030 (UNS S66009) |
| 81783-01-9 | 6,8-Nonadien-3-one,2,4,4,7-tetramethyl-,oxime | 2,4,4,7-Tétraméthylnona-6,8-dièn-3-one-oxime |
| 81818-54-4 | 1,4-Naphthalenedione, 2-methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)- | 2-méthyl-3-(3,7,11,15-tétraméthylhexadec-2-ényl)-1,4-naphtoquinone |
| 81907-73-5 | 3-Cyclopentene-1-acetic acid, 2,2,3-trimethyl-, ethyl ester | 2,2,3-Triméthylcyclopent-3-ène-1-acétate d'éthyle |
| 83120-95-0 | 2-Propenoic acid, 2-methyl-, dodecyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 2-propenoic acid | Méthacrylate de dodécyle polymérisé avec la 1-vinylpyrrolidin-2-one et l'acide acrylique |
| 83615-24-1 | Cholest-5-en-3-ol (3β)-, 3-isooctadecanoate | Cholest-5-én-3-ol (3bêta)-, 3-isooctadécanoate |
| 83763-47-7 | Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]- | 2-[(3-amino-4-méthoxyphényl)amino]éthanol |
| 83763-48-8 | Ethanol, 2-[(3-amino-4-methoxyphenyl)amino]-, sulfate (1:1) | sulfate de (3-ammonio-4-méthoxyphényl)(2-hydroxyéthyl)ammonium |
| 84041-77-0 | Ethanol, 2,2′-[(2-nitro-1,4-phenylene)diimino]bis- | 2,2′-[(2-nitro-1,4-phénylène)diimino]biséthanol |
| 84366-81-4 | Riboflavin 5′-(trihydrogen diphosphate), 5′→5′-ester with adenosine, disodium salt | 5′-(trihydrogénodiphosphate) de riboflavine, 5′→5′-ester avec adénosine, sel de disodium |
| 84563-62-2 | Chitosan, hexanedioate (salt) | Chitosane, hexanedioate (sel) |
| 84605-12-9 | 13-Docosenoic acid, 13-docosenyl ester | docos-13-enoate de docos-13-ényle |
| 84608-82-2 | 2-hydroxy-3-(oleoyloxy) propyl 5-oxo-L-prolinate | 5-oxo-L-prolinate de 2-hydroxy-3-(oléoyloxy)propyle |
| 84642-57-9 | Cyclopentanone, 2-[(3,3,5-trimethylcyclohexyl)acetyl]- | 2-[(3,3,5-triméthylcyclohexyl)acétyl]cyclopentane-1-one |
| 84643-53-8 | 1-Hexadecanaminium, 2-hydroxy-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride (1:1) | chlorure de (2-hydroxyéthyl)(2-hydroxyhexadécyl)diméthylammonium |
| 84753-08-2 | 1, 3-bis(2-ethylhexyl)cyclohexane | 1,3-bis(2-éthylhexyl)cyclohexane |
| 84878-33-1 | Isononanoic acid, hexadecyl ester | isononanoate d′hexadécyle |
| 84878-34-2 | Isononanoic acid, octadecyl ester | isononanoate d'octadécyle |
| 84878-61-5 | 2H-Pyran-2-acetic acid, 6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2S,2′R,3′S,5R,5′R)-3′-[(2,6-dideoxy-3,4-di-O-methyl-β-L-arabino-hexopyranosyl)oxy]octahydro-2-methyl-5′-[(2S,3S,5R,6S)-tetrahydro-6-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl][2,2′-bifuran]-5-yl]-9-hydroxy-2,8-dimethyl-1,6-dioxaspiro[4.5]dec-7-yl]ethyl]tetrahydro-2-hydroxy-4,5-dimethoxy-3-methyl-, ammonium salt (1:1), (2R,3S,4S,5R,6S)- | sel d'ammonium de la maduramicine |
| 85058-43-1 | 1-Piperazinecarboxylic acid, 4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, ethyl ester, rel- | 4-[4-[[(2R,4S)-2-(2,4-dichlorophényl)-2-(1H-imidazol-1-ylméthyl)-1,3-dioxolan-4-yl]méthoxy]phényl]-1-pipérazinecarboxylate d'éthyle, rel- |
| 85066-57-5 | Poly(oxy-1,2-ethanediyl), α-(1-oxooctadecyl)-ω-(octadecyloxy)- | Poly(oxy-1,2-éthanediyle), α-(1-oxooctadécyl)-oméga-(octadécyloxy)- |
| 85252-25-1 | Benzoic acid, 2-hydroxy-, isodecyl ester | salicylate d'isodécyle |
| 85264-33-1 | 1H-Pyrazole-1-methanol, 3,5-dimethyl- | 3,5-diméthyl-1H-pyrazole-1-méthanol |
| 85563-48-0 | 1-Hexadecanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-, phosphate (1:1) (salt) | dihydrogénophosphate d'hexadécyl(2-hydroxyéthyl)diméthylammonium |
| 85586-07-8 | Sulfuric acid, mono-C12-14-alkyl esters, sodium salts | acide sulfurique, esters de mono-alkyles en C12-14, sels de sodium |
| 85765-48-6 | Ethanol, 2-[4-[(2-aminoethyl)amino]-3-nitrophenoxy]- | Éthanol, 2-[4-[(2-aminoéthyl)amino]-3-nitrophénoxy]- |
| 86050-77-3 | D-glucitol, 1-deoxy-1-(methylamino)-, [N,N-bis[2-[bis[(carboxy-κO)methyl]amino-κN]glycinato(5-)-κN,κO]gadolinate(2-) (2:1) | gadopentétate de diméglumine |
| 86419-69-4 | 1,2-Ethanediamine, N1-(5-methoxy-2-nitrophenyl)-, hydrochloride (1:1) | 1,2-éthanediamine, N1-(5-méthoxy-2-nitrophényl)-, chlorhydrate (1:1) |
| 86481-08-5 | Poly(oxy-1,2-ethanediyl), α, α′.-(1-methyl-1,2-ethanediyl)bis[ω-[[(9Z)-1-oxo-9-octadecenyl]oxy]- | Poly(oxy-1,2-éthanediyle), α, α′-(1-méthyl-1,2-éthanediyl)bis[oméga-[[(9Z)-1-oxo-9-octadécényl]oxy]- |
| 88103-59-7 | 13-Docosenoic acid, 2-octyldodecyl ester, (13Z)- | 13-docosénoate de 2-octyldodécyle, (13Z)- |
| 90274-24-1 | benzenemethanol, 4-hydroxy-α-[[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]methyl]-, hydrochloride | Benzèneméthanol, 4-hydroxy-a-[[[3-(4-hydroxyphényl)-1-méthylpropyl]amino]méthyl]-, chlorhydrate (1:1) |
| 90283-04-8 | 1-Dodecanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-, chloride | 1-dodécanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-, chlorure |
| 90411-68-0 | Hexanoic acid, 2-ethyl-, C16-18-alkyl esters | acide hexanoïque, éthyl-2, esters d'alkyles en C16-18 |
| 90457-82-2 | Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- | Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique |
| 90529-57-0 | 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-soya acyl derivs., Et sulfates | propanaminium-1, amino-3 N-éthyl N,N-diméthyl-, dérivés N-acyles de soja, sulfates d''éthyle |
| 90604-80-1 | Zirconium, chloro glycine hydroxy aluminum complexes | zirconium, complexes de glycine chloro et d'aluminium hydroxy |
| 90817-34-8 | 2,3-Pyridinediamine, 6-methoxy-N2-methyl- | 2,3-pyridinediamine, 6-méthoxy-N2-méthyl- |
| 91032-11-0 | Fatty acids, C12-20, reaction products with triethanolamine, di-Me sulfate-quaternized | Acides gras en C12-20, produits de la réaction avec du 2,2′,2″-nitrilotriséthanol, quaternarisé avec du sulfate de diméthyle |
| 91995-81-2 | Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized | acides gras en C10-20 et insaturés en C16-18, produits de réaction avec la triéthanolamine, quaternisés par le sulfate de diméthyle |
| 92045-76-6 | Paraffin waxes and Hydrocarbon waxes, microcryst., hydrotreated | cires de paraffine et cires d'hydrocarbures microcristallines, hydrotraitées |
| 92045-77-7 | Petrolatum (petroleum), hydrotreated | pétrolatum (pétrole), hydrotraité |
| 92201-88-2 | Imidazolium compounds, 2-(C9-19 and C9-19-unsatd. alkyl)-1-[(C10-20 and C10-20-unsatd. amido)ethyl]-4,5-dihydro-1-Me, Me sulfates | composés de l'ion imidazolium, (alkyl en C9-19, saturé et insaturé)-2 [(amido en C10-20, saturé et insaturé)éthyl]-1 dihydro-4,5 méthyl-1, sulfates de méthyle |
| 92348-62-4 | Octanoic acid, hydroxy- | Acide hydroxyoctanoïque |
| 92761-26-7 | Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 3,3′-(1,4-phenylenedimethylidyne)bis[7,7-dimethyl-2-oxo- | Acide 3,3′-(1,4-phénylènediméthylidyne)bis[7,7-diméthyl-2-oxo-bicyclo[2.2.1]heptane-1-méthanesulfonique |
| 92952-81-3 | Phenol, 4-[(3-hydroxypropyl)amino]-3-nitro- | Phénol, 4-[(3-hydroxypropyl)amino]-3-nitro- |
| 93106-60-6 | 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo- | Acide 1-cyclopropyl-7-(4-éthyl-1-pipérazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylique |
| 93166-05-3 | 1-Propanaminium, N-(2-aminoethyl)-N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-3-(phosphonooxy)-, N-C6-18 acyl derivs ., hydroxides, inner salts, disodium salts | N-(2-Aminoéthyl)-N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-3-(phosphonooxy)propan-1-aminium, dérivés acyles en N-C6-18, hydroxydes, sels internes, sels disodiques |
| 93385-03-6 | 3,6,9,12-Tetraoxaoctacosan-1-ol, 11-methyl-, acetate | 3,6,9,12-tétraoxaoctacosan-1-ol, 11-méthyl-, acétate |
| 93385-13-8 | Ethanol, 2-[2-[2-[2-(isohexadecyloxy)propoxy]ethoxy]ethoxy]-, acetate | Éthanol, 2-[2-[2-[2-(isohexadécyloxy)propoxy]éthoxy]éthoxy]-, acétate |
| 93385-14-9 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-triisohexadecyl ester | 2-hydroxy-1,2,3-propanetricarboxylate de 1,2,3-triisohexadécyle |
| 93507-51-8 | 1-Propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-trimethyl-, chloride (1:1) | 1-propanaminium, 3-[(2-hydroxy-1-oxopropyl)amino]-N,N,N-triméthyl-, chlorure (1:1) |
| 93841-25-9 | Benzeneethanol, 2,5-diamino-, sulfate (1:1) | sulfate de 3-(2-hydroxyéthyl)-p-phénylènediammonium |
| 94158-13-1 | Ethanol, 2,2′-[(4-amino-3-nitrophenyl)imino]bis-, monohydrochloride | 2,2′-[(4-amino-3-nitrophényl)imino]biséthanol, chlorhydrate |
| 94158-14-2 | Ethanol, 2-(1,3-benzodioxol-5-ylamino)-, hydrochloride (1:1) | 2-(1,3-benzodioxole-5-ylamino)éthanol, chlorhydrate |
| 94201-62-4 | Docosanoic acid, 2-hydroxy-1,3-propanediyl ester | didocosanoate de 2-hydroxypropane-1,3-diyle |
| 94247-26-4 | Tetradecyl isooctadecanoate | isooctadécanoate de tétradécyle |
| 94277-32-4 | 1,2-Hexadecanediol, 1,1′-(hydrogen phosphate), monosodium salt | phosphate de sodium et de bis(2-hydroxyhexadécyle) |
| 94333-50-3 | 1-Cyclohexene-1-carboxylic acid, 2-ethyl-3,6,6-trimethyl-, ethyl ester | 2-Éthyl-3,6,6-triméthylcyclohexènecarboxylate d'éthyle |
| 94333-51-4 | Cyclohexanecarboxylic acid, 6-ethylidene-2,2,5-trimethyl-, ethyl ester | 6-Éthylidène-2,2,5-triméthylcyclohexanecarboxylate d'éthyle |
| 94400-98-3 | Naphth[2,3-b]oxirene, 1a,2,3,4,5,6,7,7a-octahydro-1a,3,3,4,6,6-hexamethyl-, (1aα,4α,7aα)- | (1aα,4α,7aα)-1a,3,3,4,6,6-Hexaméthyl-1a,2,3,4,5,6,7,7a-octahydronapht[2,3-b]oxirène |
| 94891-31-3 | Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite | composés de l'ion ammonium quaternaire, dialkyl en C16-18 diméthyles, sels avec l'hectorite |
| 95193-70-7 | Amines, N-(C8-18 and C18-unsatd. alkyl)trimethylenedi-, reaction products with 2-chloroethanol and sodium chloroacetate | amines, N-(alkyl en C8-18 et insaturé en C18)triméthylènedi-, produits de réaction avec le chloro-2 éthanol et le chloracétate de sodium |
| 95193-83-2 | 1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts | 2-(quinolin-2-yl)-1H-indène-1,3(2H)-dione, sulfonée, sels de sodium |
| 95371-16-7 | Sulfonic acids, C14-16-1-alkene, sodium salts | acides sulfoniques, alcène-1 en C14-16, sels de sodium |
| 95576-89-9 | 1,2-Propanediol, 3-[(4-amino-2-chloro-5-nitrophenyl)amino]- | 1,2-propanediol, 3-[(4-amino-2-chloro-5-nitrophényl)amino]- |
| 95576-92-4 | 1,2-Propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phenylene)diimino]bis- | 1,2-propanediol, 3,3′-[(2-chloro-5-nitro-1,4-phénylène)diimino]bis- |
| 96081-39-9 | Alkyl(C16-18)polyethyleneglycol tetra decylene glycolether | Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18 |
| 97375-39-8 | C.I. Food Yellow 4:2 | zirconium, complexes de dihydro-4,5 oxo-5 (sulfo-4 phényl)-1 [(sulfo-4 phényl)azo]-4 1H-pyrazole carboxylate-3 |
| 97862-59-4 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-18 acyl derivs., hydroxides, inner salts | propanaminium-1, amino-3 N-(carboxyméthyl) N,N-diméthyl-, dérivés N-acyles en C8-18, hydroxydes, sels internes |
| 97862-76-5 | Foots oil (petroleum), carbon-treated | huile de ressuage (pétrole), traitée au charbon |
| 97862-89-0 | Paraffin waxes (petroleum), carbon-treated | cires paraffiniques (pétrole), traitées au charbon |
| 97862-97-0 | Petrolatum (petroleum), carbon-treated | pétrolatum (pétrole), traité au charbon |
| 97952-68-6 | Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, salts with montmorillonite | composés de l'ion ammonium quaternaire, benzyl bis(alkyl de suif hydrogéné)méthyles, sels avec la montmorillonite |
| 99542-23-1 | 1-Propanaminium, N-ethyl-N,N-dimethyl-3-[[(9Z,12Z)-1-oxo-9,12-octadecadienyl]amino]-, ethyl sulfate | 1-propanaminium, N-éthyl-N,N-diméthyl-3-[[(9Z,12Z)-1-oxo-9,12-octadécadiényl]amino]-, sulfate d'éthyle |
| 99610-72-7 | Phenol, 2-[(2-hydroxyethyl)amino]-4,6-dinitro- | Phénol, 2-[(2-hydroxyéthyl)amino]-4,6-dinitro- |
| 99948-86-4 | 2-[(dihydroxymethylsilyl)oxy]propionic acid | acide 2-[(dihydroxyméthylsilyl)oxy]propionique |
| 100418-33-5 | Ethanol, 2-[(4-methyl-2-nitrophenyl)amino]- | Éthanol, 2-[(4-méthyl-2-nitrophényl)amino]- |
| 100684-33-1 | Petrolatum (petroleum), clay-treated | pétrolatum (pétrole), traité à la terre |
| 100684-38-6 | Residual oils (petroleum), clay-treated solvent-dewaxed | huiles résiduelles (pétrole), déparaffinées au solvant et traitées à la terre |
| 100684-49-9 | Slack wax (petroleum), carbon-treated | gatsch (pétrole), traité au charbon |
| 101831-37-2 | Benzeneacetonitrile, 2,6-dichloro-α-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)- | diclazuril |
| 102868-96-2 | Zinc, bis[N-(acetyl-κO)-L-methioninato-κO]-, (T-4)- | Zinc, bis[N-(acétyl-κO)-L-méthioninato-κO]-, (T-4)- |
| 103055-07-8 | Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro- | lufénuron |
| 103622-85-1 | 3,6,9,12-Tetraoxatriacont-21-en-1-ol | 3,6,9,12-tétraoxatriacont-21-én-1-ol |
| 103810-94-2 | Methanone, diphenyl-, dihydroxy deriv. | Méthanone, diphényl-, dérivés dihydroxy |
| 104226-19-9 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | 3-((4-(bis(2-hydroxyéthyl)amino)-2-nitrophényl)amino)-1-propanol |
| 104333-00-8 | 1,2-Propanediol, 3-[[2-nitro-4-(trifluoromethyl)phenyl]amino]- | 1,2-propanediol, 3-[[2-nitro-4-(trifluorométhyl)phényl]amino]- |
| 104365-75-5 | 2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol | Acide 2-propénoïque, homopolymère, ester avec le 1,2,3-propanetriol |
| 105859-93-6 | Propanoic acid, 2,2-dimethyl-, tridecyl ester | 2,2-diméthylpropanoate de tridécyle |
| 105883-51-0 | Copper, bis[N-(acetyl-κO)-L-methioninato-κO]- | Cuivre, bis[N-(acétyl-κO)-L-méthioninato-κO]- |
| 105883-52-1 | Cobalt, bis[N-(acetyl-κO)-L-methioninato-κO]- | Cobalt, bis[N-(acétyl-κO)-L-méthioninato-κO]- |
| 106233-09-4 | Poly(oxy-1,2-ethanediyl),α-hydro-ω-hydroxy-,mono-C16-18-alkyl ethers, phosphates | Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éthers monoalkyliques en C16-18, phosphates |
| 106392-12-5 | Oxirane, 2-methyl-, polymer with oxirane, block | Oxirane, 2-méthyl-, polymérisé avec l'oxirane, séquencé |
| 106631-38-3 | 1-Naphthalenepropanol, α-ethenyldecahydro-α,5,5,8a-tetramethyl-2-methylene- | α-Vinyldécahydro-α,5,5,8a-tétraméthyl-2-méthylènenaphtalène-1-propanol |
| 108050-54-0 | Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]- | Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-α-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]- |
| 108347-90-6 | Poly[oxy(methyl-1-,2-ethanediyl)], α-benzoyl-ω-(octadecyloxy)- | α-Benzoyl-ω-(octadécyloxy)poly(oxypropylène) |
| 109423-22-5 | Benzoic acid, 2-hydroxy-, 5-methyl-2-(1-methylethyl)cyclohexyl ester | salicylate de menthyle |
| 109485-61-2 | Nonane, 2,2,4,4,6,6,8-heptamethyl- | 2,2,4,4,6,6,8-heptaméthylnonane |
| 110332-91-7 | Oxirane, methyl-, polymer with oxirane, monoacetate, isohexadecyl ether, block | Oxirane, méthyl-, polymérisé avec l'oxirane, monoacétate, éther isohexadécylique, séquencé |
| 113010-52-9 | Benzoic acid, 4-amino-, ethyl ester, polymer with oxirane | 4-aminobenzoate d'éthyle, polymérisé avec l'oxirane |
| 113089-59-1 | Collagens, hydrolyzates, reaction products with 3-chloro-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride | Collagènes, hydrolysats, produits de réaction avec le chlorure de 3-chloro-2-hydroxy-N,N,N-triméthyl-1-propanaminium |
| 113221-73-1 | 2-Naphthalenecarboxaldehyde, 5,6,7,8-tetrahydro-5,5,7,8,8-pentamethyl- | 5,5,7,8,8-Pentaméthyl-5,6,7,8-tétrahydronaphtalène-2-carbaldéhyde |
| 113431-54-2 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, triisooctadecyl ester | 2-hydroxy-1,2,3-propanetricarboxylate de triisooctadécyle |
| 113507-06-5 | Milbemycin B, 5-O-demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-butenyl]-6,28-epoxy-23-(methoxyimino)-, (6R,23E,25S)- | Moxidectine |
| 115340-78-8 | 1-Propanaminium, 3-amino-N-ethyl-N,N-dimethyl-, N-apricot-oil acyl derivs., Et sulfates | 1-propanaminium, 3-amino-N-éthyl-N,N-diméthyl-, dérivés N-acylés d'huile d'abricot, sulfates d'éthyle |
| 117704-25-3 | Avermectin A1a, 25-cyclohexyl-5-O-demethyl-25-de(1-methylpropyl)- | Doramectine |
| 119691-49-5 | 1-Eicosanol, 2-tetradecyl- | 2-Tétradécylicosan-1-ol |
| 119831-19-5 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), dioctadecanoate | Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), dioctadécanoate |
| 120066-54-8 | Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]- | Gadolinium, [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tétraazacyclododécane-1,4,7-triacétato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]- |
| 121546-77-8 | Alcohols, C12-15 ethoxylate, sulfonate, sodium salt | Alcools, éthoxylate en C12-15, sulfonate, sel sodique |
| 121684-92-2 | α-D-Glucopyranoside, β-D-fructofuranosyl, acetate dioctadecanoate | α-D-glucopyranoside, bêta-D-fructofuranosyl-, acétate, dioctadécanoate |
| 121734-19-8 | 1,3-Benzenediamine, 4-methoxy-, sulfate | 1,3-benzènediamine, 4-méthoxy-, sulfate |
| 121888-66-2 | Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, benzoate lauryl sulfate, salts with bentonite | Composés d'ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, benzoate sulfate de lauryle, sels avec le bentonite |
| 121888-67-3 | Quaternary ammonium compounds, benzylbis(hydrogenated tallow alkyl)methyl, bis(hydrogenated tallow alkyl)dimethylammonium salt with hectorite | Composés d'ammonium quaternaires, benzylbis(alkyle de suif hydrogéné)méthyle, sel de bis(alkyle de suif hydrogéné)diméthylammonium avec l'hectorite |
| 121888-68-4 | Quaternary ammonium compounds, benzyl(hydrogenated tallow alkyl)dimethyl, stearates, salts with bentonite | Composés d'ammonium quaternaires, benzyl(alkyle de suif hydrogéné) diméthyle, stéarates, sels avec le bentonite |
| 123776-56-7 | 1-Propanaminium, 3-(acetylamino)-N,N,N-trimethyl-, chloride (1:1) | 1-propanaminium, 3-(acétylamino)-N,N,N-triméthyl-, chlorure (1:1) |
| 123997-26-2 | Avermectin B1, 4"-(acetylamino)-4"-deoxy-, (4"R)- | Eprinomectine |
| 124046-05-5 | Benzenemethanaminium, N-(3-aminopropyl)-N,N-dimethyl-, N-babassu-oil acyl derivs., chlorides | Benzèneméthanaminium, N-(3-aminopropyl)-N,N-diméthyl-, dérivés N-acylés d'huile de babassu, chlorures |
| 124046-40-8 | Amides, wheat germ-oil, N-[3-(dimethylamino)propyl], lactates | Amides, huile de germe de blé, N-[3-(diméthylamino)propyl]-, lactates |
| 125109-85-5 | Benzenepropanal, β-methyl-3-(1-methylethyl)- | β-Méthyl-3-isopropylbenzènepropanal |
| 125804-04-8 | Docosanoic acid, compd. with N-[3-(dimethylamino)propyl]docosanamide (1:1) | Acide docosanoïque, composé avec le N-[3-(diméthylamino)propyl]docosanamide (1:1) |
| 125804-08-2 | Docosanoic acid, 2-octyldodecyl ester | Docosanoate de 2-octyldodécyle |
| 125804-10-6 | 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, compd. with (9Z,12Z)-N-[3-(dimethylamino)propyl]-9,12-octadecadienamide (1:1) | Acide (9Z,12Z)-9,12-octadécadiénoïque, dimère, composé avec le (9Z,12Z)-N-[3-(diméthylamino)propyl]-9,12-octadécadiénamide (1:1) |
| 126121-35-5 | 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2-bis(2-octyldodecyl) 3-(2-octyl-7-pentylheptyl) ester | 2-hydroxy-1,2,3-propanetricarboxylate de 1,2-bis(2-octyldodécyle) et de 3-(2-octyl-7-pentylheptyle) |
| 126506-93-2 | 1,3,2-Dioxastibolane-4,5-dicarboxylic acid, 2-hydroxy-, 2-oxide | Acide 2-hydroxy-1,3,2-dioxastibolane-4,5-dicarboxylique, 2-oxyde |
| 126595-07-1 | Propanoic acid, 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bis-, homopolymer | Acide 3,3′-(1,3-dioxo-1,3-digermoxanediyl)bispropanoïque, homopolymère |
| 127061-56-7 | L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-YL hydrogen phosphate], potassium salt (1:1) | Acide L-ascorbique, 2-[(2R)-3,4-dihydro-2,5,7,8-tétraméthyl-2-[(4R,8R)-4,8,12-triméthyltridécyl]-2H-1-benzopyran-6-ylhydrogénophosphate], sel de potassium (1:1) |
| 127311-98-2 | 1-Propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadecenyl]amino]-N,N,N-trimethyl-, chloride | 1-propanaminium, 3-[[(9Z,12R)-12-hydroxy-1-oxo-9-octadécènyl]amino]-N,N,N-triméthyl-, chlorure |
| 128729-28-2 | 1,3-bis[(4-aminophenyl)(2-hydroxyethyl)amino]-2-propanol, tetrahydrochloride | 2-propanol, 1,3-bis[(4-aminophényl)(2-hydroxyéthyl)amino]-, chlorhydrate (1:4) |
| 128973-71-7 | Siloxanes and Silicones, a-D-mannopyranuronoyloxy Me, hydroxy-terminated | Siloxanes et silicones, a-D-mannopyranuronoyloxyméthyl-, à terminaison hydroxy |
| 128973-73-9 | Siloxanes and Silicones, Me[1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy, hydroxy-terminated | Siloxanes et silicones, méthyl[1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy-, à terminaison hydroxy |
| 128973-74-0 | Siloxanes and Silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy] Me, hydroxyl-terminated | Siloxanes et silicones, (2S-trans)-[[4-hydroxy-2-pyrrolidinyl)carbonyl]oxy]méthyl-, à terminaison hydroxyle |
| 129496-10-2 | Milbemycin, oxime | Milbemycin, oxime |
| 129541-40-8 | Tetradecanamide, N-[3-(dimethylamino)propyl]-, phosphate (1:1) | Tétradécanamide, N-[3-(diméthylamino)propyl]-, phosphate (1:1) |
| 129757-76-2 | 2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol | Oxépan-2-one polymérisée avec le 1,6-diisocyanate d'hexane et le propylidynetriméthanol |
| 130291-58-6 | 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, homopolymer, compd. with bromomethane | 2-méthyl-2-propénoate de 2-(diméthylamino)éthyle, homopolymère, composé avec le bromométhane |
| 130353-64-9 | Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-ethers with cellulose 2-hydroxyethyl ether, chlorides | Composés d'ammonium quaternaire, cocoalkyl(2,3-dihydroxypropyl)diméthyl, 3-éthers avec l'éther 2-hydroxyéthylique de cellulose, chlorures |
| 130381-02-1 | Protein hydrolyzates, soya, [3-(dodecyldimethylammonio)-2-hydroxypropyl], chlorides | Hydrolysats de protéines, soja, [3-(dodécyldiméthylammonio)-2-hydroxypropyl]-, chlorures |
| 130381-04-3 | Protein hydrolyzates, wheat germ, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides | Hydrolysats de protéines, germe de blé, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures |
| 130381-05-4 | Protein hydrolyzates, wheat germ, [3-(dimethyloctadecylammonio)-2-hydroxypropyl], chlorides | Hydrolysats de protéines, germe de blé, [3-(diméthyloctadécylammonio)-2-hydroxypropyl], chlorures |
| 131044-77-4 | Copper, N-acetyl-L-tyrosine hydroxy-terminated (S)-[2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropoxy] Me siloxanes | Cuivre, complexes de N-acétyl-L-tyrosine et de (S)-[2-(acétylamino)-3-(4-hydroxyphényl)-1-oxopropoxy]méthylsiloxanes à terminaison hydroxy |
| 131044-78-5 | Copper, hydroxy-terminated Me (S)-[[(5-oxo-2-pyrrolidinyl) carbonyl]oxy] siloxanes 5-oxo-L-proline complexes | Cuivre, complexes de (S)-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]méthylsiloxanes et de 5-oxo-L-proline |
| 131216-83-6 | Siloxanes and Silicones, 2-(acetylamino)-4-(methylthio)-1-oxobutyoxy Me, hydroxy-terminated | Siloxanes et silicones, 2-(acétylamino)-4-(méthylthio)-1-oxobutyoxyméthyl-, à terminaison hydroxy |
| 131410-48-5 | Gadolinium, [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-(oxo-κO)ethyl]-3-(oxo-κO)-2,5,8,11-tetraazatridecan-13-oato(3-)-κN5,κN8,κN11,κO13]- | Gadodiamide |
| 131812-48-1 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl)- | 2,4-Diméthyl-2-(5,6,7,8-tétrahydro-3,5,5,6,8,8-hexaméthylnapht-2-yl)-1,3-dioxolane |
| 131812-49-2 | Naphthalene, 7-(diethoxymethyl)-1,2,3,4-tetrahydro-1,1,2,4,4-pentamethyl- | 7-(Diéthoxyméthyl)-1,2,3,4-tétrahydro-1,1,2,4,4-pentaméthylnaphtalène |
| 131812-51-6 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, cis- | 1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis- |
| 131812-52-7 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-, trans- | 1,3-dioxolane, 2,4-diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tétraméthyl-2-naphtalènyl)-, cis- |
| 131812-67-4 | 1,3-Dioxolane, 2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)- | 2,4-Diméthyl-2-(5,6,7,8-tétrahydro-5,5,8,8-tetraméthyl-2-naphtyl)-1,3-dioxolane |
| 131954-48-8 | 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with 1-ethenyl-2-pyrrolidinone | 1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec la 1-éthényl-2-pyrrolidinone |
| 132467-76-6 | 1-Octadecanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-dimethyl-4-oxobutoxy]propyl]-N,N-dimethyl-, chloride | 1-Octadécanaminium, N-[2-hydroxy-3-[3-hydroxy-4-[(3-hydroxypropyl)amino]-2,2-diméthyl-4-oxobutoxy]propyl]-N,N-diméthyl-, chlorure |
| 133934-09-5 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-wheat-oil acyl derivs., inner salts | 1-propanaminium, 3-amino-N-(carboxyméthyl)-N,N-diméthyl-, dérivés N-acylés d'huile de blé, sels internes |
| 134112-42-8 | 1-Propanaminium, N-[2-(dodecyloxy)-2-oxoethyl]-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-,chloride | 1-propanaminium, N-[2-(dodécyloxy)-2-oxoéthyl]-N,N-diméthyl-3-[(1-oxoisooctadécyl)amino]-, chlorure |
| 134375-99-8 | Aluminum Zirconium Trichlorohydrex Glycine | Aluminum zirconium trichlorohydrex glycine |
| 135326-54-4 | Propanol, (tetradecyloxy)-, acetate | Propanol, (tétradécyloxy)-, acétate |
| 136207-49-3 | 3,6,9,12,15-Pentaoxaheptatriacontan-1-ol | 3,6,9,12,15-pentaoxaheptatriacontan-1-ol |
| 136504-87-5 | 1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-,N-soya acyl derivs., inner salts | 3-Amino-N-(carboxyméthyl)-N,N-diméthylpropan-1-aminium, dérivés N-(acyl de soya), sels internes |
| 136505-01-6 | 2-Propenenitrile, homopolymer, hydrolyzed, block, reaction products with N,N-dimethyl-1,3-propanediamine | 2-propènenitrile, homopolymère, hydrolysé, séquencé, produits de réaction avec la N,N-diméthyl-1,3-propanediamine |
| 136920-08-6 | 1-Propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-dimethyl-, N-coco acyl derivs., chlorides | 1-propanaminium, N-(3-aminopropyl)-2,3-dihydroxy-N,N-diméthyl-, dérivés N-cocoacylés, chlorures |
| 137044-11-2 | 1-Propanaminium, 3-[2-(acetylamino)ethoxy]-N,N,N-trimethyl-, chloride | 1-propanaminium, 3-[2-(acétylamino)éthoxy]-N,N,N-triméthyl-, chlorure |
| 137330-13-3 | Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-, phosphate (1:1) (salt) | Tylosine, 4A-O-dé(2,6-didésoxy-3-C-méthyl-a-L-ribo-hexopyranosyl)-20-désoxo-20-[(3R,5S)-3,5-diméthyl-1-pipéridinyl]-, phosphate (1:1) (sel) |
| 139096-04-1 | Indate(2-)-111In, [N,N-bis[2 [bis(carboxymethyl)amino]ethyl]glycinato(5-)]-, disodium | Indate(2-)-111In, [N,N-bis[2 [bis(carboxyméthyl)amino]éthyl]glycinato(5-)]-, disodique |
| 139247-28-2 | Poly(oxy-1,2-ethanediyl), α,α′,α″-1,2,3-propanetriyltris[ω-hydroxy-, benzoate | Poly(oxy-1,2-éthanediyle), α,α′,α″-1,2,3-propanetriyltris(oméga-hydroxy)-, benzoate |
| 142104-11-8 | 2-Butenedioic acid (2E)-, di-C12-15-alkyl esters | (2E)-2-butènedioate de dialkyles en C12-15 |
| 142164-39-4 | Nickel carbonate hydroxide | Hydroxyde de carbonate de nickel |
| 142657-60-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[[(3-coco amidopropyl)dimethylammonio]acetate], chlorides | Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[[(3-cocoamidopropyl)diméthylammonio]acétate] de polyéthylèneglycol, chlorures |
| 142891-20-1 | 2-Propenoic acid, 2-chloro-3-[2-chloro-5-(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)phenyl]-, ethyl ester, (2Z)- | cinidon-éthyl |
| 144377-73-1 | 4,6-Dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dien-1-aminium, 5-[3-[dimethyl[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tetramethyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]amino]propyl]-, 5-oxide, chloride (1:3), (23Z,26Z)- | 4,6-dioxa-14-aza-10-azonia-5-phosphadotriaconta-23,26-dién-1-aminium, 5-[3-[diméthyl[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl]amino]propyl]ammonio]-2-hydroxypropoxy]-2,8-dihydroxy-N,N,10,10-tétraméthyl-15-oxo-N-[3-[[(9Z,12Z)-1-oxo-9,12-octadécadién-1-yl] |
| 144610-93-5 | Propanoic acid, 2,2-dimethyl-, tetradecyl ester | 2,2-diméthylpropanoate de tétradécyle |
| 145269-34-7 | Hydrolyzed wheat protein hydroxypropyltriammonium | Hydroxypropyltriammonium de protéines de blé hydrolysées |
| 146192-98-5 | 2-Butenedioic acid (2Z)-, monobutyl ester, polymer with ethenyl acetate and 1,7,7-trimethylphenylbicyclo[2.2.1]hept-2-yl 2-propenoate | (2Z)-2-butènedioate de monobutyle, polymérisé avec l'acétate d'éthényle et le 2-propénoate de 1,7,7-triméthylphénylbicyclo[2.2.1]hept-2-yle |
| 146632-08-8 | Siloxanes and Silicones, di-Me, Bu group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with 2-[[(heptadecafluorooctyl)sulfonyl]methylamino]ethyl acrylate and iso-Bu methacrylate | Siloxanes et silicones, diméthyl-, à terminaison butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec l'acrylate de 2-[[(heptadécafluorooctyl)sulfonyl]méthylamino]éthyl et le méthacrylate d'isobutyle |
| 147398-77-4 | Ethanaminium, N-(carboxymethyl)-N,N-dimethyl-2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, inner salt, polymer with methyl 2-methyl-2-propenoate | Éthanaminium, N-(carboxyméthyl)-N,N-diméthyl-2-[(2-méthyl-1-oxo-2-propén-1-yl)oxy]-, sel interne, polymérisé avec le 2-méthyl-2-propénoate de méthyle |
| 147550-61-6 | Copper carbonate hydroxide | Hydroxyde de carbonate de cuivre |
| 148506-50-7 | Poly[oxy-1,2-ethanediyl(dimethyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(dimethyliminio)-1,2-ethanediyl chloride (1:2)] | Poly[oxy-1,2-éthanediyl(diméthyliminio)-1,3-propanediylimino(1,6-dioxo-1,6-hexanediyl)imino-1,3-propanediyl(diméthyliminio)-1,2-éthanediyle, chlorure (1:2)] |
| 148812-63-9 | Protein hydrolyzates, wheat, reaction products with palmitoyl chloride | Hydrolysats de protéines, blé, produits de réaction avec le chlorure de palmitoyle |
| 150599-70-5 | 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenyl-2-pyrrolidinone | Méthylsulfate de 1-vinyl-3-méthyl-1H-imidazolium polymérisé avec la 1-vinylpyrrolid-2-one |
| 155601-30-2 | 1H-Pyrazole-1-ethanol,4,5-diamino-, sulfate (1:1) | 1H-Pyrazole-1-éthanol, 4,5-diamino-, sulfate (1:1) |
| 155683-77-5 | Oxirane, 2-methyl-, polymer with oxirane, monoisodecyl ether | Oxirane, 2-méthyl-, polymérisé avec l'oxirane, éther monoisodécylique |
| 155715-93-8 | Gelatins, polymers with keratin hydrolyzates and L-lysine, hydroxy-N,N,N-trimethyl-1 propanaminium chloride-quaternized | Gélatines, polymérisées avec les hydrolysats de kératine et la L-lysine, chlorure d'hydroxy-N,N,N-triméthyl-1 propanaminium quaternisé |
| 156028-14-7 | 1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt, sodium salt (1:1) | 1H-imidazolium, 1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-2-undécyl-, sel interne, sel sodique (1:1) |
| 156679-41-3 | N-dodecyl-[3-(4-dimethylamino)benzamido)-propyl]dimethylammonium tosylate | Tosylate de N-dodécyl-[3-(4-diméthylamino)benzamido)propyl]diméthylammonium |
| 156715-43-4 | Protein hydrolyzates, soya, [3-(cocoalklydimethylammonio)-2-hydroxypropyl], chlorides | Hydrolysats de protéines, soja, [3-(cocoalklydiméthylammonio)-2-hydroxypropyl]-, chlorures |
| 156798-09-3 | Keratins, hydrolyzates, [3-(coco alkyldimethylammonio)-2-hydroxypropyl], chlorides | Kératines, hydrolysats, [3-(cocoalkyldiméthylammonio)-2-hydroxypropyl]-, chlorures |
| 156798-11-7 | Protein hydrolyzates, wheat, [2-hydroxy-3-(trimethylammonio)propyl] chlorides | Hydrolysats de protéines, blé, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures |
| 157009-77-3 | 9,12-Octadecadienoic acid (9Z,12Z)-, dimer, diisoeicosyl ester | (9Z,12Z)-9,12-octadécadiénoate de diisoeicosyle, dimère |
| 158483-23-9 | Poly(oxy-1,2-ethanediyl),α,α′,α"-1,2,3-propanetriyltris[ω-hydroxy-,2-hydroxypropanoate | Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris[oméga-hydroxy-,2-hydroxypropanoate |
| 158765-79-8 | Micrococcus luteus, lysate | Micrococcus luteus, lysat |
| 159317-32-5 | Acetic acid, hydroxy-, isooctadecyl ester | Hydroxyacétate d'isooctadécyle |
| 162030-43-5 | Mannopyranuronic acid, 1-O-[hydroxymethyl [[(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purin-7-yl)acetyl]oxy]silyl]- | Acide mannopyranuronique, 1-O-[hydroxyméthyl [[(1,2,3,6-tétrahydro-1,3-diméthyl-2,6-dioxo-7H-purin-7-yl)acétyl]oxy]silyl]- |
| 162353-59-5 | Quaternary ammonium compounds, (C10-20 and C10-20-unsatd. alkyl) (3-chloro-2-ydroxypropyl) dimethyl, chlorides, reaction products with silk protein hydrolyzates | Composés d'ammonium quaternaire, (alkyles en C10-20 et alkyles insaturés en C10-20) (3-chloro-2-hydroxypropyl)diméthyl, chlorures, produits de réaction avec des hydrolysats de protéines de soie |
| 162888-05-3 | Octadecanoic acid, 12-hydroxy-, 16-methylheptadecyl ester | 12-hydroxy-octadécanoate de 16-méthylheptadécyle |
| 164288-56-6 | 1-Propanaminium, 3-amino-N-[2-[(2-hydroxyethyl)amino]-2-oxoethyl]-N,N-dimethyl-, N-C12-18 acyl derivs., chlorides | 1-propanaminium, 3-amino-N-[2-[(2-hydroxyéthyl)amino]-2-oxoéthyl]-N,N-diméthyl-, dérivés N-acylés en C12-18, chlorures |
| 165745-27-7 | Carbamic acid, N-butyl-, 3-iodo-2-propyn-1-yl ester, mixt. with N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxymethyl)urea | N-butylcarbamate de 3-iodo-2-propyn-1-yle, mélange avec la N-[1,3-bis(hydroxyméthyl)-2,5-dioxo-4-imidazolidinyl]-N,N′-bis(hydroxyméthyl)urée |
| 168677-75-6 | Poly(oxy-1,2-ethanediyl), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadecadien-1-yliminio]di-2,1-ethanediyl]bis[ω-hydroxy-, chloride (1:1) | Poly(oxy-1,2-éthanediyle), α,α′-[[(9Z,12Z)-(2,3-dihydroxypropyl)-9,12-octadécadién-1-yliminio]di-2,1-éthanediyl]bis(oméga-hydroxy)-, chlorure (1:1) |
| 169590-61-8 | Protein hydrolyzates, silk, [2-hydroxy-3-(trimethylammonio)propyl], chlorides | Hydrolysats de protéines, soie, [2-hydroxy-3-(triméthylammonio)propyl]-, chlorures |
| 172376-82-8 | 6,10-Dodecadienal, 3,7,11-trimethyl-, (6Z)- | 6,10-Dodécadiénal, 3,7,11-triméthyl-, (6Z)- |
| 173010-79-2 | Quaternary ammonium compounds, coco alkyl(2,3-dihydroxypropyl)dimethyl, 3-phosphates (esters), chlorides, sodium salts | Sels de sodium, chlorures, 3-phosphates (esters) de composés coco alkyl(2,3-dihydroxypropyl)diméthyl ammonium quaternaire |
| 173763-15-0 | Aluminum Sesquichlorohydrate | sesquichlorohydrate d'aluminium |
| 174761-16-1 | 1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate (1:1), polymer with 1-ethenylhexahydro-2H-azepin-2-one and 1-ethenyl-2-pyrrolidinone | 1H-imidazolium, 1-éthényl-3-méthyl-, sulfate de méthyle (1:1), polymérisé avec la 1-éthénylhexahydro-2H-azépin-2-one et la 1-éthényl-2-pyrrolidinone |
| 175357-18-3 | L-Phenylalanine, N-(1-oxo-10-undecen-1-yl)- | L-phénylalanine, N-(1-oxo-10-undécén-1-yl)- |
| 175893-70-6 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, diesters with caroboxymethyl wheat protein hydrolyzates | Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, diesters avec des hydrolysats de protéines de blé carbométhylés |
| 175893-71-7 | 2-Propenamide, N-[3-(dimethylamino)propyl]-2-methyl-, polymer with 1-ethenyl-2-pyrrolidinone, sulfate | N-[3-(diméthylamino)propyl]-2-méthylpropèn-2-amide, polymérisée avec la 1-vinyl-2-pyrrolidinone, sulfate |
| 177080-35-2 | Phenol, 4-[(3-hydroxypropyl)amino]-2-nitro- | Phénol, 4-[(3-hydroxypropyl)amino]-2-nitro- |
| 177190-98-6 | 1-Propanaminium, N,N,N-trimethyl-3-[(1-oxo-3-phenyl-2-propen-1-yl)amino]-,chloride (1:1) | 1-propanaminium, N,N,N-triméthyl-3-[(1-oxo-3-phényl-2-propén-1-yl)amino]-, chlorure (1:1) |
| 179005-04-0 | Siloxanes and Silicones, 3-[4-[[[3-[(2,3-dihydroxypropyl)dimethylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl Me, di-Me, 3-[3-[[3-(C8-22-acylamino)propyl]dimethylammonio]-2-hydroxypropyl phosphates], chlorides, sodium salts | Siloxanes et silicones, méthyl-3-[4-[[[3-[(2,3-dihydroxypropyl)diméthylammonio]propyl]amino]carbonyl]-2-oxo-1-pyrrolidinyl]propyl, diméthyl-, 3-[3-[[3-(C8-22-acylamino)propyl]diméthylammonio]-2-hydroxypropyl phosphates], sels de chlorures et de sodium |
| 182700-78-3 | Siloxanes and Silicones, 3-[(3-aminopropyl)amino]propyl Me, di-Me, 3-hydroxypropyl Me, ethoxylated, [(hydroxydimethylsilyl)oxy]-terminated | Siloxanes et silicones, 3-[(3-aminopropyl)amino]propylméthyl-, diméthyl, 3-hydroxypropylméthyl-, éthoxylés, à terminaison [(hydroxydiméthylsilyl)oxy] |
| 183476-82-6 | L-Ascorbic acid, 2,3,5,6-tetrakis(2-hexyldecanoate) | Acide 2,3,5,6-tétrakis(2-hexyldécanoate)-L-ascorbique |
| 185018-43-3 | L-Ascorbic acid, 2-[(3β)-cholest-5-en-3-yl hydrogen phosphate], monosodium salt | Acide L-ascorbique, 2-[hydrogénophosphate de (3bêta)-cholest-5-én-3-yle], sel monosodique |
| 185429-83-8 | Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethyl-2-naphthalenyl)-, cis- | Éthanone, 1-(1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tétraméthyl-2-naphthalényl)-, cis- |
| 187175-42-4 | Silsesquioxanes, Me, hydroxy-terminated, alginate, compds. with caffeine | Silsesquioxanes, méthylés, à terminaison hydroxy, alginate, composés avec la caféine |
| 187991-39-5 | L-ascorbic acid, 6-O-(dihydroxymethylsilyl)- | Acide L-ascorbique, 6-O-(dihydroxyméthylsilyl)- |
| 190270-74-7 | L-Lysine dihydroxymethylsilyl ester | L-lysinate de dihydroxyméthylsilyle |
| 193888-44-7 | 1-Propanaminium, N-(carboxymethyl)-2-hydroxy-N-(2-hydroxyethyl)-N-[2-[(1-oxododecyl)amino]ethyl]-3-(phosphonooxy)-, inner salt, monosodium salt | 1-propanaminium, N-(carboxyméthyl)-2-hydroxy-N-(2-hydroxyéthyl)-N-[2-[(1-oxododécyl)amino]éthyl]-3-(phosphonooxy)-, sel interne, sel monosodique |
| 193892-43-2 | Poly[oxy(dimethylsilylene)], α-docosyl-ω-(docosyloxy)- | Poly[oxy(diméthylsilylène)], α-docosyl-oméga-(docosyloxy)- |
| 197969-51-0 | 1-Propanaminium, N,N,N-trimethyl-3-[(2-methyl-1-oxo-2-propen-1-yl)amino]-, chloride (1:1), polymer with methyl 2-propenoate and 2-propenoic acid | 1-propanaminium, N,N,N-triméthyl-3-[(2-méthyl-1-oxo-2-propén-1-yl)amino]-, chlorure (1:1), polymérisé avec le 2-propénoate de méthyle et l'acide 2-propénoïque |
| 198404-98-7 | Cyclopropanemethanol, 1-methyl-2-[(1,2,2-trimethylbicyclo[3.1.0]hex-3-yl)methyl]- | 1-méthyl-2-[(1,2,2-triméthylbicyclo[3.1.0]hex-3-yl)méthyl]cyclopropaneméthanol |
| 205537-77-5 | Poly[oxy(dimethylsilylene)], α-hydro-ω-hydroxy-, mixt. with dimethicone | Poly[oxy(diméthylsilylène)], α-hydro-oméga-hydroxy-, mélange avec la diméthicone |
| 208126-52-7 | Resin acids and Rosin acids, mixed esters with dipentaerythritol and 12-hydroxyoctadecanoic acid and stearic acid | Acides résiniques et colophaniques, esters mixtes avec le dipentaérythritol, l'acide 12-hydroxyoctadécanoïque et l'acide stéarique |
| 208126-56-1 | Octadecanoic acid, 12-hydroxy-, mixed esters with dipentaerythritol and isostearic acid | Acide 12-hydroxyoctadécanoïque, esters mixtes avec le dipentaérythritol et l'acide isostéarique |
| 213127-10-7 | 2-Propen-1-aminium,N,N-dimethyl-N-2propenyl-, chloride, polymer with 2-propenoic acid AND partially neutralized sodium salt | 2-propèn-1-aminium, N,N-diméthyl-N-2-propényl-, chlorure, polymérisé avec l'acide 2-propénoïque, sel sodique |
| 214047-00-4 | L-Serine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-threonyl-L-lysyl- | L-sérine, N2-(1-oxohexadécyl)-L-lysyl-L-thréonyl-L-thréonyl-L-lysyl- |
| 220119-17-5 | Avermectin A1a, 25-cyclohexyl-4′-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)- | Avermectine A1a, 25-cyclohexyl-4′-O-dé(2,6-didésoxy-3-O-méthyl-α-L-arabino-hexopyranosyl)-5-déméthoxy-25-dé(1-méthylpropyl)-22,23-dihydro-5-(hydroxyimino)-, (5Z)- |
| 220714-63-6 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl Me, ethers with polyethylene glycol mono[3-(dimethyloctadecylammonio)-2-hydroxypropyl hydrogen phosphate], inner salts | Siloxanes et silicones, diméthyl-, 3-hydroxypropylméthyl-, éthers avec le mono[3-(diméthyloctadécylammonio)-2hydroxypropylhydrogénophosphate] de polyéthylèneglycol, sels internes |
| 220828-91-1 | 1-Propanaminium, N-(2-hydroxyethyl)-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, chloride (1:1) | 1-propanaminium, N-(2-hydroxyéthyl)-N,N-diméthyl-3-[(1-oxodocosyl)amino]-, chlorure (1:1) |
| 222400-35-3 | Protein hydrolyzates, wheat, isostearoyl, compds. with 2-amino-2-methyl-1-propanol | Hydrolysats de protéines, blé, isostéaroyl-, composés avec le 2-amino-2-méthyl-1-propanol |
| 223717-75-7 | Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl D-glucopyranoside (4:1), tri-(9Z)-9-octadecenoate | Poly(oxy-1,2-éthanediyle), α-hydro-oméga-hydroxy-, éther avec le méthyl-D-glucopyranoside (4:1), tri-(9Z)-9-octadécénoate |
| 224948-78-1 | Poly(oxy-1,2-ethanediyl),α-[2-[bis(2-aminoethyl)methylammonio]ethyl]-ω-hydroxy-,N,N′-di-C14-18 acyl derivs., Me sulfates (salts) | Poly(oxy-1,2-éthanediyle), α-[2-[bis(2-aminoéthyl)méthylammonio]éthyl]-oméga-hydroxy-, dérivés N,N′-diacylés en C14-18, sulfates de méthyle (sels) |
| 227200-22-8 | L-Ascorbic acid, reaction products with methylsilanetriol and pectin | Acide L-ascorbique, produits de réaction avec le méthylsilanetriol et la pectine |
| 227605-22-3 | Lithium magnesium sodium oxide silicate (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28) | Silicate d'oxyde de lithium, de magnésium et de sodium (Li0.03Mg0.39Na0.07O0.15(Si2O5)0.28) |
| 243133-67-7 | Poly(oxy-1,2-ethanediyl), α-(2-hydroxytetradecyl)-ω-hydroxy-,ω-C16-18-alkyl ethers | Poly(oxy-1,2-éthanediyle), α-(2-hydroxytétradécyl)-oméga-hydroxy-, oméga-alkyloxydes en C16-18 |
| 243137-53-3 | Siloxanes and Silicones, di-Me, polymers with mono[(ethenyldimethylsilyl)oxy]-terminated di-Me siloxanes | Siloxanes et silicones, diméthyl-, polymérisés avec des diméthylsiloxanes à terminaison mono[(éthényldiméthylsilyl)oxy] |
| 245443-07-6 | L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl 2-octyldodecyl esters | Mélange de N-(1-oxododécyl)-L-glutamate de (3β)-cholest-5-én-3-yle et de 2-octyldodécyle |
| 246864-39-1 | Decanoic acid, 1,2,3-propanetriyl ester, reaction products with polyethylene glycol and 1,2,3-propanetriyl trioctanoate | Décanoate de 1,2,3-propanetriyle, produits de réaction avec le polyéthylèneglycol et le trioctanoate de 1,2,3-propanetriyle |
| 261713-82-0 | Poly(oxy-1,2ethanedily),α(2-hydoxypropyl)-w-[1-methyl-2-[(1-oxododecyl)oxy]ethoxy]ethoxy-(9Cl) | Poly(oxy-1,2-éthanediyle), alpha-(2-hydroxypropyl)-oméga-[1-méthyl-2-[1-méthyl-2-[(1-oxododécyl)oxy]éthoxy]éthoxy]- |
| 288839-50-9 | 1-Octadecanaminium, N,N-dimethyl-N-octyl-, methyl sulfate (1:1) | 1-octadécanaminium, N,N-diméthyl-N-octyl-, sulfate de méthyle (1:1) |
| 305812-16-2 | Poly(oxy-1,2-ethanediyl),α,α′., α".-1,2,3-propanetriyltris [ω-methoxy- | Poly(oxy-1,2-éthanediyle), α,α′,α"-1,2,3-propanetriyltris(oméga-méthoxy)- |
| 308067-11-0 | Glycerides, C8-10 mono-, di- and tri-, ethoxylated | Glycérides, C8-10, mono-, di- et tri-, éthoxylés |
| 308068-34-0 | Glycerides, C16-18 mono-, ethoxylated | Glycérides, C16-18, mono-, éthoxylés |
| 308068-94-2 | Imidazolium compounds, 2-C12-14-alkyl-1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-, inner salts | Composés d′imidazolium, 2-alkyles en C12-14-1-(carboxyméthyl)-4,5-dihydro-1-(2-hydroxyéthyl)-, sels internes |
| 308068-97-5 | Onium compounds, isoquinolinium, C12-18-alkyl, bromides | Composés d'onium, isoquinolinium, alkyles en C12-18, bromures |
| 308074-11-5 | Protein hydrolyzates, compds. with (Z)-N-[3-(dimethylamino)propyl]-9-octadecenamide | Hydrolysats de protéines, composés avec le (Z)-N-[3-(diméthylamino)propyl]-9-octadécénamide |
| 321735-39-1 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate | Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d'isobutyle |
| 321735-42-6 | Siloxanes and Silicones, di-Me, 3-hydroxypropyl group- and 3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl group-terminated, polymers with iso-Bu methacrylate and 2,2,2-trifluoroethyl methacrylate | Siloxanes et silicones, diméthyl-, à terminaison 3-hydroxypropyle et butyle et 3-[(2-méthyl-1-oxo-2-propényl)oxy]propyle, polymérisés avec le méthacrylate d'isobutyle et le méthacrylate de 2,2,2-trifluoroéthyle |
| 329925-33-9 | Oxacyclopentadec-10-en-2-one, 13-methyl- | 13-Méthyloxacyclopentadéc-10-èn-2-one |
| 345648-01-3 | 1-Propanaminium N- (3-aminopropyl) -2,3-dihydroxy-N,N-dimethyl-,N-limnanthes alba seed-oil acyl derivs., chlorides | Minéraux du groupe des micas |
| 348120-88-7 | Hexanoic acid, 3,5,5 -trimethyl-, octadecyl ester | 3,5,5 –triméthylhexanoate d'octadécyle |
| 350708-35-9 | Aspartic acid, compd. with α-methylbenzeneethanamine (1:1) | Acide aspartique, composé avec l'α-méthylbenzèneéthanamine (1:1) |
| 350708-40-6 | D-Glucaric acid, compd. with (αS)-α-methylbenzeneethanamine (1:2) | Acide D-glucarique, composé avec l'(αS)-α-méthylbenzèneéthanamine (1:2) |
| 361459-38-3 | Glycerides, mixed decanoyl and octanoyl mono-, di- and tri-, ethoxylated | Mélange de mono-, di- et tri- décanoyl et octanoylglycérides, éthoxylés |
| 480995-77-5 | 2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate, hexadecyleicosyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate | Acide 2-méthyl-2-propénoïque, polymérisé avec le 2-propénoate de butyle, le 2-méthyl-2-propénoate d'hexadécylicosyle et le 2-méthyl-2-propénoate de méthyle |
| 642072-46-6 | Ethanol, 2,2′-iminobis-,compd. with α-sulfo-ω-(tetradecyloxy)poly(oxy-1,2-ethanediyl) | Éthanol, 2,2′-iminobis-, composé avec l'α-sulfo-oméga-(tétradécyloxy)poly(oxy-1,2-éthanediyle) |
| 756819-45-1 | Siloxanes and Silicones, di-Me, mono[3-[(2-methyl-1-oxo-2-propenyl)oxy]propyl] group-terminated, polymers with Bu methacrylate, 2-ethylhexyl acrylate and Me methacrylate | Polydiméthylsiloxanes à terminaisons mono[3-[(2-méthylprop-2-énoyl)oxy]propyles, polymérisés avec du méthacrylate de butyle, de l'acrylate de 2-éthylhexyle et du méthacrylate de méthyle |
| 827596-80-5 | Octadecanoic acid, 12-hydroxy-, polymer with oxirane, triblock | Acide 12-hydroxyoctadécanoïque, polymérisé avec l'oxirane, à trois blocs |
| 869734-19-0 | acids, Cannabis sativa seed-oil, esters with polyethylene glycol ether with glycerol (3:1) | Acides, huile de Cannabis sativa, esters avec l'éther de polyéthylèneglycol avec le glycérol (3:1) |
| 915223-67-5 | Siloxanes and Silicones, di-Me, Me 3,3,4,4,5,5,6,6,6-nonafluorohexyl, Me stearyl | Siloxanes et silicones, diméthyl-, méthyl-3,3,4,4,5,5,6,6,6-nonafluorohexyl-, méthyl-stéaryl- |
| 958873-87-5 | ethanaminium, 2-amino-N-(2-aminoethyl)-N-[2-(2-hydroxyethoxy)ethyl]-N-methyl-, N,N′-di-limnanthes alba seed-oil acyl derivs., Me sulfates (salts) | Éthanaminium, 2-amino-N-(2-aminoéthyl)-N-[2-(2-hydroxyéthoxy)éthyl]-N-méthyl-, dérivés N,N′-diacylés d'huile de graines de Limnanthes alba, sulfates de méthyle (sels) |
| 1007304-55-3 | Poly(oxy-1,2-ethanediyl), ω′-hydroxy-ω-[(1- oxoisooctadecyl)oxy]-ω″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]- α,α′,α″-1,2,3-propanediyltris- | Poly(oxy-1,2-éthanediyle), oméga′-hydroxy-oméga-[(1-oxoisooctadécyl)oxy]-oméga″-[[(5-oxo-2-pyrrolidinyl)carbonyl]oxy]-α,α′,α″-1,2,3-propanediyltris- |
| 1034015-50-3 | Polysaccharides, sugarcane, 3-(dimethyloctadecylammonio)-2-hydroxypropyl ethers, chlorides | Polysaccharides, canne à sucre, éthers 3-(diméthyloctadécylammonio)-2-hydroxypropyliques, chlorures |
| 1072005-10-7 | Decanoic acid, mixed diesters with octanoic acid and 1,3-propanediol | Acide décanedioïque, diesters mixtes avec l'acide octanoïque et le 1,3-propanediol |
| 1384982-80-2 | Quaternary Ammonium Compounds, dimethylbis (mixed C12-15-alkyl and cetyl and stearyl), chlorides | Composés d'ammonium quaternaire, diméthylbis(mélange d'alkyles en C12-15, de cétyle et de stéaryle), chlorures |
| 1429320-75-1 | Butanedioic acid, 2-sulfo-, 1(or 4)-C10-16-alkyl esters, disodium salts | 2-sulfobutanedioate de 1(ou 4)-alkyles en C10-16, sels disodiques |
SCHEDULE 2
Persons required to provide information
- This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice.
- This notice applies to any person who, during the 2014 or 2015 calendar year, manufactured a total quantity greater than 100 kg of a substance listed in Part 4 of Schedule 1 to this notice that is a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act or is intended to be a component in such products.
- This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance listed in Part 1, Part 2 or Part 3 of Schedule 1 to this notice, whether the substance is
- (a) alone;
- (b) at a concentration equal to or above 0.1% by weight (w/w%) in a mixture or in a product; or
- (c) listed in Part 3 of Schedule 1 and at a concentration equal to or above 0.1% by weight (w/w%) in a manufactured item that is
- (i) intended to be used by or for children under the age of six years,
- (ii) intended to come into contact with the mucosa of an individual, other than eyes,
- (iii) cookware, or a cooking or serving utensil that is intended to come into direct contact with heated food within a residence, unless the component that comes into direct contact with heated food is made of glass, stainless steel or porcelain,
- (iv) food packaging that is intended to come into direct contact with food, unless the component that comes into direct contact with food is made of glass, stainless steel or porcelain,
- (v) a reusable food or beverage container, unless the component that comes into direct contact with food or beverage is made of glass, stainless steel or porcelain,
- (vi) intended to release the substance during conditions of use such that the substance may be inhaled or come into dermal contact with an individual,
- (vii) clothing or footwear,
- (viii) bedding, a sleeping bag or a towel,
- (ix) furniture, a mattress, a cushion or a pillow intended to be used in a residence, where the substance is contained in foam or leather or in a textile fibre, yarn or fabric, or
- (x) carpet, vinyl or laminate flooring, or foam underlay for flooring, intended to be used in a residence.
- This notice applies to any person who, during the 2014 or 2015 calendar year, imported a total quantity greater than 100 kg of a substance, listed in Part 4 of Schedule 1 to this notice, that is, is contained in, or is intended to be a component in, a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act.
- Any person for whom the criteria set out in Schedule 2 have been met for both the 2014 and 2015 calendar years shall provide information prescribed in sections 6 to 10 of Schedule 3 to this notice for the 2015 calendar year only.
- This notice does not apply to a substance listed in Schedule 1, whether alone, in a mixture, in a product, or in a manufactured item, that
- (a) is in transit through Canada;
- (b) is Tin fluoride (CAS RN 7783-47-3) contained in dental care products or mixtures;
- (c) is, or is contained in, a hazardous waste or hazardous recyclable material within the meaning of the Export and Import of Hazardous Waste and Hazardous Recyclable Material Regulations and was imported pursuant to a permit issued under these Regulations;
- (d) is, or is contained in, a pest control product registered under the Pest Control Products Act;
- (e) is, or is contained in, a fertilizer or supplement registered under the Fertilizers Act;
- (f) is, or is contained in, a feed registered under the Feeds Act; or
- (g) is mixed with, or attached to, a seed registered under the Seeds Act.
- If a person provided information under the New Substances Notification Regulations, for a substance listed in Part 4 of Schedule 1, a response from that person is not required under this notice for that substance.
- Any person to whom this notice applies who
- (a) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 1 or Part 3, shall provide the information requested in sections 4, 5, 6, 7, and 8 of Schedule 3;
- (b) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 2, shall provide the information requested in sections 4, 5, 6, 7, 8 and 9 of Schedule 3;
- (c) manufactured, or imported alone, in a mixture or in a product, a substance listed in Part 4, shall provide the information requested in sections 4, 5, 7, and 8 of Schedule 3;
- (d) imported a substance listed in Part 3 or Part 4 in a manufactured item shall provide the information requested in sections 4, 5, and 10 of Schedule 3.
SCHEDULE 3
Information required
- 1. The definitions in this section apply in this notice.
- “manufacture” includes the incidental production of a substance.
- “manufactured item” An item that is formed into a specific physical shape or design during manufacture and has, for its final use, a function or functions dependent in whole or in part on its shape or design.
- “mixture” A combination of substances that does not produce a substance that is different from the substances that were combined, including prepared formulations and reaction mixtures that are fully characterized in terms of their constituent substances, hydrates, and homogenous and heterogeneous alloys.
- “product” excludes “mixture” and “manufactured item.”
- 2. If the person subject to the notice is a company that owns more than one facility, a single response to the notice shall be submitted. Except for the purpose of section 6 of this Schedule, the single response shall amalgamate the information from all facilities owned by the company for each applicable question in the notice.
- 3. Where information required under Schedule 3 to this notice has already been sent to the Government of Canada, it may be relied on as a response to any question in Schedule 3 to this notice if
- (a) the information previously submitted is applicable to the calendar year for which the person is reporting;
- (b) the person provides the following information:
- (i) the CAS RN or Confidential Accession Number of the substance to which the submitted information relates,
- (ii) the date on which the information was submitted,
- (iii) the name of the person who submitted the information, and
- (iv) the program and/or individuals to which the information was submitted.
- 4. Any person to whom this notice applies shall provide the following information: name of the person (e.g. company name), Canadian head office address, Federal Business Number (see footnote 18) and contact name and information.
- 5. For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture, in a product or in a manufactured item, during either the 2014 or 2015 calendar year, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
- (a) the CAS RN or the Confidential Accession Number of the substance; and
- (b) whether the person manufactured a quantity greater than 100 kg of the substance, or imported a quantity greater than 100 kg of the substance whether alone, or in a mixture, a product, or a manufactured item at a concentration equal to or above 0.1% by weight (w/w%), during each of the 2012, 2013, 2014, and 2015 calendar years, by indicating “yes” or “no”.
- 6. For each of the person's facilities where substances listed in Part 1, 2 or 3 of Schedule 1 were manufactured, or to which they were imported alone, in a mixture or in a product, for activities other than distribution and warehousing during the calendar year for which the person is responding to this notice, the person to whom this notice applies shall provide
- (a) the name and address;
- (b) the CAS RN or the Confidential Accession Number of the substance; and
- (c) each applicable six-digit North American Industry Classification System (NAICS) (see footnote 19) code.
- 7. For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
- (a) the CAS RN or the Confidential Accession Number of the substance; and
- (b) the total quantity of the substance that the person manufactured, imported and exported, reported in kilograms (rounded to two significant digits).
- 8. (1) For each substance listed in Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
- (a) the CAS RN or the Confidential Accession Number of the substance;
- (b) the Substance Function Code(s) set out in section 11 that apply to the substance;
- (c) for each Substance Function Code provided, the Consumer and Commercial Code(s) set out in section 12 that describe the known or anticipated final goods containing the substance;
- (d) for each Consumer and Commercial Code provided, the quantity of the substance, reported in kilograms (rounded to two significant digits);
- (e) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use in commercial activities, by indicating “yes” or “no”;
- (f) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use in consumer activities, by indicating “yes” or “no”; and
- (g) for each Consumer and Commercial Code provided, whether any known or anticipated final goods containing the substance are intended for use by or for children 14 years of age or younger, by indicating “yes” or “no.”
- 8. (2) Where code U999 is provided for paragraph (1)(b), a written description of the substance function must be provided.
- 8. (3) Where code C105, C108 or C999 is provided for paragraph (1)(c), a written description of the known or anticipated final goods containing the substance must be provided.
- 9. (1) For each substance listed in Part 2 of Schedule 1 that a person manufactured, or imported alone, in a mixture or in a product, during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
- (a) the CAS RN;
- (b) the name, city and province of the 10 persons in Canada to whom the largest quantity of the substance above 100 kg was sold; and
- (c) the total quantity of the substance sold to each person, reported in kilograms (rounded to two significant digits).
- 9. (2) Subsection (1) does not apply to importers of the substance in a mixture or a product intended for use by consumers for non-commercial purposes.
10. (1) For each substance listed in Part 3 or Part 4 of Schedule 1 that a person imported in a manufactured item during the calendar year for which the person is responding to this notice, for which the criteria set out in Schedule 2 have been met, the person shall provide the following information:
- (a) the CAS RN or the Confidential Accession Number of the substance;
- (b) for a substance in Part 3, each applicable category of manufactured items listed in subparagraphs 3(c)(i) to (x) of Schedule 2;
- (c) for a substance in Part 4, whether it is, is contained in, or is intended to be a component in a cosmetic, food, therapeutic product or natural health product subject to the Food and Drugs Act;
- (d) the Consumer and Commercial Code(s) set out in section 12 that describe the manufactured item containing the substance;
- (e) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use in commercial activities, by indicating “yes” or “no”;
- (f) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use in consumer activities, by indicating “yes” or “no”; and
- (g) for each Consumer and Commercial Code provided, whether the manufactured item containing the substance is intended for use by or for children 14 years of age or younger, by indicating “yes” or “no.”
10. (2) Where code C105, C108 or C999 is provided for paragraph (1)(c), a written description of the manufactured item containing the substance must be provided.
| Substance function codes | Title | Description |
|---|---|---|
| U001 | Abrasives | Substances used to wear down or polish surfaces by rubbing against the surface. |
| U002 | Adhesives and sealant substances | Substances used to promote bonding between other substances, promote adhesion of surfaces, or prevent seepage of moisture or air. |
| U003 | Adsorbents and absorbents | Substances used to retain other substances by accumulation on their surface or by assimilation. |
| U004 | Agricultural substances (non-pesticidal) | Substances used to increase the productivity and quality of farm crops. |
| U005 | Anti-adhesive agents | Substances used to prevent bonding between other substances by discouraging surface attachment. |
| U006 | Bleaching agents | Substances used to lighten or whiten a substrate through chemical reaction, usually an oxidative process which degrades the colour system. |
| U007 | Corrosion inhibitors and anti-scaling agents | Substances used to prevent or retard corrosion or the formation of scale. |
| U008 | Dyes | Substances used to impart colour to other materials or mixtures by penetrating into the surface of the substrate. |
| U009 | Fillers | Substances used to provide bulk, increase strength, increase hardness, or improve resistance to impact. |
| U010 | Finishing agents | Substances used to impart such functions as softening, static-proofing, wrinkle resistance, and water repellence. |
| U011 | Flame retardants | Substances used on the surface of or incorporated into combustible materials to reduce or eliminate their tendency to ignite when exposed to heat or a flame. |
| U012 | Fuels and fuel additives | Substances used to create mechanical or thermal energy through chemical reactions, or which are added to a fuel for the purpose of controlling the rate of reaction or limiting the production of undesirable combustion products, or which provide other benefits such as corrosion inhibition, lubrication, or detergency. |
| U013 | Functional fluids (closed systems) | Liquid or gaseous substances used for one or more operational properties in a closed system. This code does not include fluids used as lubricants. |
| U014 | Functional fluids (open systems) | Liquid or gaseous substances used for one or more operational properties in an open system. |
| U015 | Intermediates | Substances consumed in a reaction to produce other substances for commercial advantage. |
| U016 | Ion exchange agents | Substances that are used to selectively remove targeted ions from a solution. This code also includes aluminosilicate zeolites. |
| U017 | Lubricants and lubricant additives | Substances used to reduce friction, heat, or wear between moving parts or adjacent solid surfaces, or that enhance the lubricity of other substances. |
| U018 | Odour agents | Substances used to control odours, remove odours, mask odours, or impart odours. |
| U019 | Oxidizing and reducing agents | Substances used to alter the valence state of another substance by donating or accepting electrons or by the addition or removal of hydrogen to a substance. |
| U020 | Photosensitive substances | Substances used for their ability to alter their physical or chemical structure through absorption of light, resulting in the emission of light, dissociation, discoloration, or other chemical reaction. |
| U021 | Pigments | Substances used to impart colour to other materials or mixtures by attaching themselves to the surface of the substrate through binding or adhesion. |
| U022 | Plasticizers | Substances used in plastics, cement, concrete, wallboard, clay bodies, or other materials to increase their plasticity or fluidity. |
| U023 | Plating agents and surface treating agents | Substances applied to metal, plastic, or other surfaces to alter physical or chemical properties of the surface. |
| U024 | Process regulators | Substances used to change the rate of a reaction, start or stop the reaction, or otherwise influence the course of the reaction. |
| U025 | Processing aids, specific to petroleum production | Substances added to water, oil, or synthetic drilling muds or other petroleum production fluids to control foaming, corrosion, alkalinity and pH, microbiological growth or hydrate formation, or to improve the operation of processing equipment during the production of oil, gas, and other products or mixtures from beneath the earth's surface. |
| U026 | Processing aids, not otherwise covered in this table | Substances used in applications other than the production of oil, gas, or geothermal energy to control foaming, corrosion or alkalinity and pH, or to improve the operation of processing equipment. |
| U027 | Propellants and blowing agents | Substances used to dissolve or suspend other substances and either to expel those substances from a container in the form of an aerosol or to impart a cellular structure to plastics, rubber, or thermo set resins. |
| U028 | Solids separation agents | Substances used to promote the separation of suspended solids from a liquid. |
| U029 | Solvents (for cleaning or degreasing | Substances used to dissolve oils, greases and similar materials from textiles, glassware, metal surfaces, and other articles. |
| U030 | Solvents (which become part of formulation or mixture) | Substances used to dissolve another substance to form a uniformly dispersed solution at the molecular level. |
| U031 | Surface active agents | Substances used to modify surface tension when dissolved in water or water solutions, or reduce interfacial tension between two liquids or between a liquid and a solid or between liquid and air. |
| U032 | Viscosity adjustors | Substances used to alter the viscosity of another substance. |
| U033 | Laboratory substances | Substances used in a laboratory for chemical analysis, chemical synthesis, extracting and purifying other chemicals, dissolving other substances, and similar activities. |
| U034 | Paint additives and coating additives not otherwise covered in this table | Substances used in a paint or coating formulation to enhance properties such as water repellence, increased gloss, improved fade resistance, ease of application or foam prevention. |
| U061 | Pest control substances | Substances used as active ingredients in products, mixtures or manufactured items used for directly or indirectly controlling, destroying, attracting or repelling a pest or for mitigating or preventing its injurious, noxious or troublesome effects. |
| U062 | Active ingredients in health products | Substances used as active ingredients in natural health products or prescription or non-prescription drugs. |
| U063 | Flavourants | Substances used as non-medicinal ingredients or excipients in foods, natural health products, and drugs that impart a certain flavor to the food, natural health product or drug. |
| U064 | Contaminants | Substances naturally present in a reactant or substances that are produced as a result of the manufacturing process and have no beneficial properties in the final product, mixture or manufactured item. |
| U065 | By-products | Substances resulting from the manufacturing process that can be partially or completely removed from the intended product, mixture or manufactured item and have commercial value on their own or when added to another product, mixture or manufactured item. |
| U066 | Wastes | Substances that are removed from the final product, mixture or manufactured item during the manufacturing process and have no commercial value. |
| U999 | Other (specify) | Substances with a function not otherwise described in this table. A written description must be provided when using this code. |
12. For the purpose of sections 8 and 10, the following are the consumer and commercial codes and their corresponding descriptions:
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C101 | Floor coverings | Substances contained in floor coverings. This code does not include wood and pressed wood flooring products included in Building or construction materials — Wood and engineered wood code. |
| C102 | Foam seating and bedding | Substances contained in foam mattresses, pillows, cushions, and any seating, furniture and furnishings containing foam. |
| C103 | Furniture and furnishings not otherwise covered in this table | Substances contained in furniture and furnishings made from metal, wood, leather, plastic or other materials. This code does not include foam seating and bedding products. |
| C104 | Fabric, textile and leather articles not otherwise covered in this table | Substances contained in fabric, textile and leather products to impart color and other desirable properties such as water, soil, stain repellence, wrinkle resistance, or flame resistance. |
| C105 | Cleaning and furnishing care (specify) | Substances contained in products, mixtures or manufactured items that are used to remove dirt, grease, stains, and foreign matter from furniture and furnishings, or to cleanse, sanitize, bleach, scour, polish, protect, or improve the appearance of surfaces. A written description must be provided when using this code. |
| C106 | Laundry and dishwashing | Substances contained in laundry and dishwashing products, mixtures or manufactured items. |
| C107 | Water treatment | Substances contained in water treatment products, mixtures or manufactured items that are designed to disinfect, reduce contaminants or other undesirable constituents, and condition or improve aesthetics of water. Excludes any substance contained in pest control products as defined under the Pest Control Products Act. |
| C108 | Personal care and cosmetics (specify) | Substances contained in personal care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair, or teeth. A written description must be provided when using this code. |
| C109 | Air care | Substances contained in products, mixtures or manufactured items that are used to odorize or deodorize indoor air in homes, offices, motor vehicles, and other enclosed spaces. |
| C110 | Apparel and footwear care | Substances contained in apparel and footwear care products, mixtures or manufactured items that are applied post-market. |
| C160 | Pet care | Substances contained in pet care products, mixtures or manufactured items that are used for cleansing, grooming, improving or altering skin, hair or teeth and intended for animal use. |
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C201 | Adhesives and sealants | Substances contained in adhesive or sealant products or mixtures used to fasten other materials together or prevent the passage of liquid or gas. |
| C202.01 | Paints and coatings | Substances contained in paints or coatings. |
| C202.02 | Paint thinners and removers | Substances contained in paint thinners and removers. |
| C203 | Building or construction materials — Wood and engineered wood | Substances contained in building and construction materials made of wood and pressed or engineered wood products, mixtures or manufactured items. |
| C204 | Building or construction materials not otherwise covered in this table | Substances contained in building and construction materials not otherwise covered in this table. |
| C205 | Electrical and electronics | Substances contained in electrical and electronic products, mixtures or manufactured items. |
| C206 | Metal materials not otherwise covered in this table | Substances contained in metal products, mixtures or manufactured items not otherwise covered in this table. |
| C207 | Batteries | Substances contained in non-rechargeable and rechargeable batteries including dry and wet cell units that store energy. |
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C301 | Food packaging | Substances contained in single or multi-layered packaging consisting of paper, plastic, metal, foil or other materials which have or may have direct contact with food. |
| C302 | Paper products, mixtures or manufactured items | Substances contained in paper products, mixtures or manufactured items. |
| C303.01 | Plastic materials not otherwise covered in this table | Substances contained plastic products, mixtures or manufactured items not otherwise covered in this table. |
| C303.02 | Rubber materials not otherwise covered in this table | Substances contained in rubber products, mixtures or manufactured items not otherwise covered in this table. |
| C304 | Toys, playground and sporting equipment | Substances contained in toys, playground, and sporting equipment made of wood, metal, plastic or fabric. |
| C305 | Arts, crafts and hobby materials | Substances contained in arts, crafts, and hobby materials. |
| C306 | Ink, toner and colourants | Substances contained in ink, toners and colourants used for writing, printing, creating an image on paper; and substances contained in other substrates, or applied to substrates to change their colour or hide images. |
| C307 | Photographic supplies, film and photo-chemicals | Substances contained in photographic supplies, film, photo-processing substances, and photographic paper. |
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C401 | Automotive care | Substances contained in products, mixtures or manufactured items used in automotive cleaning and care of exterior and interior vehicle surfaces. This code does not include antifreeze, de-icing products, or lubricants. |
| C402 | Lubricants and greases | Substances contained in products, mixtures or manufactured items to reduce friction, heat generation and wear between solid surfaces. |
| C403 | Anti-freeze and de-icing | Substances added to fluids to reduce the freezing point of the mixture, or substances applied to surfaces to melt or prevent build-up of ice. |
| C404 | Fuels and related products, mixtures or manufactured items | Substances burned to produce heat, light or power, or added to inhibit corrosion, provide lubrication, increase efficiency of use, or decrease production of undesirable by-products. |
| C405 | Explosive materials | Substances capable of producing a sudden expansion, usually accompanied by the production of heat and large changes in pressure upon ignition. |
| C406 | Agricultural products, mixtures or manufactured items (non-pesticidal) | Substances used to increase the productivity and quality of plants, animals or forestry crops, produced on a commercial scale. Includes animal feed (any substance or mixture of substances for consumption by livestock, providing the nutritional requirements of livestock, or the purpose of preventing or correcting nutritional disorders of livestock, as defined in the Feeds Act and Regulations). |
| C407 | Lawn and garden care | Substances contained in lawn, garden, outdoor or potted plant and tree care products, mixtures or manufactured items. Excludes any substance contained in pest control products as defined under the Pest Control Products Act. |
| C461 | Pest control | Substances contained in any product, mixture or manufactured item for directly or indirectly controlling, preventing, destroying, mitigating, attracting, or repelling any pest. |
| C462 | Automotive, aircraft and transportation | Substances contained in automobiles, aircraft and other types of transportation, or used in their manufacture. |
| C463 | Oil and natural gas extraction | Substances that are, or are contained in, any mixtures, products or manufactured items, used for oil and natural gas drilling, extraction and processing. |
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C562 | Food and beverage | Substances contained in food and beverage products, mixtures or manufactured items. |
| C563 | Drugs | Substances contained in prescription and non-prescription drugs intended for humans or animals. |
| C564 | Natural health | Substances contained in natural health products, mixtures or manufactured items intended for humans or animals. |
| C565 | Medical devices | Substances contained in products, mixtures or manufactured items used for either the diagnosis, treatment, mitigation or prevention of a disease, disorder, or an abnormal physical state; or those used in restoring, correcting or modifying organic functions in humans or animals. |
| C566 | Tobacco products, mixtures or manufactured items | Substances contained in products, mixtures or manufactured items composed in whole or in part of tobacco, including tobacco leaves and any extract of tobacco leaves. |
| Consumer and commercial codes | Title | Description |
|---|---|---|
| C999 | Other (specify) | Substances contained in products, mixtures or manufactured items that are not described within any other consumer and commercial code. |
EXPLANATORY NOTE
(This note is not part of the notice.)
Announced as a key component of the Chemicals Management Plan (CMP), an update to the commercial status of substances of interest in Canada is critical to support priority setting and decision making for work post-CMP. To date, two inventory updates have been conducted. The first phase of the Domestic Substances List (DSL) Inventory Update (IU) was conducted in 2009 and gathered information on approximately 500 inanimate and 50 animate substances. Building on the first phase, the second phase of the DSL IU was carried out to collect information on approximately 2 700 substances. Whereas previous IUs were limited to DSL substances, the scope has been expanded and now considers emerging science, evolving domestic and international programs and the need to keep pace with chemical landscape fluctuations in order to ensure future priorities are reflective of Canada's dynamic market.
The Notice with respect to substances included as part of the 2017 Inventory Update applies to approximately 1 500 substances. The scope of the notice allows the Government of Canada to capture critical information on commercial status, downstream use and yearly market fluctuations between 2012 and 2015.
Substances included in Part 4 of Schedule 1 are currently on the revised In Commerce List (ICL). The scope of the information being collected on these substances is limited to Food and Drugs Act–related activities, such as therapeutic products (including human and veterinary drugs, and medical devices), natural health products, foods (including food additives) and cosmetics. Substances in Part 4 of Schedule 1 that are imported or manufactured with respect to use patterns beyond the scope of the Food and Drugs Act are subject to notification requirements under the New Substances Notification Regulations of the Canadian Environmental Protection Act, 1999 (hereinafter referred to as the “Act”).
Pursuant to subsection 71(3) of the Act, every person to whom this notice applies shall comply with this notice within the time specified in the notice. The time specified in this notice is July 17, 2017, 3 p.m., Eastern Daylight Saving Time. Any person making a written request pursuant to subsection 71(4) of the Act should include the name of the party requiring an extension, the Chemical Abstracts Service Registry Number (CAS RN) of the substances for which the person will provide information, as well as the reason of the extension request.
Any person making a written request pursuant to section 313 of the Act should identify each part of the information that is to be considered confidential, and provide a rationale for the sensitivity of the information.
Persons not subject to this notice who have a current or future interest in a substance set out in Schedule 1 to this notice may identify themselves as a “stakeholder” for the substance by completing the voluntary Declaration of Stakeholder Interest using the online reporting system via Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/. The person may be contacted for further information regarding their interest in the substance.
Persons who do not meet the requirements to respond and have no commercial interest in the substances covered by this notice may submit a Declaration of Non-Engagement for the notice using the online reporting system via Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/.
The Minister of the Environment and the Minister of Health are also inviting interested stakeholders to submit additional information that is deemed beneficial. Organizations that may be interested in submitting additional information in response to this invitation include those that manufacture, import, export or use these substances whether alone, in a mixture, in a product or in a manufactured item.
Compliance with the Act is mandatory and specific offences are established by subsections 272(1), 272.1(1), 272.2(1), 272.4(1) and 272.5(1) of the Act. Amendments to the fine scheme of the Act came into force on June 22, 2012. Subsections 272(2), (3) and (4) and 272.1(2), (3) and (4) of the Act set the penalties for persons who commit an offence under the Act. Offences include the offence of failing to comply with an obligation arising from the Act and the offence of providing false or misleading information. Penalties for the most serious offences include minimum fines, and the amount of the fine can range from a minimum of $5,000 for an individual convicted following summary proceedings to a maximum of $6,000,000 for a large corporation convicted on indictment. The fine range doubles for second or subsequent offences and individuals may also be liable to a term of imprisonment of up to three years. Offences other than those in the category of “serious offences” are punishable by fines capped at a maximum that ranges from $25,000 for an individual convicted following summary proceedings to $500,000 for a large corporation convicted on indictment. The maximum fines are doubled for second or subsequent offences.
The current text of the Act, including the most recent amendments, is available on the Department of Justice's website: http://laws-lois.justice.gc.ca/eng/acts/C-15.31/.
The Act is enforced in accordance with the Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999 available at www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5082BFBE-1. Suspected violations under the Act can be reported to the Enforcement Branch by email at ec.dale-enviroinfo-eed-enviroinfo.ec@canada.ca.
Responses to the notice must be provided no later than July 17, 2017, 3 p.m., Eastern Daylight Saving Time, using the online reporting system available through Environment and Climate Change Canada's Single Window at https://ec.ss.ec.gc.ca/.
An electronic copy of this notice is available at the following website: www.chemicalsubstanceschimiques.gc.ca.
[2-1-o]
DEPARTMENT OF THE ENVIRONMENT
WILD ANIMAL AND PLANT PROTECTION AND REGULATION OF INTERNATIONAL AND INTERPROVINCIAL TRADE ACT
Notice of intent to modify the Wild Animal and Plant Trade Regulations
Notice is hereby given that the Minister of the Environment intends to recommend to the Governor in Council that amendments be made to the Wild Animal and Plant Trade Regulations (WAPTR), pursuant to section 21 of the Wild Animal and Plant Protection and Regulation of International and Interprovincial Trade Act.
The purpose of these amendments is to update domestic regulations in order to meet international obligations. These amendments will reflect changes to the Appendices of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) agreed to by the Parties to the Convention during the 17th Conference of the Parties (CoP17). These changes include additions, deletions and reclassifications of species listings as well as nomenclature modifications.
The 49 amendments to the CITES Appendices that were adopted at CoP17 and that will be reflected in Schedule I of WAPTR affect 72 taxa in total. Depending on the amendment, taxa can refer to a family, genus, species, subspecies or population. In total, these amendments involve over 400 species or subspecies. Amendments that result in a decrease of trade controls have been adopted either because the controls are no longer needed or because they are not providing a conservation benefit. These amendments include
- 2 taxa deleted from Appendix II (removal of export controls), including one Canadian subspecies, the Wood bison (Bison bison athabascae);
- 33 taxa added to Appendix II (new export controls), including one Canadian species, the Common thresher shark (Alopias vulpinus);
- 9 taxa added to Appendix I (new import and export controls);
- 8 taxa transferred from Appendix I to Appendix II (removal of import controls and decrease of export controls), including one Canadian subspecies, the Eastern cougar (Puma concolor couguar);
- 14 taxa transferred from Appendix II to Appendix I (new import controls and increased export controls); and
- modifications to the annotations of 6 taxa listed in Appendix II in order to better facilitate trade in accordance with the conservation status of the taxa involved.
In addition, modifications to the CITES Appendices will also take into account changes that have been made to Appendix III, as requested by the Parties between January 2016 and November 2016. These amendments include the addition of 15 taxa to Appendix III (new export controls), including 2 species listed by the United States that are also found in Canada: the Spiny softshell turtle (Apalone spinifera) and the Common snapping turtle (Chelydra serpentina). One taxon was also deleted from Appendix III (removal of all trade controls). Other minor changes to Schedule I of WAPTR, such as nomenclature updates and changes to address miscellaneous issues identified by the Standing Joint Committee for the Scrutiny of Regulations, will also be made.
The Convention was established to help ensure that international trade in specimens of wild animals and plants does not threaten their survival. More than 35 000 species of animals and plants are listed in the three Appendices to CITES and are also listed in Schedule I to WAPTR. Species listed in Appendix I are considered threatened with extinction and generally may not be traded for commercial purposes. However, these species may be traded for non-commercial purposes such as educational, scientific and reintroduction purposes, under strict conditions. These conditions include the prior issuance of import and export permits by the importing and exporting countries, respectively. Appendix II species are those that are not considered threatened with extinction but that may become so if their trade is not regulated. Species may also be listed in Appendix II if they are similar in appearance to Appendices I and II species, to ensure the protection of the species of concern. Only export permits issued by the exporting country are required for Appendix II species. Species listed in Appendix III are under special management in a country and are listed unilaterally by that country in order to receive the assistance of other countries in preventing unauthorized exports. The export of Appendix III species requires either an export permit or a certificate of origin, depending on the circumstances.
For more information on these amendments, please refer to the following address: http://www.ec.gc.ca/cites/default.asp?lang=En&n=46CAFD9E-1.
Robert McLean
Director General
Assessment and Regulatory Affairs
Canadian Wildlife Service
[2-1-o]
DEPARTMENT OF FINANCE
POOLED REGISTERED PENSION PLANS ACT
Effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans
Notice is hereby given, pursuant to paragraph 6(4)(b) of the Pooled Registered Pension Plans Act, that the effective date for the amendments to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans is March 31, 2017.
William Francis Morneau
Minister of Finance
[2-1-o]
DEPARTMENT OF FINANCE
POOLED REGISTERED PENSION PLANS ACT
2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
Between
Canada, represented by the Minister of Finance;
British Columbia, represented by the Minister of Finance;
Nova Scotia, represented by the Minister of Finance and Treasury Board;
The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;
The Autorité des marchés financiers, represented by the President and Chief Executive Officer;
and
Saskatchewan, represented by the Minister of Justice and Attorney General;
RECITALS
Whereas Canada, British Columbia, Nova Scotia, Quebec, the Autorité des marchés financiers and Saskatchewan (hereinafter referred to as the “parties”) entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “Agreement”) which came into effect on June 15, 2016, and a copy of which is attached as Annex 1;
Whereas Quebec and the Autorité des marchés financiers agree to be bound by only Parts I, with the exception of subsections 2(6) and (7), II, VI, and VII of the Agreement;
Whereas, in accordance with Section 18 of the Agreement, Ontario wishes to become a party to the Agreement, as it will be amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (hereinafter referred to as the “2017 Agreement”);
Whereas, in accordance with Section 18 of the Agreement, the parties unanimously consent to Ontario becoming a party to the Agreement, as it will be amended by the 2017 Agreement;
Whereas the parties unanimously consent to entering into the 2017 Agreement, in accordance with Section 21 of the Agreement;
Now, therefore, the parties agree as follows:
Additional Party
1. The parties, in accordance with Section 18 of the Agreement, unanimously consent to Ontario becoming a party to the Agreement, as amended by the 2017 Agreement.
Amendments to the Agreement
2. In the list of parties to the Agreement, appearing directly before the recitals to the Agreement:
(1) The word “and” is deleted; and
(2) The following words are included at the end of the list:
and Ontario, represented by the Minister of Finance;
3. The title of Part III in the section “Contents of Agreement” of the English version of the Agreement is replaced by the following:
PART III PLAN REGISTRATION
4. The definitions “federal PRPP Act” and “voluntary retirement savings plan” in subsection 1(1) of the English version of the Agreement are replaced by the following, in alphabetical order:
“federal PRPP Act” means the Pooled Registered Pension Plans Act (S.C. 2012, c. 16) and any subordinate legislation made under that Act, both as amended from time to time.
“voluntary retirement savings plan” or “VRSP” means a plan registered under the VRSP Act.
5. The title following section 2 of the English version of the Agreement is replaced with the following
PART II LICENSING
6. Subsection 9(3) of the Agreement is replaced by the following:
(3) A decision that is made by the Superintendent under the authority of this Agreement and that relates to the application of a provincial PRPP Act that determines a matter addressed in Schedule C, subsection 11(4) or subsection 11(5) is deemed to be a decision of the supervisory authority of the applicable province and is not subject to judicial review under the Federal Courts Act (R.S.C., (1985) c. F-7), but instead is subject to the processes for review and appeal under the laws of that province.
7. Subparagraph 11(1)(b)(ii) of the French version of the Agreement is replaced by the following:
(ii) est un employé ou un travailleur indépendant ou, s'il n'est pas actuellement un employé ou un travailleur indépendant, le dernier emploi qu'il occupait ou le dernier travail qu'il effectuait et pour lequel il participait au RPAC était au Yukon, dans les Territoires du Nord-Ouest ou au Nunavut, et il contribuait au RPAC.
8. Subsection 11(2) of French version of the Agreement is replaced by the following:
(2) Pour l'application de cet article, « dernier emploi qu'il occupait » ou « dernier travail qu'il effectuait » fait référence uniquement à un emploi ou à un travail indépendant dans une autorité législative liée par la présente partie.
9. The Agreement is amended by adding the following after subsection 11(4):
(5) Despite anything in the Agreement, the valuation or division of funds, on the breakdown of a spousal or common-law relationship, in a PRPP member's account or funds that have been transferred from a PRPP account is governed by the law of a jurisdiction that would otherwise apply to a member and their spouse, former spouse, common-law partner, or former common-law partner if this Agreement did not exist.
10. Section 13 of the French version of the Agreement is replaced by the following:
13. Il est entendu que le présent accord ne s'applique pas aux dispositions de la Loi fédérale sur les RPAC ou des Lois provinciales sur les RPAC concernant les autorisations à obtenir et les exigences qui doivent être satisfaites pour conclure le présent accord, de le modifier ou d'y ajouter des Parties, ainsi que les dispositions concernant l'effet de l'accord.
11. Subsection 14(2) of the French version of the Agreement is replaced by the following:
(2) Lorsqu'une décision du Surintendant fait l'objet d'une révision ou d'un appel en vertu des lois d'une province tel qu'il est prévu en vertu du paragraphe 9(3), le Surintendant, sur demande, communique à l'organisme de surveillance de cette province le dossier dont il disposait lorsqu'il a pris cette décision.
12. Section 15 of the French version of the Agreement is replaced by the following:
15. À la suite de la résiliation du présent accord ou du retrait d'une Partie, l'article 14 continue d'avoir effet aux seules fins de répondre aux demandes en cours.
13. Section 18 of the Agreement is replaced with the following:
18. A province may become a party
- (a) with the unanimous consent of the parties; and
- (b) if the province has executed a signature page that is substantially similar to those that form part of this Agreement, and has provided copies of that page to all parties.
14. Section 19 of the Agreement is replaced with the following:
19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in paragraph (a) or (b) of section 17.
15. Subsection 20(4) of the French version of the Agreement is replaced with the following:
(4) Si une Partie autre que le Canada a transmis un avis aux autres parties de son intention de se retirer de l'accord, le Surintendant doit, dans un délai raisonnable et sous réserve de toute restriction législative, transmettre à l'organisme de surveillance de cette Partie les copies des documents concernant les RPAC touchés transmis au Surintendant en vertu de la Loi fédérale sur les RPAC par l'administrateur du régime qui sont nécessaires à la surveillance continue des RPAC et informer les organismes de surveillance des décisions administratives prises par le Surintendant concernant les RPAC touchés.
16. Schedule A of the Agreement is amended by adding the following at the end of the list of “Provincial PRPP Acts”:
Ontario
Pooled Registered Pension Plans Act, 2015, S.O. 2015, c. 9
17. Paragraphs (a), (b), (d) and (e) of Schedule B of the English version of the Agreement are replaced by the following:
- (a) be an insurer holding a life insurance class licence issued under the Act respecting insurance (CQLR, chapter A-32) in conformity with the Regulation under the Act respecting insurance (CQLR, chapter A-32, r. 1), a trust company holding a licence issued under the Act respecting trust companies and savings companies (CQLR, chapter S-29.01) or an investment fund manager registered in accordance with Title V of the Securities Act (CQLR, chapter V-1.1);
- (b) complete and file the application form for authorization to act as administrator of a VRSP;
- (d) pay the required fees to the AMF in accordance with the Regulation respecting fees and costs payable for the issuance of an authorization under the Voluntary Retirement Savings Plans Act (CQLR, chapter R-17.0.1, r. 2);
- (e) provide the following information in accordance with the Regulation respecting applications for authorization and liability insurance coverage for administrators of voluntary retirement savings plans (CQLR, chapter R-17.0.1, r. 1):
- (i) a confirmation that the amount by which the assets of the corporation exceed its liabilities is at least equal to the amount determined by regulation, or an irrevocable letter of credit or a suretyship, which letter or suretyship is in an amount determined by regulation and is issued by a financial institution licensed as an insurer, trust company or deposit institution under an Act of Canada or of a Canadian province or territory;
- (ii) a confirmation that the corporation holds liability insurance in accordance with the requirements determined by regulation;
18. Paragraphs (d) and (g) of Schedule B of the French version of the Agreement are replaced by the following:
- d) payer les droits requis à l'Autorité en application du Règlement sur les droits et frais exigibles pour la délivrance d'une autorisation en vertu de la Loi sur les régimes volontaires d'épargne-retraite (RLRQ, chapitre R-17.0.1, r. 2);
- g) s'assurer que les représentants qui distribuent des RVER sont titulaires d'un certificat valide ou sont dûment inscrits pour offrir le produit financier (assurance ou valeurs mobilières).
Execution in Counterparts
19. The 2017 Agreement may be executed in counterparts.
Execution in English and French
20. The 2017 Agreement shall be executed in both English and French, each text being equally authoritative.
Effective Date
21. This 2017 Agreement comes into force on March 31, 2017. Upon its coming into force, and providing Ontario has signed a signature page agreeing to join the Agreement as amended by this 2017 Agreement, Ontario will become one of the parties, and its signed signature page will be included as Annex 2 to this 2017 Agreement.
Agreement Unaffected
22. Except as set forth in the 2017 Agreement, the Agreement is unaffected and shall continue in full force and effect in accordance with its terms.
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Canada
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Ottawa,
The 8th day of December, 2016.
The Honourable William Francis Morneau
Minister of Finance
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For British Columbia
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Victoria,
The 6th day of December, 2016.
The Honourable Michael de Jong
Minister of Finance
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Nova Scotia
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Halifax,
The 13th day of December, 2016.
The Honourable Randy Delorey
Minister of Finance and Treasury Board
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Québec,
The 14th day of December, 2016.
For the government of Quebec
The Honourable Carlos Leitão
Minister of Finance
The Honourable Jean-Marc Fournier
Minister responsible for Canadian Relations and the Canadian Francophonie
For the Autorité des marchés financiers
Louis Morrisset
President and Chief Executive Officer
2017 AGREEMENT AMENDING THE MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Saskatchewan
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Regina,
The 13th day of December, 2016.
The Honourable Gordon Wyant
Minister of Justice and Attorney General
ANNEX 1
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
Between
Canada, represented by the Minister of Finance;
British Columbia, represented by the Minister of Finance;
Nova Scotia, represented by the Minister of Finance and Treasury Board;
The government of Quebec, represented by the Minister of Finance and by the Minister responsible for Canadian Relations and the Canadian Francophonie;
The Autorité des marchés financiers, represented by the President and Chief Executive Officer;
and
Saskatchewan, represented by the Minister of Justice and Attorney General
RECITALS
- (1) Whereas each party to this Agreement is authorized by its laws to be bound by this Agreement;
- (2) Whereas Quebec and the Autorité des marchés financiers agree to be bound by only Parts I, with the exception of subsections 2(6) and (7), II, VI, and VII of this Agreement;
- (3) Whereas a pooled registered pension plan may be subject to the legislation of more than one party;
- (4) Whereas to establish an efficient and low cost regulatory environment for pooled registered pension plans, the parties, other than Quebec and the Autorité des marchés financiers as provided in this Agreement, intend to specify the law that applies to pooled registered pension plans that are otherwise subject to the federal Pooled Registered Pension Plans Act and the pooled registered pension plan legislation of at least one province and allow, to the extent provided in this Agreement, a single supervisory authority to exercise with respect to any such pooled registered pension plans all of the licensing, registration and supervisory powers to which such pooled registered pension plans are subject;
- (5) Whereas the laws of the parties allow for entering into an Agreement respecting any matter relating to pooled registered pension plans that are subject to the federal Pooled Registered Pension Plans Act and the pooled registered pension plan legislation of at least one province, including the reciprocal application of legislative provisions and administrative powers of the supervisory authorities concerned;
- (6) Now, therefore, the parties agree as follows:
Contents of Agreement
PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT
PART II LICENSING
PART III REGISTRATION
PART IV SUPERVISION
PART V APPLICABLE LAW
PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES
PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT
PART I DEFINITIONS AND APPLICATION OF THIS AGREEMENT
Definitions
1. (1) For the purposes of this Agreement, unless the context indicates a different meaning:
- “AMF” means Autorité des marchés financiers.
- “federal PRPP Act” means the Pooled Registered Pension Plans Act, S.C. 2012, c. 16, and any subordinate legislation made under that Act, both as amended from time to time.
- “federal PRPP licence” means a licence issued by the Superintendent in accordance with section 11 of the federal PRPP Act authorizing a corporation to be an administrator of a pooled registered pension plan.
- “federally-licensed administrator” means the holder of a federal PRPP licence or an entity designated by the Superintendent under subsection 21(1) of the federal PRPP Act.
- “federally-registered PRPP” means a PRPP that has been registered in accordance with section 12 of the federal PRPP Act.
- “member” means a person who holds an account with a PRPP.
- “party” means a signatory to this Agreement as authorized to enter into it by the federal PRPP Act, a provincial PRPP Act or, in the case of Quebec and the AMF, the laws of Quebec.
- “pooled registered pension plan” or “PRPP” means a pooled registered pension plan that is required to be registered under the federal PRPP Act or a provincial PRPP Act as applicable.
- “provincial PRPP Act” means the legislation of a province listed in Schedule A and any subordinate legislation made under that Act, both as amended from time to time.
- “Superintendent” means the Superintendent of Financial Institutions appointed under section 5 of the Office of the Superintendent of Financial Institutions Act (R.S.C. (1985), c. 18 (3rd Supp.)).
- “supervisory authority” means the government ministry, department or agency of a party that has supervisory powers with respect to PRPPs under its laws and, in Quebec, the AMF with respect to a VRSP licence.
- “voluntary retirement savings plan” or VRSP means a plan registered under the VRSP Act.
- “VRSP Act” means the Voluntary Retirement Savings Plans Act, (CQLR, chapter R-17.0.1), and any subordinate legislation made under that legislation, both as amended from time to time.
- “VRSP administrator” means the holder of a VRSP licence.
- “VRSP licence” means an authorization issued by the AMF under section 29 of the VRSP Act.
Schedules
(2) The following Schedules form part of this Agreement:
- (a) Schedule A — Provincial PRPP Acts
- (b) Schedule B — Requirements to be met under the VRSP Act for the AMF to Issue a VRSP Licence to the Holder of a Federal PRPP Licence
- (c) Schedule C — Matters for the Purposes of Subsection 11(1).
Application of this Agreement
- 2. (1) Subject to subsections (4) and (5), this Agreement applies in respect of a PRPP that is required to be registered under the federal PRPP Act and one or more provincial PRPP Acts and any related matters, including its registration and supervision, the issuance of a licence authorizing a corporation to be an administrator of a PRPP, and the law applicable to a PRPP, its administrators, members and their spouse or common law partner, survivors and other beneficiaries (or the equivalent in the respective jurisdiction), and the employers offering it.
- (2) This Agreement applies, to the extent that it provides for it, in respect of the issuance of a VRSP licence.
- (3) Only Parts I, with the exception of subsections 2(6) and (7), II, VI and VII of this Agreement apply with regards to a VRSP licence.
- (4) This Agreement does not apply in respect of a PRPP that prohibits individuals in respect of whom the federal PRPP Act applies from becoming members of the PRPP.
- (5) For greater certainty, this Agreement does not apply in respect of a PRPP that is only registered provincially.
- (6) This Agreement applies despite any conflicting provision in any document that creates or supports a PRPP.
- (7) Where any provision of this Agreement conflicts with any provision of the federal PRPP Act or a provincial PRPP Act, this Agreement prevails to the extent of the conflict.
PART II LICENCES
Licensing Requirements
- 3. (1) A corporation that holds a federal PRPP licence or a VRSP licence is exempt from the requirement to obtain a licence under the applicable provincial PRPP Act.
- (2) A corporation is exempt from the requirement to obtain a licence under the federal PRPP Act if the corporation holds a VRSP licence.
- (3) The AMF shall issue a VRSP licence to a corporation that holds a federal PRPP licence if the requirements listed in Schedule B are met.
- (4) For greater certainty, this Agreement does not prohibit a provincial supervisory authority from issuing a PRPP licence under its provincial PRPP Act.
Suspension or Revocation of a VRSP Licence
- 4. Despite subsections 3(1) and (2), a VRSP administrator that has its VRSP licence revoked by the AMF is no longer exempt from the requirement to obtain a licence under the federal PRPP Act or the applicable provincial PRPP Act.
- 5. The AMF shall notify the Superintendent as soon as practicable if it has suspended or revoked the VRSP licence of a VRSP administrator, where that VRSP administrator administers a federally-registered PRPP and does not hold a federal PRPP licence.
PART III PLAN REGISTRATION
Registration Requirements
- 6. (1) A federally-licensed administrator that has a PRPP registered under the federal PRPP Act is exempt from the requirement to have that PRPP registered under the applicable provincial PRPP Act.
- (2) A VRSP administrator that has a PRPP registered under the federal PRPP Act is exempt from the requirement to have that PRPP registered under a provincial PRPP Act.
- (3) For greater certainty, this Agreement does not prohibit a provincial supervisory authority from registering a PRPP under its PRPP Act.
- (4) For greater certainty, any corporation that has a PRPP registered under the federal PRPP Act is subject to the powers of the Superintendent in respect of a federally-licensed administrator.
- (5) For greater certainty, a federally-registered PRPP and a VRSP are distinct plans.
Notification
7. The Superintendent shall notify the AMF as soon as practicable if, in relation to a federally-registered PRPP administered by a VRSP administrator, the Superintendent has ordered the VRSP administrator to transfer the federally-registered PRPP and all of its assets to an entity designated by the Superintendent, or has terminated the federally-registered PRPP.
PART IV SUPERVISION
Role of the Superintendent
- 8. The Superintendent shall supervise all federally-registered PRPPs that are subject to this Agreement.
- 9. (1) With respect to the supervision of a federally-registered PRPP, the Superintendent shall exercise the powers of a supervisory authority of a province as set out in and in accordance with this Agreement.
- (2) The Superintendent shall determine any matter or question related to supervision and related to the exercise of its powers pursuant to this Agreement.
- (3) A decision that is made by the Superintendent under the authority of this Agreement and that relates to the application of a provincial PRPP Act that determines a matter addressed in Schedule C or in subsection 11(4) is deemed to be a decision of the supervisory authority of the applicable province and is not subject to judicial review under the Federal Courts Act (R.S.C., (1985) c. F-7), but instead is subject to the processes for review and appeal under the laws of that province.
PART V APPLICABLE LAW
Application of the Federal PRPP Act
10. Subject to section 11, the provisions of the federal PRPP Act apply to a federally-registered PRPP, including in respect of all members, and their spouses or common law partners, survivors and other beneficiaries (or the equivalent in the respective jurisdiction), its administrator, the Superintendent, and the employer offering the PRPP, instead of the provisions of a provincial PRPP Act in respect of corresponding matters that would otherwise apply if this Agreement did not exist.
Exceptions
- 11. (1) The following legislation applies in respect of a member of a federally-registered PRPP, and their spouse, common law partner, survivor or other beneficiary (or the equivalent in the respective jurisdiction), in relation to a matter referred to in Schedule C or addressed under subsection (4):
- (a) subject to paragraph (b), the provincial PRPP Act of the province in which the member is employed or self-employed or, if the member is not currently employed or self-employed, was last employed or self-employed and contributed to that PRPP, or
- (b) the federal PRPP Act if the member
- (i) is employed in included employment as defined in the federal PRPP Act with an employer that participates or participated in that PRPP or, if the member is not currently employed, was last so employed and contributed to that PRPP; or
- (ii) is employed or self-employed or, if the member is not currently employed or self-employed, where he or she was last so employed or self-employed and a member of that PRPP in Yukon, the Northwest Territories or Nunavut, and contributed to that PRPP.
- (2) For the purposes of this section, “last employed” or “last self-employed” refers only to employment or self-employment in jurisdictions bound by this Part.
- (3) Where legislation referred to in subsection (1) applies in respect of amounts in a member's account, it applies in relation to the entire balance of the member's account.
- (4) For greater certainty, the provisions of a provincial PRPP Act in relation to which there are no corresponding matters addressed under the federal PRPP Act apply notwithstanding anything in this Part.
- 12. The provisions of the federal PRPP Act are adapted to the extent necessary to give effect to this Part.
- 13. For greater certainty, this Agreement does not apply to provisions of the federal PRPP Act or a provincial PRPP Act regarding authorities and requirements for entering into this Agreement, amending it, or adding parties to it as well as provisions regarding the effect of the Agreement.
PART VI RELATIONS BETWEEN PARTIES AND SUPERVISORY AUTHORITIES
Requests for assistance
- 14. (1) Each supervisory authority shall:
- (a) upon request of another supervisory authority, assist each other in any matter concerning the exercise of powers or responsibilities under this Agreement as is reasonable in the circumstances;
- (b) upon request of another supervisory authority, provide any information that it is able to regarding amendments to legislation that have been tabled and regulations that have been filed or published, to the extent that such amendments affect the application of this Agreement;
- (c) seek an amicable resolution to any dispute that arises between them with respect to the interpretation of this Agreement.
- (2) Where a decision of the Superintendent is being subjected to a review or appeal process under the laws of a province as provided for under subsection 9(3), the Superintendent shall, upon request, provide to the supervisory authority of the province the record that was before the Superintendent in making that decision.
Survival
15. Following the termination of this agreement or following the withdrawal of a party, section 14 shall survive only for the purposes of responding to pending requests.
Information on policy developments
16. Subject to any rules concerning Cabinet confidences and solicitor-client privilege, and any other confidentiality rule applicable to a party, each party shall provide to each other on a timely basis relevant information on policy developments in relation to the federal PRPP Act, a provincial PRPP Act, or the VRSP Act as applicable.
PART VII EXECUTION, AMENDMENTS TO, WITHDRAWAL FROM AND COMING INTO FORCE OF AGREEMENT
Effective Date
17. This Agreement comes into force:
- (a) on June 15, 2016, in respect of each party that signed this Agreement on or before that date; and
- (b) after June 15, 2016, in respect of any other province that wishes to become a party, on the date unanimously agreed to by all parties.
Additional Parties
18. A province may become a party:
- i) with the unanimous consent of the parties; and
- ii) if the province has executed a signature page that is substantially similar to those that form part of this Agreement, and has provided copies of that page to all parties.
Effects
19. This Agreement shall be to the benefit of and be binding upon the parties and the supervisory authorities, as of the date referred to, as the case may be, in clause (a) or (b) of section 17.
Withdrawal from Agreement
- 20. (1) A party may withdraw from the Agreement by giving at least 12 months' written notice to all the other parties to the Agreement and to the administrators of federally-registered PRPPs affected by the withdrawal. Upon expiry of the period indicated in the notification, the withdrawing party shall cease to be a party to the Agreement.
- (2) Despite subsection (1), Canada shall provide written notice to all other parties at least 18 months prior to withdrawal.
- (3) Once a party has notified the other parties that it intends to withdraw from the Agreement, but before the withdrawal takes effect, that party's supervisory authority shall work with any other supervisory authorities that would be affected to facilitate the transfer of supervisory responsibilities in respect of PRPPs affected by the withdrawal.
- (4) If a withdrawing party, other than Canada, has notified the other parties that it intends to withdraw from this Agreement, the Superintendent shall, in a reasonable time and subject to any legislative restrictions, provide to that party's supervisory authority copies of documents relating to the affected PRPPs that have been filed with the Superintendent pursuant to the federal PRPP Act by the plan administrator that are necessary for the continued supervision of those PRPPs and shall inform the supervisory authority of any administrative decisions taken by the Superintendent concerning the affected PRPPs.
- (5) If Canada has notified the other parties that it intends to withdraw from this Agreement, the Agreement shall be terminated at the end of the period referred to in subsection (2).
Amendments
- 21. (1) This Agreement may be amended with the unanimous written consent of the parties.
- (2) Despite subsection (1), the portions of Schedule A or B applicable to a specific party is amended at the initiative of that party.
- (3) Notice of an amendment to Schedule A or B shall be provided to all other parties.
Execution in Counterparts
22. This Agreement and any amendment to this Agreement may be executed in counterparts.
Execution in English and French
23. This Agreement and any amendment to this Agreement shall be executed in both English and French, each text being equally authoritative.
SCHEDULE A
Provincial PRPP Acts
British Columbia
Pooled Registered Pension Plans Act, S.B.C. 2014, c. 17
Nova Scotia
Pooled Registered Pension Plans Act, S.N.S. 2014, c. 37
Saskatchewan
The Pooled Registered Pension Plans (Saskatchewan) Act, S.S. 2013, c.P-16.101
SCHEDULE B
Requirements to be met under the VRSP Act for the AMF to Issue a VRSP Licence to the Holder of a Federal PRPP Licence
In order to obtain a licence to act as administrator pursuant to the VRSP Act, a corporation must:
- (a) be an insurer holding a life insurance class licence issued under the Act respecting insurance (chapter A-32) in conformity with the Regulation under the Act respecting insurance (chapter A-32, r. 1), a trust company holding a licence issued under the Act respecting trust companies and savings companies (chapter S-29.01) or an investment fund manager registered in accordance with Title V of the Securities Act (chapter V-1.1);
- (b) complete and file the Application form for Authorization to Act as Administrator of a VRSP;
- (c) be incorporated under a jurisdiction other than the province of Quebec;
- (d) pay the required fees to the AMF in accordance with the Regulation respecting fees and costs payable for the issuance of an authorization under the VRSP Act;
- (e) provide the following information in accordance with the Regulation respecting applications for authorization and liability insurance coverage for administrators of voluntary retirement savings plans (R-17.0.1, r. 1):
- (i) a confirmation that the amount by which the assets of the corporation exceed its liabilities is at least equal to the amount determined by regulation, or an irrevocable letter of credit or a suretyship, which letter or suretyship is in an amount determined by regulation and is issued by a financial institution licensed as an insurer, trust company or deposit institution under an Act of Canada or of a Canadian province or territory;
- (ii) a confirmation that the corporation holds liability insurance in accordance with the requirements determined by regulation;
- (f) provide a five-year business plan dealing with the proposed development of activities related to the voluntary retirement savings plan and showing how the corporation intends to comply with the conditions and obligations applicable under the VRSP Act; and
- (g) ensure representatives distributing VRSPs hold a valid licence or registration for the financial product they are providing (insurance or securities).
SCHEDULE C
Matters for the Purposes of Subsection 11(1)
For the purposes of subsection 11(1), a matter is any of the following:
- (a) provisions relating to the definition of spouse, former spouse, common-law partner and survivor (or the equivalent in the respective jurisdiction);
- (b) the locking-in, withdrawal, and surrender of funds from a member's PRPP account;
- (c) rules respecting variable payments, including the election of a member to receive variable payments from his or her PRPP account, and the annual variable payment amount;
- (d) the transfer, payment or surrender of funds or entitlement to funds in a member's account on the death of that member;
- (e) the transfer of funds from a member's PRPP account to a pension plan, retirement savings plan, locked-in account or life annuity or other similar product, as well as the rules applicable to these products, including the rules applicable to the transfer of funds from these products;
- (f) rules regarding agreements or arrangements to transfer, charge, anticipate, assign, give as security or surrender any rights or interests in:
- (i) funds in a PRPP account; and
- (ii) funds transferred from a PRPP account.
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Canada
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Ottawa,
The 10 day of June, 2016.
The Honourable William Francis Morneau
Minister of Finance
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For British Columbia
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Victoria,
The 9th day of June, 2016.
The Honourable Michael de Jong
Minister of Finance
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Nova Scotia
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Halifax,
The 7 day of June, 2016.
The Honourable Randy Delorey
Minister of Finance and Treasury Board
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
IN WITNESS WHEREOF, the undersigned, being duly authorized, agree to be bound by Parts I, with the exception of subsections 2(6) and (7), II, VI and VII of the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Québec,
The 15th day of June, 2016.
For the government of Quebec
The Honourable Carlos Leitão
Minister of Finance
The Honourable Jean-Marc Fournier
Minister responsible for Canadian Relations and the Canadian Francophonie
For the Autorité des marchés financiers
Louis Morrisset
President and Chief Executive Officer
MULTILATERAL AGREEMENT RESPECTING POOLED REGISTERED PENSION PLANS AND VOLUNTARY RETIREMENT SAVINGS PLANS
For Saskatchewan
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Signed at Regina,
The 26 day of, May 2016.
The Honourable Gordon Wyant
Minister of Justice and Attorney General
ANNEX 2
Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans, as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans
For Ontario
Ontario hereby agrees to become a party to the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans;
IN WITNESS WHEREOF, the undersigned, being duly authorized, has signed the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans as amended by the 2017 Agreement Amending the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Effective March 31, 2017.
Signed at Toronto,
The 9th day of January, 2017.
The Honourable Charles Sousa
Minister of Finance
EXPLANATORY NOTE
Proposal
Pursuant to subsection 6(1) of the Pooled Registered Pension Plans Act (PRPP Act), this Order authorizes the Minister of Finance to enter into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans with Ontario.
Objective
To enable the Government of Ontario to join the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans.
Background
The federal PRPP Act applies to pooled registered pension plans (PRPPs) that are linked to employment that falls under federal jurisdiction. Areas of employment that fall under federal jurisdiction include work in connection with navigation and shipping, banking, inter-provincial transportation and communications, and work in the Yukon, Northwest Territories or Nunavut.
PRPPs are a new, accessible, large-scale and low-cost pension option for employers, employees and the self-employed. A PRPP is administered by a corporation that holds a PRPP administrator licence. The Office of the Superintendent of Financial Institutions (OSFI) is responsible for supervising PRPPs offered to areas of employment under federal jurisdiction.
Self-employed individuals and employers in provincially regulated sectors may also join a PRPP if their respective province has PRPP legislation in place. British Columbia, Alberta, Saskatchewan, Ontario and Nova Scotia have passed PRPP legislation. Quebec has passed similar legislation called the Voluntary Retirement Savings Plans Act (VRSP). Provincial pension supervisors would normally supervise the aspects of multi-jurisdictional PRPPs that relate to members in provincially regulated employment areas. In order to streamline the supervision of PRPPs, the federal PRPP Act allows the Minister of Finance to enter into a multilateral agreement with provinces that have passed similar legislation.
Effective June 15, 2016, the Minister of Finance entered into the Multilateral Agreement Respecting Pooled Registered Pension Plans and Voluntary Retirement Savings Plans (the Agreement) with British Columbia, Saskatchewan, Quebec and Nova Scotia. Ontario's PRPP legislation is now in force, and regulatory amendments to the Pooled Registered Pension Plans Regulations have been made to designate Ontario as a province with whom the Minister can enter into the Agreement.
Implications
The Agreement helps make an attractive new retirement savings option available to those millions of Canadians — roughly 60% — who do not have access to a workplace pension plan. Additional provinces, such as Ontario, who join the Agreement, will facilitate the creation of large PRPPs with members across multiple jurisdictions, thereby increasing the number of Canadians with workplace pension plans and generating economies of scale and reducing costs.
In addition to amendments to the Agreement to include Ontario, the Agreement has also been amended to clarify that it doesn't dictate which jurisdiction's legislation would apply to the valuation or division of funds in a PRPP member's account on the breakdown of a spousal or common-law relationship and to make minor edits to the text.
Consultation
In December 2010, Canada's finance ministers agreed on a framework for PRPPs to provide Canadians with a new, low-cost, efficiently managed, portable and accessible savings vehicle that will help them meet their retirement objectives. The federal PRPP legislative framework was therefore developed in consultation with the provinces. The governments of British Columbia, Alberta, Saskatchewan, Ontario, Quebec and Nova Scotia have been involved in the drafting of the Agreement.
On June 25, 2016, the Agreement was published in the Canada Gazette, Part I, and was tabled in Parliament on August 17, 2016. The current signatory provinces have been consulted and unanimously support Ontario entering the Agreement. OSFI has also been consulted and supports the proposal.
Contact
Lisa Pezzack
Director
Financial Systems Division
Department of Finance Canada
90 Elgin Street, 13th Floor
Ottawa, Ontario
K1A 0G5
Email: Lisa.Pezzack@canada.ca
[2-1-o]
DEPARTMENT OF INDUSTRY
BOARDS OF TRADE ACT
North Battleford Chamber of Commerce
Notice is hereby given that His Excellency the Governor General in Council, by Order in Council dated December 2, 2016, has been pleased to change the name of the North Battleford Chamber of Commerce to the Battlefords Chamber of Commerce and to change its boundaries to City of North Battleford, Town of Battleford, Rural Municipality of Battle River # 438, Rural Municipality of North Battleford # 437 and Rural Municipality of Meota # 468, in Saskatchewan, upon petition made therefor under sections 4 and 39 of the Boards of Trade Act.
December 20, 2016
Virginie Ethier
Director
For the Minister of Industry
[2-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following person of the New Westminster Police Department as a fingerprint examiner:
David Stengert
Ottawa, December 20, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[2-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:
- Lisa Fitzgerald
- Ron Simms
- James Smith
Ottawa, December 20, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[2-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Saskatoon Police Service as fingerprint examiners:
- Bryon Sommacal
- Leslie van den Beuken
Ottawa, December 20, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[2-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Royal Newfoundland Constabulary as fingerprint examiners:
- Mitchell Rumbolt
- John Turpin
Ottawa, December 20, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[2-1-o]
DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS
CRIMINAL CODE
Revocation of designation as fingerprint examiner
Pursuant to subsection 667(5) of the Criminal Code, I hereby revoke the designation of the following persons of the Windsor Police Service as fingerprint examiners:
- Tracey Bloomfield
- Douglas Cowper
- Scott D. Robinson
Ottawa, December 20, 2016
Kathy Thompson
Assistant Deputy Minister
Community Safety and Countering Crime Branch
[2-1-o]
(Erratum)
GLOBAL AFFAIRS CANADA
Consultations on the fifth review of the Record of Discussion on Trade in Pharmaceutical Products
Notice is hereby given that the email address of the point of contact for questions or comments regarding Canadian tariffs in the French version of the notice bearing the above-mentioned title published in the Canada Gazette, Part I, Vol. 150, No. 52, dated Saturday, December 24, 2016, contained an error on page 4164, and should have read as follows:
fin.tariff-tarif.fin@canada.ca
[2-1-o]
PRIVY COUNCIL OFFICE
Appointment opportunities
We know that our country is stronger — and our government more effective — when decision-makers reflect Canada's diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.
The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.
Current opportunities
The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).
| Position | Organization | Closing date |
|---|---|---|
| Chairperson | Canadian Centre on Substance Abuse | January 16, 2017 |
| Director | Canadian Centre on Substance Abuse | January 16, 2017 |
| Members | Canadian Institutes of Health Research | January 16, 2017 |
| Chairperson | Canadian Museum for Human Rights | January 23, 2017 |
| Chairperson | Canadian Museum of History | January 23, 2017 |
| Vice-Chairperson | Canadian Museum of History | January 23, 2017 |
| Chairperson | Canadian Museum of Immigration at Pier 21 | January 23, 2017 |
| Chairperson | Canadian Museum of Nature | January 23, 2017 |
| Permanent Members | Canadian Nuclear Safety Commission | January 29, 2017 |
| Chairperson | Great Lakes Pilotage Authority Canada | February 19, 2017 |
| Clerk of the House of Commons | House of Commons | February 26, 2017 |
| Chief Science Advisor | Innovation, Science and Economic Development Canada | January 27, 2017 |
| Directors | The Jacques Cartier and Champlain Bridges Incorporated | February 3, 2017 |
| Chairperson | Laurentian Pilotage Authority Canada | February 5, 2017 |
| Directors | Marine Atlantic Inc. | January 22, 2017 |
| Members | National Film Board | January 15, 2017 |
| Chairperson | National Gallery of Canada | January 23, 2017 |
| Vice-Chairperson | National Gallery of Canada | January 23, 2017 |
| Director of Public Prosecutions | Office of the Director of Public Prosecutions | January 22, 2017 |
| Executive Vice-Chairperson and Member | Parole Board of Canada | February 5, 2017 |
| Chairperson | Payment in Lieu of Taxes Dispute Advisory Panel | January 15, 2017 |
| Members | Payment in Lieu of Taxes Dispute Advisory Panel | January 15, 2017 |
| Chief Public Health Officer | Public Health Agency of Canada | February 12, 2017 |
| Directors | Royal Canadian Mint | January 29, 2017 |
| Member | Telefilm Canada | January 15, 2017 |
| Directors | VIA Rail Canada Inc. | January 29, 2017 |
Upcoming opportunities
| Position | Organization |
|---|---|
| President (Chief Executive Officer) | Atomic Energy of Canada Limited |
| Commissioner for Workers | Canada Employment Insurance Commission |
| Chairperson | Canada Foundation for Innovation |
| President | Canadian Centre for Occupational Health and Safety |
| Chairperson | Canadian International Trade Tribunal |
| Directors | Canadian Race Relations Foundation |
| Citizenship Judges | Citizenship Commission |
| Directors | Farm Credit Canada |
| Directors | First Nations Financial Management Board |
| Sergeant-at-Arms | House of Commons |
| Members | National Arts Centre Corporation |
| Chairperson | National Battlefields Commission |
| Commissioner | National Battlefields Commission |
| Full-time Member | National Energy Board |
| Procurement Ombudsman | Office of the Procurement Ombudsman |
| Chairperson | Patented Medicine Prices Review Board |
| Member | Patented Medicine Prices Review Board |
| Chairperson and Member | Standards Council of Canada |
Ongoing opportunities
| Position | Organization |
|---|---|
| Full-time and Part-time Members | Immigration and Refugee Board |
| Members — All regional divisions (full-time positions and part-time positions) | Parole Board of Canada |
| Full-time and Part-time Members (Appeal Division) | Social Security Tribunal |
| Full-time and Part-time Members (General Division — Employment Insurance Section) | Social Security Tribunal |
| Full-time and Part-time Members (General Division — Income Security Section) | Social Security Tribunal |
[2-1-o]
- Footnote 1
Environment Canada and Health Canada. 2015. Review of current Significant New Activity Orders and Notices (http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/index-eng.php). - Footnote 2
The policy on the use of SNAc provisions is available at http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=5CA18D66-1. - Footnote 3
Significant New Activity Notice No. 13712: http://gazette.gc.ca/rp-pr/p1/2005/2005-06-18/pdf/g1-13925.pdf. - Footnote 4
The full text of the CCPSA is available at this address: http://laws-lois.justice.gc.ca/eng/acts/C-1.68/FullText.html. - Footnote 5
The full text of the New Substances Notification Regulations (Chemicals and Polymers) is available at this address: http://laws-lois.justice.gc.ca/eng/regulations/SOR-2005-247/FullText.html. - Footnote 6
The Guidelines for the Notification and Testing of New Substances (Chemicals and Polymers) are available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&xml=FA59945E-8DD5-D745-8A55-EA6667737FE5. - Footnote 7
A comprehensive listing of substances that are subject to SNAc provisions is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=0F76206A-1. - Footnote 8
Formerly Material Safety Data Sheet (MSDS). Please refer to the Regulations amending the New Substances Notification Regulations (Chemicals and Polymers) and the Export of Substances on the Export Control List Regulations for reference to this amendment (http://gazette.gc.ca/rp-pr/p2/2015/2015-02-11/html/sor-dors19-eng.php). - Footnote 9
The Substances Management Advisory Note Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999 is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=CC526AE6-1. - Footnote 10
The Substances Management Information Line can be contacted at eccc.substances.eccc@canada.ca (email), 1-800-567-1999 (toll-free in Canada), and 819-938-3232 (outside of Canada). - Footnote 11
The Compliance and Enforcement Policy is available at https://www.ec.gc.ca/alef-ewe/default.asp?lang=en&n=AF0C5063-1. - Footnote 12
This Annex is provided for information purposes only. In the event of a discrepancy between this document and the CCPSA, the CCPSA shall prevail. - Footnote 13
List of substances in the Consumer Product SNAc Review Group: http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/group-eng.php#a2. - Footnote 14
The Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers is available at http://publications.gc.ca/site/eng/280464/publication.html. - Footnote 15
This Annex is provided for information purposes only. In the event of a discrepancy between this document and the CCPSA, the CCPSA shall prevail. - Footnote 16
CAS RN: Chemical Abstracts Service Registry Number. The Chemical Abstracts Service Registry Number is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society. - Footnote 17
The Confidential Accession Numbers are used to identify substances listed on the confidential portion of the Domestic Substances List (DSL). - Footnote 18
The Federal Business Number is a nine-digit registration number issued by the Canada Revenue Agency (CRA) to Canadian businesses that register for one or more of the following: corporate income tax; importer/exporter account number; payroll (source) deductions (trust accounts); or goods and services tax. This number can be found on all forms issued to a business by the CRA. The first nine digits that appear on these forms is the Federal Business Number. - Footnote 19
A list of six-digit North American Industry Classification System (NAICS) codes is available at the following Statistics Canada website: http://www23.statcan.gc.ca/imdb/p3VD.pl?Function=getVDPage1&db=imdb&dis=2&adm=8&TVD=118464. Note that this address is case sensitive. - Footnote a
SOR/94-311 - Footnote b
S.C. 1999, c. 33 - Footnote c
Order 2012-87-06-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Pigment Red 3: http://www.gazette.gc.ca/rp-pr/p2/2012/2012-10-10/pdf/g2-14621.pdf. - Footnote d
Order 2013-87-08-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to n-BGE and MK: http://canadagazette.gc.ca/rp-pr/p2/2013/2013-08-28/pdf/g2-14718.pdf. - Footnote e
Order 2013-87-11-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-nitropropane, DTBSBP and MAPBAP acetate: http://www.gazette.gc.ca/rp-pr/p2/2014/2014-01-15/pdf/g2-14802.pdf. - Footnote f
Order 2014-87-01-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Methyl eugenol, TGOPE and potassium bromate: http://www.gazette.gc.ca/rp-pr/p2/2014/2014-03-12/pdf/g2-14806.pdf. - Footnote g
Order 2013-87-01-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to dimethyl sulfate, diethyl sulfate, and TCEP: http://www. gazette.gc.ca/rp-pr/p2/2013/2013-01-30/pdf/g2-14703.pdf. - Footnote h
Order 2012-87-06-02 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to phenoxymethyl oxirane: http://www.gazette.gc.ca/rp-pr/p2/2013/2013-05-22/pdf/g2-14711.pdf. - Footnote i
Order 2010-87-03-03 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Solvent Blue 4: http://gazette.gc.ca/rp-pr/p2/2010/2010-03-31/pdf/g2-14407.pdf. - Footnote j
Order 2011-87-04-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to Phenyl-D4 and MDnM-hydride: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-09-14/pdf/g2-14519.pdf. - Footnote k
Order 2010-87-05-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-EEA: http://gazette.gc.ca/rp-pr/p2/2010/2010-11-10/pdf/g2-14423.pdf. - Footnote l
Order 2010-87-07-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to FAZ: http://gazette.gc.ca/rp-pr/p2/2010/2010-08-18/pdf/g2-14417.pdf. - Footnote m
Order 2012-87-07-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to thiourea and epichlorohydrin: http://www.gazette.gc.ca/rp-pr/p2/2012/2012-07-18/pdf/g2-14615.pdf. - Footnote n
Order 2011-87-12-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to methyloxirane, ethyloxirane, and hydroquinone: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-12-21/pdf/g2-14526.pdf. - Footnote o
Order 2013-87-05-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to benzyl chloride: http://www.gazette.gc.ca/rp-pr/p2/2013/2013-05-08/pdf/g2-14710.pdf. - Footnote p
Order 2007-87-09-01 Amending the Domestic Substances List to apply the Significant New Activity provisions of CEPA 1999 to 2-Pyrrolidinone, 1-(2-hydroxyethyl)-: http://gazette.gc.ca/rp-pr/p2/2007/2007-01-10/pdf/g2-14101.pdf. - Footnote q
Environment Canada and Health Canada. 2015. Review of current Significant New Activity Orders and Notices (http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/snac-nac/index-eng.php). - Footnote r
The Policy on the Use of Significant New Activity Provisions of the Canadian Environmental Protection Act, 1999 is available at http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=5CA18D66-1. - Footnote s
The SNAN risk assessment summaries for existing substances is available at http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=725CDE50-1. - Footnote t
The full text of the New Substances Notification Regulations (Chemicals and Polymers) is available at this address: http://laws-lois.justice.gc.ca/eng/regulations/SOR-2005-247/FullText.html. - Footnote u
The full text of the Canada Consumer Product Safety Act is available at http://laws-lois.justice.gc.ca/eng/acts/c-1.68/. - Footnote v
A comprehensive listing of substances that are subject to SNAc provisions is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=0F76206A-1. - Footnote w
Formerly Material Safety Data Sheet (MSDS). Please refer to the Regulations Amending the New Substances Notification Regulations (Chemicals and Polymers) and the Export of Substances on the Export Control List Regulations for reference to this amendment (http://gazette.gc.ca/rp-pr/p2/2015/2015-02-11/html/sor-dors19-eng.php). - Footnote x
The advisory note “Clarification in relation to the submission of Significant New Activity Notifications in application of the Canadian Environmental Protection Act, 1999” is available at http://www.ec.gc.ca/subsnouvelles-newsubs/default.asp?lang=En&n=CC526AE6-1. - Footnote y
The Substances Management Information Line can be contacted at eccc.substances.eccc@canada.ca (email), 1-800-567-1999 (toll-free in Canada), or 819-938-3232 (outside of Canada). - Footnote z
The Compliance and Enforcement Policy is available at https://www.ec.gc.ca/alef-ewe/default.asp?lang=en&n=AF0C5063-1.